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Abstract
Membrane proteins function as gates and checkpoints that control the transit of
molecules and information across the lipid bilayer. Understanding their structures
will provide mechanistic insights in how to keep cells healthy and defend against
disease. However, experimental difficulties have slowed the progress of structure
determination. Previous work has demonstrated the promise of computational mod-
eling for elucidating membrane protein structures. A remaining challenge is to model
proteins coupled with the heterogeneous cell membrane environment. In the first half
of this dissertation, I detail the development, testing and integration of a biologically
realistic implicit lipid bilayer model in Rosetta. First, I describe the initial iteration
of the implicit model that captures the anisotropic structure, shape of water-filled
pores, and nanoscale dimensions of membranes with different lipid compositions.
Second, I explain my approach to energy function benchmarking and optimization
given the challenge of sparse and low-quality experimental data. Third, I outline the
second generation that incorporates a new electrostatics and pH model. All of these
developments have advanced the accuracy of Rosetta membrane protein structure
prediction and design. In the second half of this dissertation, I investigate three
challenging biological and engineering applications involving membrane proteins.
In the first application, I examine mutation-induced stability changes in the integral
ii
membrane zinc metalloprotease ZMPSTE24: a protein with a large voluminous cham-
ber that is not captured by current implicit models. In the second application, I model
interactions between the SERCA2a calcium pump and the regulatory transmembrane
protein phospholamban: a key membrane protein-protein interaction implicated
in the heart’s response to adrenaline. Finally, I explore the challenge of membrane
protein design to engineer a self-assembling transmembrane protein pore for nan-
otechnology applications. These applications highlight the next steps required to
improve computational membrane protein modeling tools. Taken together, my work
in both methods development and applications has advanced our understanding and
ability to model and design membrane protein structures.
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1.1 Overview
In a common analogy, "A cell is like a fortified city where lipid membranes form the defensive
walls and membrane proteins function as gates and checkpoints that control the transit of
molecules and information across these walls" [1]. Membrane proteins are critically
important: they constitute 30% of all proteins [2] and are targets for over 50% of
pharmaceuticals on the market [3]. Understanding membrane protein structure and
function is essential to keep cells healthy and defend against disease. However, the
"defensive walls" present many challenges for wet lab experiments, resulting in a
scarcity of experimental information [4].
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Computational methods are promising for elucidating membrane protein struc-
tures. Over the past decade, computational tools have predicted structures with a
resolution as low as 2.0 Å and enabled the design of membrane proteins with new
functions for therapeutic and nanotechnology applications [5]. These methods cap-
ture the protein fold; yet, a remaining challenge is to capture the heterogeneous lipid
environment that influences both the structure and function of resident proteins. This
challenge is further complicated by the fact that the membrane lipid composition
is diverse and varies across different cell types, organelles, and species [6]. In this
dissertation, I focus on developing and applying computational tools with novel lipid
bilayer representations for membrane protein structure prediction and design.
1.2 Structural properties of membrane proteins
Membrane proteins share basic properties with proteins in the cytoplasm or extra-
cellular space, herein referred to as "soluble proteins." Both membrane and soluble
proteins are folded polymers composed from the twenty canonical amino acids. These
polymer chains fold into α-helices, β-sheets, and loops that further assemble into ter-
tiary and quaternary structures. Their cores are stabilized by non-polar interactions,
except in the case of pore-forming proteins [7]. Further, amino acid side chains pack
in similar configurations [8].
Membrane proteins associate with the lipid bilayer in various ways. Some mem-
brane proteins can be anchored to the cytosolic surface by an amphipathic α-helix.
An example of the membrane anchored protein annexin is shown in (Figure 1.1a).
Alternatively, most transmembrane proteins extend across the bilayer as a bundle
of α-helices or a rolled-up β sheet (a β-barrel) [9]. Most open reading frames in the
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human genome encode for α-helical proteins that are predominantly found in the
plasma membrane [10]. An example of the multi-pass membrane protein bacteri-
orhodopsin is shown in (Fig. 1.1b) [11]. In contrast, β-barrel proteins are found in
the outer membrane of gram-negative bacteria, mitochondria, and chloroplasts. An
example of the β-barrel protein lysozyme OmpF is shown in (Fig. 1.1c) [12].
Figure 1.1: Proteins associated with the lipid bilayer anchor to the surface or extend
through the bilayer. (a) The protein Annexin V (PDB: 1A8A) associates with the bilayer
surface. (b) Bacteriorhodopsin (PDB: 1PY6) is an example of the α-helical fold. (c) Outer
membrane protein F (PDB: 3POQ) is an example of a β-barrel fold.
Additionally, membrane proteins occupy precise orientations in the lipid bilayer,
controlled in part by the hydrophobicity of transmembrane domains and the position
of cytosolic domains. This position is defined by three degrees of freedom: the
distance between the protein center and bilayer center d, the rotation of the protein
relative to the membrane normal, α, and the procession of the protein around the
normal axis τ. Characterizing membrane protein orientation provides a key first
glance to how membrane protein structures are coupled with the structure of the lipid
bilayer.
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1.3 Biophysical properties of lipid membranes
Biological membranes are mainly composed of phospholipids that self-assemble
to form a bilayer [13]. Each phospholipid molecule has a hydrophilic head-group
and two hydrophobic acyl tails. The membrane also includes non-bilayer lipids
such as cholesterol and non-structural lipids for signaling. When assembled, the
bilayer can be described as three phases: (1) a hydrocarbon core of lipid tails, (2) an
interfacial region of head-groups, and (3) the surrounding cytosol or extracellular
space (Fig. 1.2). The lipid composition of biological membranes varies greatly across
cell types, organelles, and species [6].
Figure 1.2: Membrane proteins reside in a bilayer with diverse lipid composition. (A)
Biological membranes are mainly composed of phospholipids that self-assemble to form a
bilayer. Each phospholipid molecule has a hydrophilic head-group and two hydrophobic acyl
tails. Thus, the bilayer can be described by three phases: (1) a hydrocarbon core of lipid tails,
(2) an interfacial region of head-groups, and (3) a layer of aqueous solvent. (B) Phospholipid
molecules can vary significantly in their chemical composition, specifically in the head-group
type, length of the hydrocarbon tails, and the degrees of saturation in the hydrocarbon tails.
Shown are three different head-groups: choline (DLPC), ethanol-amine (DLPE), and glycerol
(DLPG). Membranes also contain cholesterol (CHOL) which are part of the sterol class of
lipids.
In 1972, Singer and Nicholson proposed the fluid mosaic model of cell membrane
organization [14]. This model describes biological membranes as a phospholipid
bilayer with a "mosaic" of embedded proteins and carbohydrates. Nearly 50 years
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later, this model has persisted with a few key modifications. First, the bilayer con-
tains up to 60% protein by mass [15] in contrast to prior thinking that the bilayer is
mostly lipids [16]. Second, biological membranes include hundreds of different lipid
types, mixed non-uniformly near a miscibility critical point [17]. In fact, cells invest
significant resources into generating thousands of different lipids, many of which
populate the bilayer [18, 19]. Further, the bilayer can separate into different phases
at physiological conditions [20]. For instance, cholesterol rafts form that alter the
rigidity of the bilayer [21].
The biochemically diverse lipid composition gives rise to physical properties that
influence membrane protein function. Hydrocarbon chain length tunes the hydropho-
bic thickness of the bilayer. Hydrophobic thickness is an important variable because
proteins will re-orient themselves to maximize contact between the hydrophobic sur-
face of the protein and bilayer [22, 23]. The footprint of a phospholipid is influenced
by the size and shape of the head group [24]. For instance, a choline head group
results in a cylindrical footprint whereas a smaller or larger head group results in
a conical footprint. This difference in shape can give rise to bilayer curvature [25].
Properties of the membrane are also influenced by the environment. For example,
osmotic pressure on the bilayer surface cause the bilayer to expand and contract, a
key mechanism for the function of mechano-sensitive channels [26].
1.4 Approaches to membrane protein structure determination
Determining membrane protein structures at high-resolution is critical to under-
standing their function and role in disease. Historically, membrane protein structure
determination has been ridden with challenges. Even though the first soluble protein
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structures were solved in 1960 [27, 28] the first membrane protein structure was not
resolved at atomic resolution until 25 years later [29]. Many of the challenges persist,
as membrane protein structures constitute only 2% of the protein databank [30]. As
an encouraging sign of progress, 80% of these structures have been determined in the
last decade (Fig. 1.3).
Figure 1.3: Growth in unique membrane proteins of known structure between 1985-
present. Each bar represents the cumulative number of unique structures known in a given
year. The light purple bar represents the cumulative number of structures in 2020 as of April
10th, 2020.
Currently, there are three main approaches to membrane protein structure deter-
mination: (1) X-ray crystallography, (2) Nuclear magnetic resonance (NMR) Spec-
troscopy, and (3) Cryo-electron microscopy. Each method is discussed below.
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1.4.1 X-Ray Crystallography
X-Ray crystallography is a powerful tool for macromolecular structure determination
and has been highly successful for soluble proteins. To determine a structure, X-
Rays are diffracted from a crystal, which has an ordered and regularly repeating
arrangement of atoms. Then, the diffraction pattern is used to reconstruct the electron
density of the macromolecule [31]. With membrane proteins, a critical challenge
for this technique is amassing a large quantity of stable protein in crystals. This
step is complicated by the fact that few membrane proteins are naturally abundant
[32]. Further, several membrane proteins cannot be solubilized in detergents because
they will aggregate and/or denature. This is especially true for membrane proteins
in higher eukaryotes. Despite these challenges, X-Ray crystallography has been
the dominant tool for membrane protein structure determination. In particular, the
technique has been applied to G-protein coupled receptors, which account for a large
fraction of membrane protein drug targets [33, 34].
1.4.2 Nuclear Magnetic Resonance (NMR) Spectroscopy
NMR spectroscopy provides an alternate route to membrane protein structure de-
termination. The technique uses the magnetic spin properties of atomic nuclei in a
molecule to identify atoms that are close in space, either because they are bonded or
because folds in a protein chain bring them together [35]. A unique benefit of NMR
is that it can accommodate a wide variety of membrane mimetics including soluble
detergent micelles, detergent-free lipid bilayer membranes, and native cell envelope
preparations [36]. This permissively is in stark contrast to X-ray crystallography and
cryo-EM (discussed below), which require non-lipid amphiphiles such as detergents
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or amphiphilic polymers [37]. NMR is adept at determining intrinsically disordered
regions of membrane proteins [38]. Further, NMR is sensitive enough to capture weak
ligand binding, enabling the detection of structure-activity correlations for binding
events or conformational changes [39]. Importantly, NMR still imposes the same
limitation as X-ray crystallography of requiring a highly concentrated sample.
1.4.3 Cryo-Electron Microscopy
Cryo-electron microscopy (Cryo-EM) uses a transmission electron microscope (TEM)
to examine macromolecular structures. A beam of electrons passes through a sample
embedded in a thin layer of vitreous ice, projecting an image of the sample onto
a detector. The electron micrographs are then averaged to reveal a structure [40].
In 1975, the first membrane protein structure was determined at helix-resolving
resolution in a native lipid bilayer with this technique [41]. Once limited by resolution,
improvements to detector accuracy have elevated Cryo-EM as a leading method
[42]. Today, Cryo-EM is beneficial for membrane proteins because it requires less
sample. As a result, we have accessed several milestone structures including the
Sec61 translocon [43], TRPV1 [44], and a glutamate receptor [45]. There are still two
limits to Cryo-EM: proteins must be biochemically well-behaved and over 100 kDa
[46].
1.5 Computational membrane models
Computational protein structure prediction and design tools provide a promising
route to improving our understanding of membrane protein structure and function.
An extensive review of membrane protein modeling methods has recently written
by Koehler Leman et al. [5]. There are two key steps in computational modeling: (1)
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sampling possible conformations and (2) scoring sampled conformations to identify
near-native conformations. Many of the sampling techniques developed for soluble
proteins are also applicable to membrane proteins. The central challenge is devising
energy functions that capture the heterogeneous lipid environment.
Over the past 20 years, the field has developed a collection of methods to model
the lipid bilayer. The most popular approach is an explicit model that represents
molecules directly (Fig. 1.4a). All-atom models are the most detailed methods and
represent every atom in the system, whereas coarse-grained methods map atoms
onto representative beads to capture properties of chemical groups. Explicit mod-
els can provide detailed representations of different lipid compositions. However,
calculations with explicit lipid bilayers are computationally expensive.
Alternatively, implicit models represent the membrane as a continuum that dif-
ferentiates between the aqueous, interfacial, and hydrophobic phases (Fig. 1.4b). In
exchange for a more approximate bilayer representation, implicit models offer a
50-100 fold sampling speedup [47]. The most detailed implicit model is the Poisson-
Boltzmann (PB) equation that relates electrostatic potential to dielectric properties of
the solute through a second-order partial differential equation [48]. However, the PB
model is too expensive for long biomolecular simulations. There are several alterna-
tives to the PB model including a Generalized Born (GB) model, an empirical implicit
model, and a knowledge-based model. All of these approaches provide tradeoffs
and will be discussed in further detail throughout this dissertation. Importantly, the
choice of model has significant implications on membrane protein modeling results.
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Figure 1.4: Computational explicit and implicit approaches to modeling the heteroge-
neous lipid bilayer.]. (a) Explicit membrane models represent every atom in the biomolecular
system and rely on molecular mechanics to capture atomic interactions. All-atom models (left)
represent every atom in the system whereas coarse-grained models (right) map 4-6 atoms
onto to beads that represent various chemical groups. (B) Implicit membrane models repre-
sent the heterogeneous lipid environment as a continuous medium with variable properties.
From left-to-right, the four most common approaches are the Poisson-Boltzmann model, the
Generalized-Born approximation of the Poisson-Boltzmann model, empirical implicit models
and knowledge-based models.
1.6 Macromolecular modeling with Rosetta
The Rosetta macromolecular modeling suite was originally developed for ab initio
protein folding [49, 50]. Since its inception, Rosetta has evolved into an integrated
toolkit for biomolecular structure prediction and design [51] that can be applied
to wide ranging tasks such as docking [52] and design [53, 54] as well as systems
such as sugars [55] and RNA [56]. Rosetta follows the premise that the observed
conformations of folded proteins are almost always the low free-energy states [57, 58].
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Therefore, structure prediction is the problem of finding the lowest-energy structure
given the sequence of a protein. Design is often posed as the problem of finding the
lowest-energy sequence given a target structure [59]. To tackle both problems, Rosetta
relies on a diverse library of scoring and sampling modules.
1.6.1 Sampling
Rosetta accomplishes sampling through a Monte Carlo plus minimization scheme.
In this setup, the system degrees of freedom are perturbed, energy minimized, and
then changes are accepted or rejected according to the Metropolis criteria: given
that A = min(1, exp(∆E/kBT)), where ∆E is the change in energy, T is temperature,
and kB is Boltzmann’s constant, accept if A ≥ U(0, 1) where U(0, 1) is a random
number between zero and one (inclusive); otherwise reject the changes. Rosetta
samples macromolecular degrees of freedom as internal coordinates (ϕ,ψ,ω) rather
than Cartesian coordinates (x,y,z). Bond lengths and angles can be sampled but are
usually kept fixed. Sampling relevant conformations is a stochastic process: meaning
that the program is run many times and an ensemble of models is required to identify
a solution.
1.6.2 Scoring
Energy functions are based on Anfinsen’s hypothesis that native-like protein con-
formations represent unique, low-energy, thermodynamically stable conformations.
These folded states reside in minima on the energy landscape, and they have a net
favorable change in Gibbs free energy of each biomolecule conformation, which is
the sum of contributions from both enthalpy (∆H) and entropy (-T∆S) relative to the
unfolded state. To follow this heuristic, Rosetta uses a mathematical model that can
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discriminate between unfolded, folded, and native-like conformations. This function
is a weighted linear combination of terms that compute energies Ei as a function of




The energy terms include a combination of classical molecular mechanics terms,
empirically-derived terms, and knowledge-based terms derived from structures in
the Protein Databank. The weights on each term were determined through a Nelder-
Mead optimization scheme [60]. The energy terms are as follows: van der Waals
attractive energy, Pauli-Exclusion repulsive energy, Gaussian exclusion Lazaridis-
Karplus implicit solvation energy (EEF1), Coulomb electrostatics energy, geometry
of hydrogen and disulfide bonds, rotamer probabilities, backbone-dependent amino
acid probabilities and propensities, amino acid reference energies, and empirical
penalties to enforce the ω peptide angle, planarity of the tyrosine hydroxyl χ angle,
and proper torsions in the proline ring. Each term is reviewed extensively in Alford
et al. [61].
1.6.3 Accounting for the lipid bilayer
Rosetta had two pioneering membrane protein modeling applications: RosettaMem-
brane ab initio and relax. The RosettaMembrane ab initio protocol was one of the first
methods for ab initio structure prediction of membrane proteins. It combines the ab
initio structure prediction protocol for soluble proteins [49] with a low-resolution
score function derived from a database of structures of membrane proteins [62]. This
method was later updated to include a high-resolution refinement stage [63] that
12
uses an all-atom score function based on the Lazaridis implicit Gaussian-exclusion
solvation model (IMM1) for atoms in the membrane [64].
Since the creation of the RosettaMembrane ab initio protocol in 2006, Rosetta has
been reorganized into a set of object-oriented libraries (“Rosetta3”) [51] while Roset-
taMembrane remained in its original implementation. Rosetta3 is now a cohesive,
flexible software suite that includes separate objects for conformation and scoring, in-
teraction graphs, score functions organized by multi-body dependencies, kinematics
managed through a fold tree, maps to identify flexible portions of the molecule(s), job
distribution, and scripting interfaces. To leverage this flexible platform for membrane
proteins, we developed RosettaMP.
As an undergraduate, I developed RosettaMP with my mentor Dr. Julia Koehler
Leman [65]. The framework has central building blocks to represent the membrane
bilayer, and to sample and score both conformations and sequences. An overview of
the architecture of RosettaMP is shown in Fig 1.5. Initially, the methods were tested
with four proof-of-concept applications: (1) prediction of free energy changes upon
mutation, (2) high-resolution structural refinement, (3) protein—protein docking, and
(4) assembly of symmetric complexes, all in the membrane bilayer. The protocols
can be accessed via command line, PyRosetta [66], and RosettaScripts [67], with
various levels of customizability for both developers and users. Collectively, the
applications demonstrate how RosettaMP and existing Rosetta protocols can be
combined to quickly create powerful new methods to answer a broad range of
scientific questions. Importantly, RosettaMP also provided a platform to identify the
next scientific challenges, many of which I address in my thesis.
13
Figure 1.5: Detailed architecture of RosettaMP. RosettaMP represents the membrane bilayer
using three main components connected to a central MembraneInfo object (blue). Mem-
braneInfo stores information needed to represent the membrane (line arrows) and tracks
information present in the Pose (dotted arrows). A special Residue type is added to the Pose,
describing the geometry of the membrane bilayer by coordinates storing the center, normal
and thickness of the bilayer. A SpanningTopology object describes the transmembrane regions
of the Pose. The FoldTree uses a jump edge to establish the connection between the membrane
residue and the protein.
1.7 Dissertation Outline
This dissertation is presented in two parts. The first three chapters describe the devel-
opment of computational tools for biologically-realistic membrane protein modeling.
In Chapter 2, I describe a new biologically-realistic implicit membrane energy func-
tion. The chapter details the theory of the energy function, evaluation, and design
anecdotes. In Chapter 3, I describe my approach to evaluating implicit membrane
energy functions with multiple scientific benchmark tests. In Chapter 4, I describe
the next round of energy function improvements: accounting for electrostatics and
pH changes in the membrane environment. The remaining thee chapters describe the
application of computational modeling to biological systems involving membrane
proteins. In Chapter 5, I investigate the effects of mutations linked to pre-mature
aging diseases on stability of the integral membrane zinc metalloprotease. In Chap-
ter 6, I apply membrane protein-protein docking to explore the interaction between
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the SERCA2a calcium pump and phospholamban in cardiac muscle cells. Then, in
Chapter 7 I describe the application of the new membrane protein tools to the design
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membrane model for protein
structure prediction and design
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2.1 Overview
Protein design is a powerful tool for elucidating mechanisms of function and engi-
neering new therapeutics and nanotechnologies. While soluble protein design has
advanced, membrane protein design remains challenging due to difficulties in model-
ing the lipid bilayer. In this work, we developed an implicit approach that captures
the anisotropic structure, shape of water-filled pores, and nanoscale dimensions of
membranes with different lipid compositions. The model improves performance
in computational benchmarks against experimental targets including prediction of
protein orientations in the bilayer, ∆∆G calculations, native structure discrimination,
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and native sequence recovery. When applied to de novo protein design, this approach
designs sequences with an amino acid distribution near the native amino acid distribu-
tion in membrane proteins, overcoming a critical flaw in previous membrane models
that were prone to generating leucine-rich designs. Further, the proteins designed in
the new membrane model exhibit native-like features including interfacial aromatic
side chains, hydrophobic lengths compatible with bilayer thickness, and polar pores.
Our method advances high-resolution membrane protein structure prediction and
design toward tackling key biological questions and engineering challenges.
2.2 Introduction
Membrane proteins partner with the surrounding lipid environment to perform
essential life processes. They constitute 30% of all proteins [68] and are targets for
over 60% of pharmaceuticals [3]. However, experimental difficulties have limited
our insights into their molecular mechanisms of function. Protein design tools are
powerful for elucidating biological mechanisms and developing new therapeutics.
Over the past 20 years, soluble protein design has advanced to atomic level accuracy
[54]. A remaining challenge is to create robust tools for membrane proteins [69].
There have been several achievements in membrane protein design including a zinc-
transporting tetramer Rocker [70], an ion-conducting protein based on the Escherichia
coli Wza transporter [71], β-barrel pores with increased selectivity [72], receptors with
new ligand-binding properties [73, 74], and designed de novo α-helical bundles that
insert into the membrane [75]. A critical limitation is capturing the heterogeneous
membrane environment: models are either too computationally expensive or severely
approximate the bilayer. In fact, has been common for membrane protein structure
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prediction and design to be carried out in a 30Å hydrophobic slab. A slab is a poor
proxy for the heterogeneous membranes found in biology with varying lipid compo-
sition across different organelles, cell types, and species. To apply membrane protein
design to addressing biological questions, tools must sample a realistic distribution
of amino acids tied with the diverse lipid composition.
The foundation of computational modeling and design tools is the energy function:
a mathematical model of the physical rules that distinguish native from non-native
membrane protein conformations and sequences. Currently, most computational
studies of membrane proteins are molecular dynamics simulations with an all-atom
lipid bilayer. In this conception, the lipid molecules are represented explicitly using
force fields such as AMBER[76], CHARMM [77], or GROMOS [78], and the protein-
lipid interactions are scored with a molecular mechanics energy function. All-atom
models are attractive because they can feature hundreds of lipid types toward ap-
proximating the composition of biological membranes. With current technology,
detailed all-atom models can be used to explore membrane dynamics for hundreds
of nanoseconds [79]: the time scale required to achieve equilibrated properties on
a bilayer with approximately 250 lipids [80]. Coarse-grained representations such
as MARTINI [81] and SIRAH [82] reduce computation time by mapping atoms onto
representative beads. As a result, simulations have explored dynamics up to the
millisecond time scale to access features of membrane organization and large protein
domain motions [83].
Implicit solvent models enable simulations to reach longer timescales required
to investigate biologically-relevant conformational and sequence changes. Instead
of using explicit molecules, implicit methods represent the solvent as a continuous
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medium [84, 85], resulting in a 50-100-fold sampling speedup [86]. The most detailed
implicit model is the Poisson-Boltzmann (PB) equation, which relates electrostatic
potential to dielectric properties of the solvent and solute through a second-order
partial differential equation [87]. Numerical solvers have enabled PB calculations on
biomolecular systems [88]; however, these calculations do not scale well. To reduce
computational cost, the Generalized Born (GB) approximation of the PB equation
treats atoms as charged spheres [89]. GB methods represent the low-dielectric mem-
brane through various treatments ranging from a simple switching function [90] to
heterogeneous dielectric approaches [91]. However, evaluating the GB formalism is
still computationally expensive.
A popular approach to overcoming the computational cost of solvent electrostatics
models is the Lazaridis implicit membrane model (IMM1; [64]): a Gaussian solvent-
exclusion model that uses experimentally measured transfer energies of side-chain
analogues in organic solvents to emulate amino acid preferences in the bilayer [92].
IMM1 has been applied to various biomolecular modeling problems including studies
of antimicrobial peptides [93], de novo folding [63], and de novo design of transmem-
brane helical bundles [75]. However, organic solvent slabs differ from phospholipid
bilayers because lipids are thermodynamically constrained to a bilayer configuration,
resulting in a unique polarity gradient that influences side chain preferences [94,
95]. An alternative is to directly calculate amino acid preferences by deriving statis-
tical potentials from a database of known membrane protein structures [62, 96–98].
Yet, statistical potentials do not capture varying physiochemical properties of the
membrane.
In this work, we developed a biologically realistic implicit membrane model for
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protein structure prediction and design. We first developed the model from experi-
mental and computational modeling of phospholipid bilayers to capture biologically-
important membrane features. Next, we tested the model on four benchmarks: (1)
prediction of protein orientations in the membrane, (2) ∆∆G of mutation calculations,
(3) native structure discrimination and (4) native sequence recovery. We applied
the model to protein design and investigated properties of the in silico designed
membrane proteins including the amino acid composition. Finally, we share several
design anecdotes that exhibit native-like membrane protein features including in-
terfacial aromatic side chains, hydrophobic lengths compatible with different lipid
compositions, and polar pores.
2.3 Methods
2.3.1 Development of the implicit membrane model
2.3.1.1 Derivation of ∆Gatomw,l values
The Moon & Fleming hydrophobicity scale provides a set of water-to-bilayer transfer
energies ∆Gaaw,l for the 20 canonical amino acids [99] measured in the reversibly folding
OmpLA scaffold. Note, the default ionization state for Histidine in Rosetta is neutral
and Glu and Asp are protonated because the Moon & Fleming scale was measured at
pH 3.8. We used regression to derive energies that correspond to atom types (Table
S5), called ∆Gatomw,l . Specifically, least-squares fitting was applied solve the equation
Ax = b; where, A is a matrix of atom type stoichiometric coefficients (Table S6), b is
the vector of ∆Gaaw,l values, and x is the desired vector of ∆G
atom
w,l values. Matrix rows
for glycine, alanine, and proline were excluded to avoid over fitting. The resulting
∆Gatomw,l values are in Table S7.
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2.3.1.2 Molecular dynamics simulations of phospholipid bilayers
All-atom molecular dynamics simulations were performed to extract properties
of membranes with different phospholipid compositions. We simulated phospho-
lipid bilayers with hydrocarbon tails between 12-18 carbons long and either a phos-
phatidylethanolamine (PE), phosphatidylcholine (PC) or phosphatidylglycerol (PG)
head group (Table S1). The exceptions were DPPC and DMPG because the liquid-
to-gel phase transition temperatures are above physiological temperature [100, 101].
CHARMM-GUI [102] was used to configure each bilayer system with 75 lipids in each
leaflet, 22.5Å of water on each side, and 0.1 M NaCl. Simulations were performed
using the NAMD molecular dynamics engine [103] at a constant pressure of 1 atm
and a temperature of 37°C. We used the CHARMM36 [77] force field for lipid and the
TIP3 model for water. The simulations were equilibrated with restraints according to
the procedure outlined by Jo et al. [102]. Then, each system was simulated for 50 ns.
2.3.1.3 Derivation of water density profiles
MDAnalysis [104] was used to extract water density information from each bilayer
simulation. For each frame, the system was first re-centered on the lipid center-of-
mass. Then, we computed a normalized histogram of TIP3 z-coordinates with 1Å
bins to capture the distribution of water molecules. The histogram was recentered
at z = 0 by fitting the histogram to a cosine function to estimate the midpoint. The
time-averaged histogram was computed by averaging the histograms representing
each frame (Fig. S9).
To generate analytic profiles, we used nonlinear regression to fit each histogram
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to the logistic function, fthk:
fthk =
1
1 + τexp(−κz) . (2.1)
The function fthk depends on membrane depth (z) and has two adjustable parame-
ters: steepness κ and width τ. We derived κ and τ for all simulated lipid compositions.
The resulting parameters are in Table S2 and the analytic water density profiles are in
Fig. S10.
2.3.1.4 Calculation of water-filled pore shapes
For proteins with more than three transmembrane segments, we introduced a pore
into the implicit membrane model. To determine the pore shape, we created a new
method to transform discrete structural information into a smooth geometry described
by differentiable functional forms. First, we used the convex-hull algorithm described
in Koehler Leman et al [105] to identify backbone and side chain atoms that are in
the transmembrane region (|z| ≤ T), face the protein interior, and are not buried.
A side-chain was defined as buried if it had 23 or more neighboring atoms within
12 Å of its Cα atom [106]. Next, we computed a histogram of the z-coordinates of
pore facing atoms with a bin size of 13 T. For each bin, the (x, y) coordinates of the
atoms were collected. Then, the Khachiyan algorithm [107] was used to compute the
minimum-area ellipse that bounds these coordinates. Each ellipse is defined with
the following parameters: major radius (a), minor radius (b), rotation angle (θ), and
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Cubic spline interpolation was used to fit polynomials to describe the depth-
dependence of each parameter. The result is five continuous and differentiable
parametric functions: a(z), b(z),θ(z), x0(z), and y0(z). The transition between the
water-filled pore and lipid phase is defined by gradius given the transition steepness n:




2.3.2 Validation of model parameters
2.3.2.1 ∆Gatomw,l values
To verify ∆Gatomw,l values, we first recalculated the side chain transfer energies by
solving Ax = b. The Pearson correlation coefficient between the calculated and
experimentally measured side chain transfer energies was R2 = 0.99 (Fig. S13).
In addition, we used the procedure outlined in the Scientific Benchmarks section of
Methods to estimate the ∆∆Gmut values from Moon & Fleming [99]. Specifically, we
sought to verify that ∆Gaaw,l trends were preserved in context of the full energy function.
The correlation between predicted and experimentally measured ∆∆Gmut values was
R2 = 0.84 (Fig. S11) and the residuals are listed in Table S8. Note, the ∆∆Gmut for




We validated the water-density profiles computed from Molecular Dynamics by
comparing the derived membrane thickness parameters with thickness measured
at various temperatures via x-ray and neutron scattering experiments [108]. First,
we computed the membrane half thickness t from each logistic curve as the Gibbs
dividing surface between the water and lipid phases ( f (z) = 0.5). We then calculated
a line of best fit through the measured thickness values at each temperature (Fig. S14).
2.4 Results
2.4.1 Biologically realistic realistic implicit membrane model
We developed a biologically realistic implicit membrane model inspired by Lazaridis’
implicit model (IMM1; [64]). Similar to IMM1, the membrane is modeled as a contin-
uum of three phases: an isotropic phase representing bulk lipids, an isotropic phase
representing bulk water, and an anisotropic phase representing the interfacial region.
To accurately model the polarity gradient and dimensions of native membranes, we
derived new equations and parameters from biophysical measurements. The result
is a new energy term called ∆Gmemb that computes protein stability given the water-









(1 − fhyd)(∆Gatomw,l (a)). (2.5)
The parameter ∆Gatomw,l captures the thermodynamics of protein-lipid interactions.
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We derived ∆Gatomw,l from the Moon & Fleming side-chain hydrophobicity scale [99] be-
cause the energies were measured in bilayers with phospholipids, a major component
of biological membranes [6]. Further, we chose this scale because the measurements
capture the stability of the final folded protein relative to the fully hydrated, unfolded
state. Side-chain burial vs. solvent exposure is accounted for through neighbor count
calculations in the Rosetta energy functions. Then, following Lazaridis’ formalism
[109], the function fhyd captures the three-dimensional shape of the implicit mem-
brane as a dimensionless number that describes the phase given the position of an
atomic group. When an atomic group is exposed to the lipid phase, fhyd = 0; whereas
when an atomic group is exposed to the water phase, fhyd = 1.0. The transition
between the two isotropic phases is modeled by a composition of two functions: fthk
captures the membrane thickness and fpore captures the geometry of a water-exposed
pore:
fhyd = fthk + fpore − fthk fpore. (2.6)
The function fthk (Eq. 2.1, see Methods) models the transition between the wa-
ter and lipid phase along the z-axis, and is thus an implicit representation of the
hydrophobic thickness. We developed parameters for fthk by fitting to molecular
dynamics simulations and scattering density profiles of phospholipid bilayers. The
result is a logistic curve that depends on two parameters. We derived parameters
for thirteen phospholipid bilayer compositions (Table S1-2, see SI Appendix). The
membrane thickness can be derived by setting fthk = 0.5 (Fig. 2.1A-B). Thus, the user
can perform simulations with any of these thirteen different phospholipid composi-
tions, or in principle, with any mix of membrane components by using a molecular
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Figure 2.1: Features of the biologically realistic implicit membrane model. The implicit
membrane is modeled as three phases: two isotropic phases for water and lipid and a
transition region that represents the interfacial head groups. (A) The transition between
phases in the z-dimension is modeled by a logistic curve which can be parameterized for
different lipid compositions. Example curves for DLPC (solid, black) and POPC (dot-dash,
black) are shown in comparison to the sigmoid curve used in IMM1 (dashed, gray). (B)
Implicit solvent phases for the Ammonium transporter Amt-1 (PDB 2b2f) in the z-dimension.
The water phase is shown in blue, the interface is in teal, and the lipid is in gray. (C) The
transition between phases due to an elliptical pore is modeled by a sigmoid curve. (D) Top
view of implicit solvent phases due to a pore in Amt-1 with the same coloring scheme as B.
The three panels of (E) demonstrate the variation in pore shape (purple) for different cross
sections in the x, y plane along the z-axis.
The function fpore defines the shape of a water-exposed pore (Fig. 2.1C-E). Previ-
ously, Lazaridis developed a cylindrical model of pores for β-barrel proteins [109].
This geometric assumption is straightforward for β-barrel proteins; however, α-helical
protein pores require varied geometric descriptors such as cones, cylinders, and el-
lipses [110]. To accommodate, we created a model that approximates pores as an
elliptical tube with varying cross sections. This parameterization allows the model to
describe cavities that do not penetrate through the membrane and pores that constrict,
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expand, or twist relative to z. The energy function accounts for the pore by first
calculating a relative radius, gradius (Eqs. 2.2 and 7.1, see Methods). The transition
between the two phases is modeled by a sigmoid curve fpore (Eq. 7.2, see Methods)
with two parameters: gradius and the transition steepness n (default n = 10). Addi-
tional examples for larger proteins with multiple pores and proteins with ellipsoidal
architecture are shown in Supplemental Fig. 12.
We integrated our model into the current all-atom energy function for model-
ing soluble proteins in Rosetta, called REF15 [61]. REF15 computes macromolecu-
lar energies through a linear combination of terms for van der Waals, solvation,
electrostatics, hydrogen bonding, backbone- and side-chain interactions. To ac-
count for the membrane environment, we added ∆Gmemb with an empirically deter-
mined weight of 0.5. The resulting energy function, called franklin2019, is given by
∆Efranklin2019 = ∆EREF15 + ∆Gmemb.
2.4.2 Computational benchmark performance of the biologically realistic
implicit membrane
We evaluated the accuracy of franklin2019 using four computational benchmark tests
against experimental targets. The tests were designed to evaluate an energy function’s
ability to replicate measured membrane protein stabilities and perform accurate
structure prediction and design. We compared the performance of franklin2019 to three
existing models: (1) an implicit membrane parameterized from the behavior of side-
chain analogues in organic solvents (M07; [63]), (2) a knowledge-based model that
captures depth-dependent amino acid preferences (M12; [111]), and (3) the Rosetta
all-atom energy function for soluble proteins (R15; [60, 61]). For brevity, we will refer
to franklin2019 as M19. We chose these models because the low computational cost
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enabled evaluation with structure prediction and design tests. Additional details
describing the benchmark tests and command lines are provided in the SI Appendix.
2.4.2.1 Test #1: Prediction of membrane protein orientation and insertion energy
Membrane proteins are thermodynamically stable in the bilayer due to a favorable
orientation and insertion energy. Therefore, implicit membrane energy functions must
accurately estimate these quantities. First, we evaluated the partitioning properties of
oligomeric proteins into the implicit membrane. Here, we chose to study oligomers
because the single-TM peptides may be marginally hydrophobic with insertion de-
pending on the sequence context. We performed calculations for the acetylcholine
receptor (pentamer, Fig. 2.2) and the influenza A M2 proton channel (tetramer, Fig.
S2). Remarkably, M19 was the only model to predict a favorable insertion energy
for both proteins. The mapping of peptide orientation to energies is shown for the
acetylcholine receptor in Fig. 2.2. The M07 energy landscape (Fig. 2.2C) has three
small, low energy wells, and they are isoenergetic with the water phase (since M07
was not parameterized for the water environment). This behavior is not physical.
In contrast, the lipid phase is more thermodynamically favorable than the water
phase for both M12 (Fig. 2.2D) and M19 (Fig. 2.2E). This result is quantified by a
favorable transfer energy from the water phase (G1) to the lipid phase (G3; Fig. 2.2F).
Ultimately, M19 is the most native-like because the model accurately captures the
aqueous reference state relative to the bilayer phase.
In addition, we predicted the tilt angle for five proteins with single transmembrane
spans: influenza A M2 (1mp6), acetylcholine receptor segment 2 (1a11), NR1 subunit
of the NMDA receptor (2nr1), VPU domain of HIV-1 (1pje) and WALP (WALP23).



























































































































































Figure 2.2: Prediction of membrane insertion and orientation for acetylcholine receptor.
(A) Sequence of the monomer and structures of both the monomer (PDB 1a11) and pentamer
(PDB 1eq8). (B) Important conformations given as a function of peptide depth (z) and tilt
angle (θ): G1 is the energy of the unfolded state in solution (z = 30, θ = 90°). G2 is the energy
of the folded state at the interface, parallel to the plane of the interface (z = 15, θ = 90°), G3 is
the energy of the peptide oriented vertically (z = 0, θ = 0°), and G4 is the energy of a peptide
buried in the membrane (z = 0, θ = 90°). The mapping of protein orientations to energies
calculated by the M07, M12, and M19 energy function respectively is shown in panels C-E for
the monomer and G-I for the pentamer. The partitioning energies between two lipid-buried
conformations (∆G4→3), from interface to lipid (∆G2→3) and from water to lipid (∆G1→3) are
shown in (F) for the monomer and (J) for the pentamer.
the sequences are less than 35% homologous and tilt angles have been measured by
solid-state NMR spectroscopy. We also included WALP because the sequence was
rationally designed [112]. The dependence of energy on orientation is shown in Fig.
2.2C-E for 1a11 and Fig. S2 and S3 for the remaining targets. The dependence of
energy on tilt angle is shown in Fig. S1 and the low energy tilt angles are listed in
Table S3. We found that M19 predicted tilt angles within ±10°of the experimentally
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measured value for four of the five peptides. Further, M19 predicted tilt angles
closest to the measured value in contrast to M07 and M12. Together, these results
demonstrate that M19 is both predictive for insertion and orientation.
2.4.2.2 Test #2: Predicting the ∆∆G of mutation
Predicting changes in protein stability upon single amino acid substitutions at lipid
exposed positions informs predictions of the effects of genetic mutations and de novo
protein design. We evaluated the ability of M19 to capture the change in protein
stability upon mutation, called ∆∆Gmut, by comparing experimentally measured
values with computational predictions. Here, we used a dataset of mutations at
position 111 on outer membrane palmitoyl transferase (PagP) [113]. The dataset
contains mutations from the host amino acid (alanine) to all 19 other canonical
amino acids. Therefore, the ∆∆G computed in this test represents side chain stability
relative to alanine. A summary of prediction accuracy relative to the experimentally
measured values is given in Fig. 2.3. The raw predicted values are also listed in Table
S4. Calculated energies are given in Rosetta Energy Units (REU).
The correlation between M19 predicted and experimentally measured ∆∆Gmut
values was R2 = 0.85. Note, the ∆∆Gmut for proline was excluded for all three
energy functions because steric clashes resulted in large values. While prediction
accuracy was improved relative to M12 (R2 = 0.77), accuracy was comparable to M07
(R2 = 0.84). We were surprised that M07 and M19 demonstrated similar predictive
ability. This is because a second set of measurements in OmpLA [99] correlates well
with PagP measurements but not with M07 predictions [65]. According to Marx et
al., the largest deviations were for side chains containing polar atoms. We therefore
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Figure 2.3: Comparison between computationally predicted and experimentally measured
∆∆Gmut for mutations in PagP. For all correlation plots (B-D), proline is not shown due to
steric clashes resulting in a large ∆∆Gmut value. The dotted gray line is the line of best fit and
the solid gray line is y = x. In addition, amino acids are colored according to the following
categories: charged (orange), nonpolar (red), aromatic (blue), polar (purple), special case
(green). (A) Structure of the PagP scaffold (PDB 3gp6) with the mutation site V111 highlighted
in dark grey. The implicit solvent phases in A are colored in a similar manner to Fig 2.1. The
∆∆Gmut predictions for mutations in PagP by M07, M12, and M19 are shown in panels B, C,
and D respectively.
correlations were 0.78, 0.58, and 0.94 for M07, M12, and M19 respectively. Note, this
is mainly due to Asp and Glu as the overall correlation coefficients without these side
chains are 0.90, 0.87, and 0.85 for M07, M12, and M19 respectively. Nonetheless, we
were encouraged by these results because they demonstrate the ability of our model
to capture the behavior of polar side chains in the bilayer.
We examined ∆∆Gmut predictions that deviate more than 1.5 REU from the mea-
sured value. For M19, this included predictions for G, T, V, Y, and L. To investigate,
we analyzed contributions of the component energies to the overall ∆∆Gmut (Fig.
S4-6). From the component energies, we found that glycine, threonine, and valine
had errors arising from over- or under-estimation of van der Waals energy. This
suggests double counting between the physics-based terms and the water-to-bilayer
energy that captures all of the enthalpic contributions to ∆∆Gmut. On the other hand,
tyrosine was predicted to be too favorable due to a large attractive van der Waals and
water-to-bilayer energy, also suggesting double counting. We were most surprised
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by the prediction of leucine as less favorable relative to alanine since it is typically
one of the most common side chains in the bilayer. This difference arises from a large
positive contribution from the two-body solvation term (fa_sol), a term we have not
yet refit for the membrane because of insufficient experimental data.
2.4.2.3 Test #3: Native structure discrimination
Identification of native-like structures in an ensemble of candidate structures is a key
function of biomolecular modeling energy functions. To evaluate native structure
discrimination, we refined ensembles of candidate structures generated by molec-
ular dynamics [114] and then computed the root-mean-squared-deviation (RMSD)
between the native crystal and the candidate models. We performed the analysis for
five targets: bacteriorhodopsin (Brd7), fumarate reductase (Fmr5), lactose permease
(LtpA), rhodopsin (RhoD), and V-ATPase (Vatp). To quantify decoy discrimination,
we computed the Boltzmann-weighted average RMS value, called WRMS, for all tar-
gets (Table 2.1, see SI Appendix for definition of WRMS). In addition, a mapping of
energy vs. RMSD for each target is shown in Fig. S7.
Table 2.1: Weighted RMSD of refined and rescored candidate models by each energy function
Target R15 (Å) M07 (Å) M12 (Å) M19 (Å)
Brd7 1.95 3.21 5.89 2.59
Fmr5 3.33 3.62 3.50 3.11
LtpA 2.25 1.65 1.69 2.20
RhoD 1.88 1.77 1.62 1.93
Vatp 1.38 1.52 1.36 1.55
Average 2.16 2.81 2.35 2.28
On average, all of the energy functions distinguished near-native from non-native
conformations up to 2.1-2.3 Å from the native crystal structure, except M12 which
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distinguished conformations at 2.8 Å from the native crystal structure. In addition,
for all targets except LtpA, all energy models score the native conformation as lower
energy than the decoy structures. Upon examination of individual targets, we also
found that no specific energy model was consistently better or worse.
We were surprised that the new implicit membrane model did not have an im-
pact on native structure discrimination. Further, R15 which does not consider the
membrane, was able to distinguish near-native from non-native decoys at similar
resolution. This result suggests while membrane environment energy terms are im-
portant, most of the high-resolution discrimination is driven by van der Waals and
side chain packing at high-resolution. This finding complements recent work by
Mravic et al. [115] that demonstrates side-chain packing is a key driver for stability.
2.4.2.4 Test #4: Native sequence recovery
A fourth test evaluates sequence recovery: the fraction of amino acids recovered
after performing complete redesign on naturally occurring proteins. High sequence
recovery has long been correlated with strong energy function performance for soluble
proteins [106]. We therefore performed this test in the context of our membrane
protein energy function. In this work, we used a test set of 133 α-helical and β-barrel
membrane proteins. The test set is a subset of the 222-member dataset from Koehler
Leman et al. [105] and was chosen because it is the largest possible subset of high-
resolution structures with diverse sequences, further filtered for proteins with known
host lipid compositions.
To perform redesign, we used a Monte Carlo fixed-backbone design protocol
which samples possible sequences using a full protein rotamer-and-sequence opti-
mization and a multi-cool annealer-simulated annealing protocol [116]. Each protein
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is initialized in the orientation computed from the Orientations of Proteins in Mem-
branes database [117] and the orientation is kept fixed during sequence search. Then,
we computed two metrics: (a) the fraction of all amino acids recovered and (b) the
fraction of amino acid types with individual recovery rates greater than 0.05, the same
probability of choosing an amino acid at random. Overall, 31.8% of the amino acids
designed by M19 were identical to the native amino acid (Fig. 2.4A). The soluble
protein energy function R15 recovered the second highest percentage of amino acid
positions at 29.9%. In contrast, the two existing implicit membrane models lagged
behind with M07 at 26.5% and M12 at 26.7%. The individual amino acid recovery
rates were also revealing. Here, M19 and R15 recovered all 20 amino acids at rates
above random; whereas M12 recovered 19 and M07 recovered 14.
To examine the influence of different solvent environments, we recomputed
sequence recovery over subsets of residues. First, we compared buried vs. solvent-
exposed side chains (Fig. 2.4B). For all energy functions, recovery was significantly
higher for buried side chains than solvent-exposed side chains, as noted in previous
studies due to higher packing density [106]. On the surface, M12 recovered 25% of
acid positions, slightly higher than the 22% recovery rate by M19. However, M19
recovered 16 amino acids at rates above random; whereas, M12 recovered only 12
amino acids. In essence, M19 gets the overall answer correct slightly less frequently;
however, it is better at getting more amino acid types correct.
Next, we examined sequence recovery differences between side chains facing the
water and lipid phases (Fig. 2.4C). In the lipid phase, all membrane energy functions
recovered nearly the same fraction of amino acids. The main differentiating feature is






























































































Figure 2.4: Properties of designed membrane protein sequences relative to their native
counterparts. Panels A-C rank the performance of each energy function by two metrics: the
fraction of all amino acids recovered on the y-axis and the fraction of amino acid types with
individual recovery rates greater than 0.05 on the x-axis. An accurate energy function would
have a high sequence recovery rate both overall and for the individual amino acid types. The
results are shown for all positions in panel (A), buried vs. surface-exposed positions in (B)
and water vs. lipid exposed positions in (C). Panel D shows the amino acid composition
of the native sequences in the benchmark set. Panels E-G show the Kullback-Leibler (KL)
divergence of the amino acid distribution of the designed proteins relative to the distribution
in native membrane proteins. The designs by M07, M12, and M19 are shown in panels
E, F, and G respectively. A positive value indicates that an amino acid is over-enriched,
whereas a negative value indicates that an amino acid is under-enriched. Values are given
on a logarithmic scale. An amino acid composition pie chart for sequence designed by each
candidate energy function is also shown in the bottom left hand corner of the divergence
plots.
M07 and M12 recovered four and five amino acids respectively, M19 recovered 14
amino acids. We observed a similar trend in the water phase. Here, M12 has the
highest overall sequence recovery rate of 27%, next to M19 with a recovery rate of
23%. However, M12 only recovered 10 amino acid types whereas M19 recovers 14.
These results reveal that early energy functions used a rudimentary design strategy:
prioritizing only some amino acid types. In contrast, M19 is capable of designing
more chemically diverse sequences.
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Looking ahead, there are many ways to expand this benchmark to provide more
insight. Here, we used a fixed-backbone design algorithm to generate new sequences.
An interesting future area is to use flexible-backbone design to enable a larger range of
possible sequences. This is an easy extension because the pore shape calculation plus
energy evaluation is efficient. In addition, we can compute sequence logos for each
design relative to homologous sequences. This provides insight into recovered posi-
tions that are also conserved. Thus, our sequence recovery test provides a foundation
for learning more about energy function features in the future.
2.4.2.5 Comparison with ref15_memb
While this work was in revision, another membrane energy function was published
by Weinstein et al. [118] (ref15_memb, R15M). This presented a good opportunity to
compare performance of franklin2019 with a more recent Rosetta model. We ran all
four benchmark tests and the results are reported in Supplementary Fig. S8. Overall,
M19 outperformed R15M on all tests. The largest discrepancy was performance on
the ∆∆G of mutation test, with R15M incorrectly predicting ∆∆G values for both
OmpLA and PagP. The predicted tilt angles were correct for only one of five targets.
The resolution of decoy discrimination was overall higher than for M19. Specifically,
for R15M, the weighted RMS values were 6.00, 7.22, 2.47, 3.26, and 2.99 for brd7,
fmr5, ltpa, rhod, and vatp respectively. Further, while both methods predicted a more
near-native distribution of amino acids during design, M19 outperformed in both KL
divergence and recovery metrics, especially for lipid facing residues.
We were surprised about the discrepancy between M19 and R15M because both
energy functions use the same foundation (R15) and the transfer energies in R15M
from the dSTβL assay [119] have been shown to correlate with the Moon & Fleming
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scale. We hypothesize that the main challenge is consideration of side chain exposure.
R15M does not account for lipid composition or pores and cavities. Further, the
method was predominantly benchmarked on docking and folding of single-span
dimers, whereas the benchmarks in this paper are larger and quantitatively more
diverse. Therefore, these results suggest that while R15M may be specialized for
single-TM dimers, M19 is capable of handling more complex membrane protein
topologies.
2.4.3 Designed membrane proteins exhibit native-like features
The sequence recovery experiment enables us to study properties of in silico designed
membrane proteins. These properties are crucial for demonstrating that the implicit
model has native membrane properties and is capable of facilitating realistic design
experiments. Below, we examine various sequence and structural features important
for membrane protein stability and function.
2.4.3.1 Amino acid distribution in designed proteins mirrors the native distribu-
tion
We examined the distribution of amino acids in design protein sequences relative
to their native counterparts. Specifically, we measured the Kullback-Leilber (DKL)
divergence (Eq. S2, see SI Appendix) on our membrane protein dataset. A negative
DKL value indicates that sequences are under-enriched in specific amino acid types;
whereas, a positive DKL value indicates that sequences are over-enriched. An ideal
KL value is zero. Remarkably, sequences designed by M19 are near-native with
DKL = −2.7. This is in stark contrast to sequences designed by M07 and M12 which
are strongly divergent from native membrane protein sequences, with DKL = −24.6
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and DKL = −26.6 respectively.
To learn more about the design implications of each energy function, we computed
the KL for each amino acid type (Fig. 2.4D-G) and compared to the composition of
amino acids in the native set. The M07 sequences are over-enriched in non-polar
amino acids and under-enriched in all other categories. The deficits are large with
under-enrichment values ranging from 10−2 to 10−4. The M12 sequences are less
skewed with the magnitude of under-enrichment deficits ranging between 10−1
and 10−2. However, there is still a large over-enrichment of non-polar amino acids
including I, L, and M, as well as W and T. In contrast, the distribution of amino
acids in M19 sequences is comparable to the native distribution, with the magnitude
of under- and over-enrichment values ranging between 101 and 10−1. Thus, M07
and M12 employ a rudimentary design strategy: only choosing non-polar amino
acids guaranteed to be compatible with the greasy membrane environment. The M19
model does not rely on this assumption and can design every amino acid type within
each phase. As a result, M19 designs proteins with an amino acid distribution that
is close to the native membrane protein sequence composition. We thus expect that
M19 will more accurately evaluate the effects of genetic mutations on protein stability.
Further, the diversified sequences will enable designed membrane proteins to achieve
a broader range of architectures and functions.
2.4.3.2 Three-dimensional membrane geometry enables design of polar pores
We were interested to see whether a three-dimensional implicit membrane shape
facilitates accurate protein design. To do so, we investigated the native and de-
signed sequence of the scaffold protein voltage-dependent anion channel 1 (VDAC1;
PDB 3emn; Fig. 2.5). The native sequence of this β-barrel protein pore is rich in
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charged amino acids. In the two-dimensional membranes used by M07 and M12, the
pore-facing residues are designed as if they are in the lipid phase; and as a result,
the designed sequences are rich in non-polar amino acids. In contrast, the three-
dimensional implicit membrane geometry treats pore-facing residues as exposed to
the water phase; thus, the designed sequence contains both polar and charged amino
acids. These positive features are reflected in the sequence for this specific target.
Here, M19 exhibits the highest recovery over all surface residues, lipid-facing, and
aqueous-facing residues when compared with other energy functions. This result













































































Figure 2.5: An in silico redesigned β-barrel membrane protein with a polar aqueous pore.
(A) Structure of the design scaffold protein voltage-dependent anion channel VDAC1 (PDB
3emn) from a lateral and top view. The horizontal black lines denote the approximate position
of the membrane. (B) Sequence composition and solvation properties of the pore redesigned
by the M07 (top right), M12 (bottom left), and M19 (bottom right) energy functions in contrast
to the native sequence (top left). The M07 and M12 treat the pore as lipid-exposed resulting
in a non polar sequence. In contrast, the M19 energy function calculates a custom pore shape
resulting in a polar pore sequence. (C) Recovery of the native 3EMN sequence upon redesign.
In contrast to other energy functions, the M19 recovers the most native sequence for the total
surface, lipid-exposed, and aqueous-solvated residues.
An unexpected result was that M19 outperformed R15 in the aqueous pore of
VDAC1. In fact, we expected the performance of R15 to match M19 because in the
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pore region, fhyd = 0. We hypothesize that the pore size and transition steepness
were underestimated and thus the calculation was influenced by M19. While it is
hard to draw a quantitative conclusion about the improved performance, we suggest
a future step of investigating the amino acid composition of a larger set of β-barrel
pores to understand the result.
2.4.3.3 Biologically-relevant lipid composition parameters improve per-target se-
quence recovery
Finally, we were eager to explore whether implicit membrane parameters for differ-
ent lipid compositions can improve design outcomes. This question is difficult to
evaluate because the host membrane composition of proteins is not always known.
At the same time, this question is crucial because of the long-standing criticism that
implicit membrane models do not accurately capture the properties of different lipid
membrane compositions. In this work, we investigated this question anecdotally by
examining two examples from our membrane protein design dataset.
First, we examined the β-barrel protein scaffold outer membrane transporter FecA
from Escherichia coli. The outer membranes of gram-negative bacteria are signifi-
cantly thinner than eukaryotic plasma membranes. We therefore hypothesized that
sequence recovery of lipid-facing residues in this protein would be higher in a thinner
membrane. To test this hypothesis, we again searched for low energy sequences in an
M19 membrane with either DLPC or POPC parameters. Encouragingly, the recovery
of lipid facing residues in this protein was 33% in DLPC in contrast to 28% in POPC.
We also repeated this test on the α-helical protein scaffold VCX1 calcium/proton ex-
changer from Saccharomyces cerevisiae. Here, we expected the reverse trend: improved
design in a POPC membrane over DLPC. Again, the design results followed: 22%
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sequence recovery in DLPC and 29% in POPC. These results demonstrate that lipid
composition parameters facilitate more biologically realistic structure prediction and
design.
In addition, there was an inevitable question that we wanted to ask about our
β-barrel protein scaffold. Experimental studies have long demonstrated that β-barrel
membrane proteins have high concentrations of aromatic side chains near the in-
terfacial head groups [120]. While the thermodynamics of this phenomena are not
completely understood, it is suggested that stacking of the aromatics nearby polar
head-groups stabilizes the protein [121]. Thus, we asked the questions: does M19 also
design aromatics near the anisotropic phase representing interfacial head groups? To
answer, we calculated the apparent membrane thickness according to the average
positions of aromatic side chains in native and designed FecA (Fig. 2.6). We found
that M19 designed with a larger apparent thickness in POPC rather than DLPC mem-
branes. Notably, the DLPC aromatic thickness is near the native aromatic thickness.
While still anecdotal, these results suggest that M19 designs proteins with native-like
features.
2.5 Discussion
In this work, we developed, implemented, and tested a new energy function for
membrane protein structure prediction and design. The energy function, called
franklin2019, uses an implicit approach to represent the anisotropic structure and
nanoscale dimensions of membranes with varied phospholipid composition, a key
component of biological membranes. Through computational benchmarking, we
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Figure 2.6: In silico redesigned β-barrel membrane proteins in native-like lipid composi-
tions. (A) Structure of the design scaffold Outer Membrane Transporter FecA (PDB 1kmo)
from Escherichia coli. The backbones redesigned by the M19 energy function with DLPC
and POPC parameters are shown in panels (B) and (C) respectively. The native scaffold is
colored in light grey and the design scaffolds are colored in dark grey. Aromatic amino acids
near the interface (>7 and < 25 from the center) are colored in light pink. The grey arrow
shows the bilayer thickness and the pink arrow shows the thickness according to the average
position of interfacial aromatic residues. The dotted lines denote the approximate position of
the bilayer. The thickness from the DLPC design best matches the native and results in the
highest recovery of lipid facing residues in the transmembrane region. DLPC is closest to the
thickness in E. coli.
and orientations. With multiple diverse benchmark sets, we demonstrated that
franklin2019 improves modeling and design of membrane proteins with complex
topologies, pores, and juxta-membrane domains. Further, proteins designed by
franklin2019 exhibit native-like features including amino acid distribution, aromatic
amino acids near interfacial head groups, and hydrophobic match with specific lipid
compositions. Together, these features demonstrate the potential of franklin2019 to
advance high-resolution membrane protein structure prediction and design.
Through the goal of developing a new energy function, our study interrogated
fundamental questions about the design rules for native membrane proteins. First,
the implicit model is based on transfer energies from a thermodynamic hydropho-
bicity scale measured in a phospholipid bilayer. The high sequence recovery rate
demonstrates the importance of thermostability and bulk phospholipid chemistry in
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constraining membrane protein sequences. Further, previous work relied on narrow
membrane protein design rules such as enrichment of leucine side-chains in the
hydrophobic core. We demonstrated that native membrane protein sequences are
diverse and not constrained to hydrophobic amino acids. Accordingly, our energy
function uses the full palette of amino acid chemistries during design.
This work was enabled by the Moon & Fleming [99] hydrophobicity scale. While
there has been extensive work to quantify transfer energies [122], the Moon & Flem-
ing scale captures the actual equilibrium change in free energy in the context of a
membrane protein in a phospholipid bilayer [123]. Thus, the implicit model captures
more biologically realistic context relative to prior models that approximated the
membrane as a slab of non-polar organic solvent. One consideration of using the
Moon & Fleming scale is that franklin2019 would not capture non-thermodynamic
(kinetic) end-states of ab initio folding where chaperones are required. For example, in
α-helical membrane protein folding, the intermediate states in the two-stage folding
process may not be captured [124]. However, because the goal of Rosetta calculations
is to capture the free energy minima, this does not impose limitations. Second, the
measurements were taken at pH 3.8. As a result, the energetics of Asp and Glu are
undervalued because the side chains are protonated. This may affect estimates of
transfer energies for soluble proteins and marginally hydrophobic proteins. Accu-
rately assigning the protonation states of Asp and Glu is an ongoing challenge due to
membrane-induced pKa shifts that alter the protonation equilibrium [125].
Next, we sought to develop a model that describes bilayers with different lipid
compositions. We were inspired by prior studies that added more detail to implicit
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"slab" models, including anionic lipid parameters [126] and adjustable bilayer thick-
ness [91]. In this work, we focused on single-component phospholipid bilayers for
two reasons: (1) there is significant SAXS and neutron scattering data available for
validation, and (2) many experiments are performed in single-component bilayers,
enabling easy comparison. We coined our model "biologically realistic" to highlight
the advance of using phospholipid models over prior organic slab models. Impor-
tantly, there are many future steps required to achieve a "biologically accurate" model.
First, native membranes include hundreds of lipid types, distributed non-uniformly
[6]. While all-atom models remain difficult, there has been excellent progress in
coarse-grained modeling of native lipid bilayers [127]. Thus, a possible step is to
develop model parameters from these coarse-grained models. Another important
step is to generate parameters for the asymmetric lipid composition to emulate the
outer membrane of gram-negative bacteria [128]. Additionally, the membrane bends
and curves to accommodate the hydrophobic surface of proteins [129]. A further
challenge is accounting for local properties such as specific protein interactions with
lipids and cholesterol, which may be captured by a hybrid implicit-explicit approach
such as SPadES [130] or HMMM [131]. Finally, an open question is how to account
for mechanical properties such as lateral pressure and strain due to local curvature.
In these scenarios, it is most likely that implicit membrane simulations will compli-
ment information from emerging membrane protein modeling tools and molecular
dynamics simulations to investigate structure, dynamics, and function.
Another important methodological step is modeling of membrane protein pores
and cavities. Previously, implicit models approximated pores as cylinders [109] or
segregated side chains using grid-based approaches [132]. In contrast, franklin2019
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uses continuous functions to model a wide range of pore geometries. We chose this
approach over solvent-accessible surface area calculations to reduce computational
cost, enabling scalability for more sophisticated molecular modeling applications
such as flexible backbone design. For future work, we aim to capture membrane
deformations [133] through the integration of continuum elastic models [24, 134] or
hybrid continuum-atomistic models [135]. Additionally, more work is needed to ac-
count for fenestrations that alter the solvent exposure of lipid accessible residues [48].
Ultimately, these features will advance franklin2019 from capturing static membrane
features to incorporate dynamics important for protein function.
We evaluated our implicit membrane model using sparse, high-resolution exper-
imental data. This approach contrasts soluble protein energy function evaluation,
where there is an abundance of thermodynamic and spectroscopic measurements
of small molecules [136] and high-resolution protein structures [137]. To overcome
the possibility of over-fitting, we limited the validation data to high-quality measure-
ments. For instance, we did not use crystal structures ≥ 3 Å resolution or ∆∆Gmut
values that were not measured in a reversible system. Further, we benchmarked our
energy function against both thermodynamic and structure prediction data. Previous
studies have evaluated membrane energy functions on a single test such as tilt angles
[47], native structure discrimination [114, 138], predicting hydrophobic lengths [132],
∆∆G prediction [139] and sequence recovery [140]. Simultaneously performing the
benchmarks enables a well-rounded evaluation of the energy function for diverse
biomolecular modeling tasks.
Looking ahead, a larger benchmark set will enable broader energy function devel-
opment and optimization. This work focused on developing a single empirical term
45
that captures water-to-bilayer transfer energetics that could be added to the existing
Rosetta energy function. Naturally, this introduces double-counting between the new
term and existing physics-based terms such as solvation and electrostatics. Previous
work on the soluble protein energy function used a Nelder-Mead optimization scheme
[60] to remove double counting. While there is currently insufficient data to apply
this approach, we envision that as more data emerges we will be able to apply more
robust fitting techniques including machine learning. Further, additional benchmark
data will enable adding membrane dependence to the solvation and electrostatic
terms, which will improve modeling of local side chain environments. Important
future requirements for a larger benchmark set include more diverse modeling tasks,
such as capturing multiple conformation states and diverse data sources such as
models from X-Ray Crystallography, Cryo-EM, and NMR spectroscopy.
An important remaining task is to compare the performance of franklin2019 with
the latest methods in other molecular modeling packages. Currently, there are several
technical hurdles: (1) alternate membrane representations are not implemented within
the Rosetta package and (2) other packages cannot generate all of the requisite data
for each benchmark (e.g., design is computationally expensive for classical molecular
dynamics packages). Notably, the latest energy functions for membrane protein
modeling use a wide-range of physical, empirical, and statistical models for energy
calculations. Therefore, direct comparison will provide important information to the
community about the best strategies for membrane protein structure prediction and
design.
In summary, we developed a biologically realistic energy function for membrane
protein structure prediction and design. The energy function is implemented within
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the Rosetta software and can be used for a wide range of macromolecular modeling
tools. By pursuing a balance of efficiency and accuracy, we anticipate that the implicit
membrane will enable high-throughput and high-resolution membrane protein struc-
ture prediction and design. Importantly, this model transforms once protein-centric
tools to techniques that can predict and design structures tied with varied biologically
relevant lipid compositions.
2.6 Appendix
2.6.1 Test #1 Methods: Prediction of transmembrane peptide orientation
Dataset curation. We computed energy landscapes for five transmembrane helical
peptides [47]: acetylcholine receptor segment (1a11), M2 proton channel segment
(1mp6) NMDA glutamate receptor (2nr1), VPU-forming domain of HIV-1 (1pje),
and WALP23. Coordinates for the first four peptides were downloaded from the
Protein Data Bank [141]. The structure of WALP23 was modeled as an ideal helix with
ϕ = −47°and ψ = −57°. For calculations with the new implicit membrane model, we
chose lipid composition parameters that were consistent with the lipid composition
used for the experimental measurement (Table 2.12).
Protocol Information.Low-free-energy peptide orientations were identified by
calculating an energy landscape: a mapping between all possible peptide orientations
relative to the membrane and their energies. Orientation was defined by two coordi-
nates: (1) distance between the membrane center and peptide center of mass, d and
(2) angle between the membrane normal and helical axis, θ. For the oligomeric forms
of the M2 proton channel and acetylcholine receptor, the helical axis was defined as
the average of the helical axis for each transmembrane segment.
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To compute the mapping, we first applied side-chain packing and minimization
to resolve steric clashes in the peptide structure. Then, we applied rigid-body moves
to sample all combinations of θ and d values. Membrane depths were sampled
between −60 Å and 60 Å with a 1 Å step size and tilt angles were sampled between
0° − 360° with a 1° step size. In addition, the water-to-bilayer transfer energy ∆Gw,l
was computed for each peptide as the difference in energy between the aqueous
phase (∆Gw: peptide at (60 Å,270 °)) and the lipid phase (∆Gl: peptide at (0 Å, 270°)):
∆Gw,l = ∆Gl − ∆Gw.
Detailed command lines. The MembraneEnergyLandscapeSampler samples and
scores all peptide orientations within the specified range of membrane depth values






























The protocol is deterministic and outputs a single file with a mapping between




-in:file:s 1a11.pdb # Input PDB File
-mp:setup:spanfiles 1a11.span # Input span file
-parser:protocol # Name of XML script file
sample_energy_landscape.xml
-parser:script_vars # Energy function to use
sfxn_weights=franklin2019
-mp:lipids:composition DLPC # Lipid composition (for f19)
2.6.2 Test #2 Methods: ∆∆Gmut predictions
Protocol information. ∆∆Gmut values were computed using the protocol described
in Alford et al. [65]. Here, a mutation is introduced at the host site and the side
chains are optimized within 8Å of the mutated residue. The ∆∆Gmut was calculated
as the difference in energy between the mutant (∆Gmutant) and native (∆Gnative) con-
formations: ∆∆Gmut = ∆Gmutant − ∆Gnative. ∆∆Gmut prediction was evaluated on
mutations in position 111 in outer membrane palmitoyl transferase (PagP; 3qd6) [113].
The dataset included mutations from the native amino acid to all 19 other canonical
amino acids. For calculations with the new implicit membrane model, parameters for
DLPC membranes at 20°C were chosen to match experimental conditions.
Detailed command lines. To calculate ∆∆Gmut values, we used the MPddG pro-
tocol described in Alford et al. [65]. The protocol combines the RosettaMP framework
with a fixed-backbone ∆∆G prediction protocol similar to the method described in
Kellogg et al. [142]. The MPddG protocol is captured in a PyRosetta script [66]. The
following command line and options were used for prediction of ∆∆Gmut values for
mutations in the OmpLA and PagP scaffolds:
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python predict_ddG.py
--pdb sample.pdb # Input PDB file
--spanfile sample.span # Input spanfile
--out_ddGs ddGs.txt # Predicted ddGs
--out_breakdown decomposed.sc # Predicted per-term ddGs
--lipid_composition DLPC # Lipid composition
--res ## # Host site
--repack_radius 8.0 # Repack radius
The script will predict ∆∆Gmut values for all canonical amino acids. The first
output file, ddGs.txt includes the predicted ∆∆Gmut values. The second output file,
decomposed.sc includes the contribution of each energy term to the overall ∆∆Gmut.
2.6.3 Test #3 Methods: Native structure discrimination
Protocol information. Native structure discrimination is the ability of an energy
function to distinguish near-native from non-native conformations. To measure dis-
crimination, we used ensembles of five α-helical proteins generated by Dutagaci et al.
[114]: bacteriorhodopsin (BRD7; 1py6), fumarate reductase (FMR5; 1qla), lactose per-
mease (LTPA; 1pv6), rhodopsin (RHOD; 1u19), and V-ATPase (VATP; 2bl2). Structures
in each ensemble were between 1-11Å from the coordinates of the crystal structure.
We refined each conformation using RosettaMPRelax [65] with constraints to the
starting Cα coordinates. For structures refined using the new implicit membrane
model, we used POPC parameters for eukaryotic targets and DLPC for targets from
bacteria. The root-mean-squared-deviation (RMS) between the Cα coordinates of the
native and refined models was computed with the MMTSB package [143]. Then,
we computed the Boltzmann-weighted average RMS WRMS [144]. Here, WRMS is
computed over N refined candidates with scores ∆G and distances from the native
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Detailed command lines. To measure native structure discrimination, we refined
decoys using the mp_relax protocol [65]. The mp_relax protocol combines the Roset-
taMP Framework with FastRelax [145]: a protocol that perturbs the protein using
small backbone torsion moves, followed by side-chain repacking and energy mini-
mization along all torsion angles (ϕ, ψ, ω). The protocol is captured by the Rosetta
XML script mp_relax.xml listed below:
<ROSETTASCRIPTS>
<SCOREFXNS>


















-in:file:native sample_native.pdb # Native PDB coordinates
-in:file:l sample_candidates.list # List of candidate models
-mp:setup:spanfiles sample.span # Spanning topology file
-parser:script_vars
sfxn_weights=franklin2019 # Name of candidate energy function
-parser:protocol mp_relax.xml # XML script for relax protocol
-out:file:scorefile model_scores.sc # File with energies and RMS values
-out:path:all /path/to/output/pdbs # Refined models
-mp:lipids:composition DLPC # Choose phospholipid composition
To compute the RMSD between the native and refined models, we used the
score_jd2 application with the following options:
/path/to/Rosetta/main/source/bin/score_jd2.linuxgccrelease
-in:file:l refined_models.list # List of refined models
-in:file:native native.pdb # Native structure
-in:file:spanfile sample.span # Input spanfile
-in:membrane # Use RosettaMP
-score:weights franklin2019 # Energy function
-mp:lipid:composition DLPC # Lipid composition
Finally, we estimated the native structure discrimination score, Wrms
using score_energy_landscape.py:
/path/to/Rosetta/bakerlab_scripts/boinc/score_energy_landscape.py
-terms rms total_score # Name of rms and energy term
-abinitio_scorefile candidates.sc # Energies and rms values
2.6.4 Test #4 Methods: Native sequence recovery
Dataset curation. To evaluate recovery, we used a benchmark set curated by Koehler
Leman et al. [105] of α-helical and β-barrel proteins, each between 40-10,000 residues
with less than 25% sequence identity and better than 3.0 Åresolution. While the
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original dataset included 222 proteins, we reduced the set to 133 proteins with a
known host lipid composition in the Orientations of Proteins in Membranes database
[117]. We chose this approach to dataset curation because it resulted in the largest
possible set of high-resolution membrane protein structures with diverse sequences
and known host lipid composition. For design with the new implicit membrane
model, all targets were designed with DOPC membrane parameters. This is because
it was difficult to assign a lipid composition to all targets given inconsistencies in
the membrane environments used for expression and structure determination. The
protein coordinates were downloaded from the Orientations of Proteins in Membranes
database [117].
Protocol Information. The fixed-backbone Rosetta Design protocol [116] was
used to search for low-free energy-sequences. Sequence recovery, Rseq, was calculated






In addition, we examined sequence recovery rates for individual amino acid types,
relative the background probability of guessing a random amino acid type (1 in 20
types, or 5%). This metric, NAA is the fraction of amino acid types recovered with
rates higher than random.
Detailed command lines. To measure native sequence recovery, we used an
adapted version of the fixed-backbone design protocol from Leaver-Fay et al. [116].
Here, we combined this protocol with the RosettaMP framework to keep proteins
oriented in the bilayer during design. Each protein in our dataset was redesigned
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using the following command line:
/path/to/Rosetta/main/source/bin/fixbb.linuxgccrelease
-in:file:s sample.pdb # Input PDB coordinates
-mp:setup:spanfiles sample.span # Input spanfile
-score:weights candidate_efxn # Energy function weights file
-in:membrane # Load the membrane framework
-out:path:all # Output redesigned structures
-in:ignore_unrecognized_res # Ignore unknown residues
-mp:lipids:composition DOPC # Lipid composition
Then, we computed sequence recovery with the mp_seqrecov application using
the command line given below:
/path/to/Rosetta/main/source/bin/mp_seqrecov.linuxgccrelease
-native_pdb_list natives.list # List of native protein PDBs
-redesign_pdb_list redesigned.list # List of redesigned protein PDBs
-seq_recov_filename seqrecov.txt # File for sequence recovery data
2.6.5 Computing properties of in silico designs
Sequence divergence. We examined properties of the in silico designed proteins
using the Kullback-Leibler (KL) divergence. This metric quantifies the divergence
between the distribution of amino acid types (i) in the native (Nnat,i) and designed
(Ndes,i) sequences:





Aromatic thickness. To compute aromatic thickness, the aromatic carbon center-
of-mass (m) was computed for all tyrosine and tryptophan side chains. Side chains
were assigned to two bins: if the z-coordinate of m was less than 5Å , the coordinate
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was assigned to the lower bin, and if the z coordinate of m was greater than 5Åthe
coordinate was assigned to the upper bin. The ring center-of-mass M was computed
as the center-of-mass of each bin. Then, the aromatic thickness was calculated as the
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Figure 2.7: Dependence of total energy on tilt angle. Dependence of total energy on the




































































































































Figure 2.8: Prediction of insertion and orientation for monomeric and tetrameric M2 pro-
ton channel. The mapping of protein orientations to energies calculated by the M07, M12,
and M19 energy function respectively is shown in panels A-C for the monomer and E-G for
the pentamer. The partitioning energies between two lipid-buried conformations (∆G4→3),
from interface to lipid (∆G2→3) and from water to lipid (∆G1→3) are shown in (D) for the
monomer and (H) for the tetramer. Here, G1 is the energy of the unfolded state in solution
(z = 30, θ = 90°). G2 is the energy of the folded state at the interface, parallel to the plane of the
interface (z = 15, θ = 90°), G3 is the energy of the peptide oriented vertically (z = 0, θ = 0°),



































































































































































































Figure 2.9: Prediction of peptide orientation for VPU-forming domain, NMDA-receptor,
and WALP23. Prediction of peptide orientation for the remaining three peptides in the test
set: the NR1 subunit of NMDA glutamate receptor (2nr1, top row), the VPU-forming domain
of HIV-1 (1pje, middle row), and a rationally designed WALP peptide (WALP23, bottom row).
The mapping of protein orientations to energies calculated by the M07, M12, and M19 energy
function respectively is shown in panels A-C for 2nr1, E-G for 1pje, and I-K for WALP23.
The partitioning energies between two lipid-buried conformations (∆G4→3), from interface to
lipid (∆G2→3) and from water to lipid (∆G1→3) are shown in (D) for 2nr1, (H) for 1pje, and
(J) for WALP23. Here, G1 is the energy of the unfolded state in solution (z = 30, θ = 90°).
G2 is the energy of the folded state at the interface, parallel to the plane of the interface
(z = 15, θ = 90°), G3 is the energy of the peptide oriented vertically (z = 0, θ = 0°), and G4 is
the energy of a peptide buried in the membrane (z = 0, θ = 90°).
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Figure 2.10: Contributions of M07 component energies to the ∆∆Gmut for each mutation
in PagP. Energies are only listed for contributions > 0.1 REU to the ∆∆Gmut.
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Figure 2.11: Contributions of M12 component energies to the ∆∆Gmut for each mutation
in PagP. Energies are only listed for contributions > 0.1 REU to the ∆∆Gmut.
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Figure 2.12: Contributions of M19 component energies to the ∆∆Gmut for each mutation
in PagP. Energies are only listed for contributions > 0.1 REU to the ∆∆Gmut.
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Figure 2.13: Discrimination of candidate conformations from the native crystal structure.
Each panel is a plot of the score in Rosetta energy units (REU) vs. the root-mean-squared-
deviation between the Cα coordinates of the model and native crystal structure. The refined
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Figure 2.14: Performance of the Weinstein energy function (ref15_memb) on four scientific
benchmarks. (A) Tilt angle test - Mapping of protein orientation to energies for five target
peptides: 1a11, 1mp6, 1pje, 2nr1, and WALP23. The minimum energy peptide tilt angle is
annotated in the bottom right corner of each panel. (B) ∆∆G of mutation test - Comparison
between experimentally measured and predicted values for mutations in OmpLA and PagP.
For both correlation plots, proline is not shown due to steric clashes resulting in large energies.
The dotted gray line is the line of best fit and the solid gray line is y = x. In addition,
amino acids are colored according to the following categories: charged (orange), nonpolar
(red), aromatic (blue), polar (purple), special case (green). (C) Sequence recovery test - The
left panel ranks the performance of ref15_memb by two metrics: the fraction of all amino
acids recovered on the y-axis and the fraction of amino acid types with individual recovery
rates greater than 0.05 on the x-axis. Each point represents a different subset of amino acids.
The right panel shows the Kullback-Leibler (KL) divergence of the amino acid distribution
of the designed protiens relative to the distribution in native membrane proteins. Values
are given on a logarithmic scale and the bars are colored according to same scale in (B). (D)
Decoy discrimination test - Ranking of models by total score in Rosetta Energy Units (REU) and
root-mean-squared-deviation (RMS) from the Cα coordinates of the native crystal structure.
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Figure 2.15: Numeric and analytic profiles of depth-dependent water density for 15 lipid
compositions. (A) The raw time-averaged water density for 15 different lipid compositions
is shown in red and the standard deviation across time steps is shaded in gray. Note that for
DMPG lipids, the bilayer is in the liquid-crystalline phase [100]. As a result, it does not form
a cohesive bilayer, resulting in high error rates when estimating the fractional hydration. (B)
The raw histograms were centered at z = 0 and fitted to a logistic function (see Main Text eq.
1). The re-centered raw histogram is shown in red and the analytic fit is shown in blue.
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Figure 2.16: Hydration profiles along the membrane normal for simulated phospholipid
bilayers at physiological temperature. Each profile is colored by acyl chain type with
12:0/12:0 in red, 14:0/14:0 in blue, 16:0/16:0 in green, 18:1/18:1 in purple, and 16:0/18:1
in orange. For each lipid composition, membrane thickness increases with increasing acyl
chain length. The exception is for 16:0/18:1 where the degree of saturation makes the chains
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Figure 2.17: Comparison of derived per-atom transfer energies for franklin2019 with prior
computational models (M07/IMM1) and experimental measurements. (A) Comparison of
derived per-atom transfer energies with values from the Implicit Membrane Model 1. Carbon
atom types are in red, nitrogen in blue, oxygen in green, and sulfur in purple. The mean
absolute error (MAE) between IMM1 and derived values is 1.20 kcal/mol. (B) Comparison of
calculated per-residue transfer energies with experimental values from Moon & Fleming. The






Aquaporin (1j4n) CLC-1 chloride channel (6qvb)
Figure 2.18: Example calculations for a protein with multiple pores and a protein with
ellipsoidal architecture. The pore geometry is illustrated by coloring each side chain by
implicit solvent phase. The water phase is shown in blue, the interface is in teal, and lipid
exposed positions are in gray. Panels (A) and (B) show a top and membrane view of the
aquaporin-1 channel (1j4n). Aquaporin-1 is a tetramer with four pores. Panels (C) and (D)


























































































Figure 2.19: Comparison between computationally predicted and experimentally mea-
sured ∆∆Gmut values in OmpLA. The experimental values were measured by [99]. For
all correlation plots (B-D), proline is not shown due to steric clashes resulting in a large
∆∆Gmut value. The dotted gray line is the line of best fit and the solid gray line is y = x.
Amino acids are colored according to the following categories: charged (orange), nonpolar
(red), aromatic (blue), polar (purple), special case (green). (A) Structure of the OmpLA scaffold
(PDB 1qd6) with the mutation site A181 highlighted in dark grey. The implicit solvent phases
are colored in a similar manner to Fig. 1 (Main Text). The ∆∆Gmut predictions for mutations

































































Figure 2.20: Comparison of the membrane thickness computed from simulated water den-
sity and measured by X-Ray and neutron scattering experiment. The measurements were
taken by Kucerka et al. [108, 146, 147] and Jambeck et al. [148]. Measured thicknesses are
represented by filled circles and thicknesses computed from molecular dynamics trajectories
are represented by open circles. The solid line is the line of best fit through the measured val-
ues. (A) DLPC (B) DMPC (C) POPC (D) DLPE (E) DLPG (F) DOPG (G) POPG. The calculated
values closely follow the thickness vs. temperature trend for each lipid composition.
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2.6.7 Supplemental Tables
Table 2.2: Full names of lipid types and abbreviations
















Table 2.3: Water density parameters fit from all-atom molecular dynamics
Lipid Type Chain Thickness (t) Pseudo Thk (τ) Steepness (s) Temp (°C)
DLPC 12:0/12:0 15.35 199.57 0.343 37
DLPE 12:0/12:0 16.45 1538.31 0.446 37
DLPG 12:0/12:0 14.38 457.67 0.413 37
DMPC 14:0/14:0 17.97 390.54 0.343 37
DMPE 14:0/14:0 19.26 7906.16 0.446 37
DOPC 18:1/18:1 18.64 707.00 0.343 37
DOPE 18:1/18:1 19.61 3419.03 0.446 37
DOPG 18:1/18:1 17.97 1233.72 0.413 37
DPPC 16:0/16:0 20.03 925.15 0.343 37
DPPE 16:0/16:0 22.11 13436.10 0.446 37
DPPG 16:0/16:0 18.92 1229.49 0.413 37
POPC 16:0/18:1 19.10 815.94 0.343 37
POPG 16:0/18:1 18.69 2379.13 0.413 37
Table 2.4: Lowest energy peptide orientation, given by tilt angle (θ) and depth (d)
Target Exp M07 d (Å) M07 θ (°) M12 d (Å) M12 θ (°) M19 d (Å) M19 θ (°)
1a11 11 -20 87 1 3 4 26
1mp6 37 -19 76 0 24 2 43
2nr1 40 -60 33 19 59 -7 42
1pje 16 8 66 -6 19 -1 18
WALP23 25 1 2 0 18 -2 32
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Table 2.5: Experimentally measured and predicted ∆∆Gmut values in PagP





A 0 0 -0.017 0
C -0.72 1.49 1.30 0.53
D 2.49 5.17 5.37 3.91
E 1.18 4.00 4.34 0.37
F -2.44 -0.89 -1.91 -4.03
G 1.64 2.14 2.32 4.00
H 3.32 3.38 2.34 3.44
I -2.17 -1.80 -1.92 -1.97
K 3.54 3.07 2.03 4.65
L -2.01 -0.50 -1.41 0.91
M -1.15 -1.54 -1.78 -0.89
N -2.95 2.94 3.40 3.00
P 3.82 216.14 215.09 168.83
Q 2.54 1.76 1.49 1.73
R 3.22 2.73 0.45 4.02
S 1.83 1.35 0.92 0.96
T 0.95 0.14 -0.25 -1.34
V -1.75 -1.95 -1.00 -4.20
W -2.21 -0.59 -2.39 -2.39
Y -1.02 0.36 -0.56 -4.35
Table 2.6: Rosetta atom types
Atom Type Description
CH0 carbon with no hydrogens
CH2 carbon with two hydrogens
CH1 carbon with one hydrogen
CH3 methyl carbon
CNH2 Glu amine carbon
COO carbonyl carbon
S sulfur
SH1 sulfur with one hydrogen
aroC aromatic carbon
Nhis His nitrogen
Ntrp Trp and HIs nitrogen
Nlys Lys nitrogen
NH2O Glu amine nitrogen
Narg arginine nitrogen
NtrR Trp secondary nitrogen




Table 2.7: Constraint equations for water-to-bilayer transfer energy fit.
Amino Acid Equation
A xCH3
C xCH2 + xSH1
D xCH2 + xCOO + 2xOOC
E 2xCH2 + xCOO + 2xOOC
F xCH0 + xCH2 + 5xaroC
G –
H xCH0 + xCH2 + 2xaroC + xNhis + xNtrp
I 2xCH3 + 2xCH2
K 4xCH2 + xNlys
L 2xCH3 + xCH2 + xCH1
M xCH3 + 2xCH2 + xS
N xCH2 + xONH2 + xCNH2 + xNH2O
P xNpro + 3xCH2
Q 2xCH2 + xONH2 + xCNH2 + xNH2O
R 3xCH2 + xaroC + 2xNarg + xNtrR
S xCH2 + xOH
T xCH3 + xCH2 + xOH
V 2xCH3 + xCH1
W 3xCH0 + xCH2 + 5xaroC + xNtrp
Y 2xCH0 + xCH2 + 4xaroC + xOH
Table 2.8: Per-atom water-to-bilayer transfer energies, ∆Gatomw,l




















Table 2.9: Residuals for predicted ∆∆Gmut values in OmpLA
Mutation M07 (REU) M12 (REU) M19 (REU)
A 0.00 0.01 0.00
C 1.57 1.43 0.88
D 1.90 2.04 1.00
E 2.00 2.23 0.58
F 1.10 0.37 1.12
G 0.35 0.48 1.67
H 0.04 0.69 0.09
I 0.26 0.18 0.14
K 0.33 1.07 0.79
L 1.07 0.43 2.07
M 0.28 0.46 0.18
N 4.09 3.86 4.21
P – – –
Q 0.55 0.75 0.58
R 0.35 1.96 0.56
S 0.34 0.65 0.62
T 0.58 0.85 1.62
V 0.14 0.53 1.73
W 1.15 0.13 0.13
Y 0.98 0.33 2.36
Table 2.10: Weights for membrane energy functions based on score_12
Energy Term Description M07 [63] M12 [111]
fa_atr van der Waals attractive energy 0.78 0.8
fa_rep Repulsive energy 0.43 0.44
fa_intra_rep Intra-residue repulsive energy 0.004 0.004
fa_pair Statistical residue-pair interaction energy 0.48 0.49
fa_dun Knowledge-based rotamer energy 0.56 0.56
fa_mpsolv Lazaridis IMM1 membrane solvation energy 0.60 0.35
fa_mpenv Lazaridis IMM1 membrane environment energy 0.48 0.3
fa_mpenv_smooth Knowledge-based membrane environment energy 0 0.5
ref Amino acid reference energy 1.0 1.0
hbond_lr_bb Long-range backbone hydrogen bond energy 1.16 1.17
hbond_sr_bb Short-range backbone hydrogen bond energy 1.16 1.17
hbond_bb_sc Backbone to side-chain hydrogen bond energy 1.16 2.34
hbond_sc Side-chain to side-chain hydrogen bond energy 1.1 2.2
p_aa_pp ϕ, ψ-dependent amino acid propensity 0.64 0.32
dslf_ss_dst Disulfide bonding energy for S-S distance 0.5 0.5
dslf_cs_ang Disulfide bond energy for CSS angle 2 2
dslf_ss_dih Disulfide bond energy for SS dihedral 5 5
dslf_ca_dih Disulfide bond energy for CC dihedral 5 5
pro_close Proline closure energy 1.0 1.0
rama Rakmachandran energy 0.2 0.2
omega ω torsion energy 0.5 0.5
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Table 2.11: Weights for membrane energy functions based on ref2015
Energy Term Description R15 [60, 61] M19
fa_atr van der Waals attractive energy 1.0 1.0
fa_rep Repulsive energy 0.55 0.55
fa_sol Lazaridis-Karplus solvation energy 1.0 1.0
fa_intra_sol_xover4 Intra-residue solvation energy 1.0 1.0
lk_ball_wtd Orientation-dependent solvation energy 1.0 1.0
fa_intra_rep Intra-residue repulsive energy 0.005 0.005
fa_elec Coulomb electrostatics energy 1.0 1.0
pro_close Proline closure energy 1.25 1.25
fa_dun Knowledge-based rotamer energy 0.56 0.56
hbond_lr_bb Long-range backbone hydrogen bond energy 1.0 1.0
hbond_sr_bb Short-range backbone hydrogen bond energy 1.0 1.0
hbond_bb_sc Backbone to side chain hydrogen bond energy 1.0 1.0
hbond_sc Side chain to side chain hydrogen bond energy 1.0 1.0
dslf_fa13 Disulfide bonding energy 1.25 1.25
rama_prepro Ramachandran energy 0.45 0.45
omega ω torsion energy 0.5 0.5
p_aa_pp ϕ, ψ-dependent amino acid propensity 0.6 0.6
fa_dun Knowledge-based rotamer energy 0.7 0.7
yhh_planarity Tyrosine χ3 torsion energy 0.625 0.625
ref Amino acid reference energy 1.0 1.0
fa_water_to_bilayer Water-to-bilayer transfer energy 0.0 1.0
Table 2.12: Lipid composition parameters for α-helical peptide energy landscape calculations.
Target PDB Code Conditions Parameters Ref.
Acetylcholine M2 segment 1a11 DPC micelles DLPC, 20°C [149]
Influenza A M2 channel 1mp6 DMPC vesicles DMPC, 30°C [150]
VPU-forming domain HIV-1 1pje DOPC:DOPG 9:1 DOPC, 30°C [151]
NMDA receptor segment 2nr1 DPC micelles DLPC, 20°C [149]
WALP23 NA DOPC DOPC, 30°C [112, 152]
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Chapter 3
Diverse scientific benchmarks for
implicit membrane energy
functions
This chapter contains material that will be submitted to the Journal of
Chemical Theory and Computation. If accepted and published, then this
chapter will contain material that is reproduced with permission of the
American Chemical Society, as per the statement of author rights.
3.1 Overview
Energy functions are fundamental to biomolecular modeling. Their success depends
on robust physical formalisms, efficient optimization, and high-resolution data for
training and validation. Over the past 20 years, progress in each area has advanced
soluble protein energy functions. Yet, energy functions for membrane proteins lag
behind due to sparse and low-quality data, leading to overfit tools. To overcome
this challenge, we assembled a suite of 12 tests on independent datasets varying in
size, diversity, and resolution. The tests probe an energy function’s ability to capture
membrane protein orientation, stability, sequence, and structure. In this chapter, we
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present the tests and use the franklin2019 energy function to demonstrate them. We
then present a vision for transforming these “small” datasets into “big data” that can
be used for more sophisticated energy function optimization. The tests are available




Accurate energy functions are critical for biomolecular structure prediction and design.
Through physical, empirical, and statistical models of intermolecular interactions,
these functions discriminate near-native from non-native conformations and optimize
sequences to stabilize structures. Over the past 20 years, an influx of high quality
structural data paired with new optimization tools have boosted the accuracy of
soluble protein energy functions [61]. A remaining task is to improve energy functions
for membrane proteins, a class of molecules that constitutes 30% of all proteins [68]
and targets for over 50% of drugs [3].
The heterogeneous lipid bilayer introduces several challenges for membrane pro-
tein energy function development. Biomolecular modeling tasks such as docking
and design require benchmarking with both thermodynamic data and macromolec-
ular structures. Yet, difficulties in over-expression and purification of membrane
proteins have limited the quality and quantity of experimental validation data [153].
For instance, membrane proteins represent less than 2% of structures in the Protein
Databank [154] and less than 1% of entries in ProTherm [155]. Additionally, biomolec-
ular modeling programs accelerate calculations with implicit membrane models that
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represent the solvent as a continuous medium. This choice obfuscates the comparison
between predictions and experimental data measured in a real lipid bilayer.
As a consequence, many membrane protein energy functions are trained for a
single task on a small dataset. This strategy has been applied to various membrane
protein modeling tools including estimating the ∆∆G of mutation [139], hydrophobic
thickness [132], native structure discrimination [114, 138], refinement [156], protein
design [140], symmetry [157], and protein-protein docking [158, 159]. These tools
enabled a decade of membrane protein modeling; however, their generalizability
is unclear. Small quantities of data prevent cross-validation [160]: a technique that
ensures performance on targets that are different from the training set. Further, small
datasets may be feature-poor. For example, a set of membrane proteins may only
contain transmembrane domains and exclude juxta-membrane domains important
for function.
Recent advances have enabled energy function development with up to four
training and testing sets. In the Rosetta community, this includes two new implicit
membrane energy functions. The first model, developed by Weinstein et al. [118],
was fit to transfer free energies from the dSTβL assay [119] and tested on datasets
describing the folding and thermodynamics of single-span dimers. The second model
is franklin2019 [161], our "biologically realistic" implicit membrane model that permits
use of parameters for different lipid compositions. This model was fit with the Moon
& Fleming hydrophobicity scale [99] and evaluated on four tests describing α-helical
and β-barrel membrane proteins with complex topologies. Interestingly, Weinstein
et al. reported excellent performance on homo-dimers of single transmembrane
segments; however, the same model underperformed on our tests. This outcome
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demonstrates another important complication in this area: developers use different
criteria to evaluate membrane protein energy functions, resulting in ambiguity in
performance.
For soluble proteins, these challenges are addressed by using multiple large, qual-
itatively and quantitatively diverse datasets that aim to fully describe the biomolec-
ular system [116]. For example, inclusion of both small-molecule thermodynamic
data along with macromolecule structures from X-Ray crystallography and NMR
spectroscopy resulted in significant improvements to Lennard-Jones, electrostatic,
and solvation parameters in the Rosetta soluble protein energy function [60]. The
CHARMM force field is parameterized with a large collection of biophysical data
[162]. The Open Force Field project integrated multiple data sources with a Bayesian
statistical framework to improve atom typing [163]. It would be ideal to apply a simi-
lar solution for membrane proteins. The closest examples involve parameterization
of an anisotropic model for orientation prediction with free energy calculations [164]
and explicit lipid force fields for molecular dynamics with a combination of quantum
mechanical calculations and experimental thermodynamic data [77]. However, these
examples do not yet incorporate benchmarks on macromolecule structures. Further,
for membrane proteins there are only multiple small and non-diverse datasets that
partially describe the system.
The goal of this work was to overcome this validation challenge by developing
a set of sparse and diverse scientific benchmarks for evaluating membrane protein
energy functions. We created tests that probe four areas of the membrane protein
energy landscape: (1) protein orientation in the bilayer, (2) stability, (3) sequence, and
(4) complete structures. The tests rely on a mixture of datasets that range in both size
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and quality, resulting in overall feature-rich optimization targets. Importantly, the
tests are fast to evaluate to enable multiple iterations for optimization protocols. As
a demonstration, we applied the scientific benchmarks to evaluate the accuracy of
the franklin2019 energy function. The tests identified energy function strengths and
imperative areas for optimization. These optimization imperatives lay the ground-
work for future energy function development and potentially enable use of more
sophisticated optimization tools such as deep learning.
3.3 Results
To evaluate implicit membrane energy functions, we developed a set of 12 scientific
benchmark tests (Table 3.1) In the following sections, we present each test and demon-
strate the analysis with franklin2019, a current Rosetta implicit membrane energy
function.
3.3.1 Test #1: Orientation of transmembrane peptides
Membrane proteins occupy precise orientations in the lipid bilayer to perform their
biological functions. Thus, a key challenge for energy functions is to recapitulate this
position during structure prediction and design. This first test verifies that the most
stable computed orientation of a transmembrane peptide corresponds to the native
orientation. This test is the cornerstone of our benchmark because it was used for
validation of early implicit membrane models [64, 89]. Here, the native orientation is
defined as the tilt angle measured by solid-state NMR spectroscopy in the context of
oriented lipid bilayers [168].
To predict orientation, we developed a protocol to sample all possible orientations
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Table 3.1: Membrane protein energy function benchmarks
Test # Experiment Data Ref.
Protein orientation in the bilayer
Transmembrane peptide tilt angle 1 ssNMR [47]
Surface-adsorbed peptide rotation angle 2 ssNMR [47]
Protein tilt & depth 3 PPM Server [132]
Hydrophobic length 4 PPM Server [132]
Protein stability
∆Gw,l at constant pH 5 Translocon [165]
∆∆Gw,l with pH shift 6 Trp [166]
∆∆Gmut 7 Trp [99, 113, 121]
Design
Sequence recovery 8 X-Ray [117]
Depth-dependent side chain distribution 9 X-Ray [117]
Native structure features
Decoy discrimination 10 X-Ray [114]
Helix kink identification 11 X-Ray [167]
Protein-protein interface prediction 12 X-Ray [158, 159]
of the peptide relative to the implicit membrane within ± 60 Å of the bilayer center
and tilt angles between ±180°(see SI Appendix). The global energy minimum of all
sampled positions is defined as the most stable predicted orientation for comparison
to the experimental measurements. More generally, based on our biophysical intuition
and the observation that transmembrane peptides typically prefer tilt angles between
0-45°, we expect those tilt angles and depths that span the membrane to be lower in
energy relative to the aqueous phase or interface.
Dataset. The test set contains seven peptides with a single transmembrane domain
(Table 3.4). The first four peptides are segments of biological membrane proteins from
Ulmschneider et al. [47]. The fifth peptide is the designed WALP23 peptide [112]. Their
tilt angles were measured in different lipid compositions including DPC micelles [149],
DMPC vesicles [150], mixed DOPC:DOPG bilayers [151], and pure DOPC bilayers
[112]. While the experimental uncertainty is not available for all measurements [47],
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tilt angle measurements have a typical error range of ± 3-5°. In addition, to evaluate
the preference of aromatic side chains for the membrane interface, we added to the
set two designed poly-alanine helices with flanking tryptophan and tyrosine residues
[120, 169]. Orientations have not been measured for these peptides, but predictions
can still be compared to biophysical intuition.
Demonstration & Assessment. Test results with franklin2019 are shown for a
biological and a designed transmembrane peptide in Fig. 3.1a and 3.1b, respectively.
The remaining results are shown in Fig. 3.9 and 3.10. We rated performance according
to how many predictions fall within ± 10° of the measured value, a little more than
the usual experimental error since some cases do not have reported errors.
As previously reported (Fig. 1 in Alford et al. [161]), franklin2019 predicts the tilt
angles of WALP and three of four biological peptides within 10°. For the poly-alanine
aromatic-flanked peptides, the minimum energy occurs at a low energy tilt angle
between 10-20°, which would reasonably expose the aromatic side chains to the
aqueous solvent.
3.3.2 Test #2: Orientation of membrane surface adsorbed peptides
Many proteins perform their functions by binding to the membrane surface at a
specific orientation. This test verifies that the most stable surface-adsorbed peptide
orientation corresponds to the native orientation. We define the native orientation by
the rotation of the peptide relative to the helix axis and a specific membrane depth.
Similar to Test #1, we sampled all pairs of membrane depths and rotation angles (SI
Appendix).






























































Figure 3.1: Implicit potentials capture the orientation of membrane associated-peptides
with biological and designed sequences. A mapping between all sampled orientations and
energies for (a) nicotinic acetylcholine receptor segment (b) poly-alanine trp-flanked peptide,
(c) magainin, and (d) leucine-lysine repeat peptide. Tilt or rotation angle is on the x-axis and
depth relative to the bilayer center is on the y-axis. Each grid point represents a 1 Å and
1°and is colored by franklin2019 energy, with low (favorable) energies in dark blue and high
energies in yellow. The predicted lowest energy orientation is shown as a white circle, and
where applicable the experimentally measured orientation is shown as an open triangle.
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leucine-lysine (LK) repeat peptide [170] (Table 3.5). The experimental reference data
are rotation angles measured by solution NMR in dodecylphosphocholine micelles
or trifluoroethanol [171]. In the experiment, rotation angles are reported with an
uncertainty of ± 6-12°[47].
Demonstration & Assessment. The mapping of orientations to energies for mag-
ainin and the LK repeat peptide calculated in an assumed DLPC bilayer are shown
in Fig. 3.1c and Fig. 3.1d, respectively. The remaining targets are shown in Fig. 3.11.
We rated performance according to how many predictions fall within the maximum
experimental uncertainty across all of the measurements, i.e., 12°.
Fig. 3.1c-d and Fig. 3.11 show the energy landscapes with the predicted low-
energy orientation (white circle) overlaying the measured value (white triangle).
The landscapes reveal a repeating pattern of high energy (yellow) and low energy
patches (dark blue) near the membrane interfaces (± 18-23 Å). This pattern matches
the biophysical intuition that the non-polar side of amphipathic peptides is more
compatible with the membrane surface than aqueous solvent. Where experimentally
measured values are available, the franklin2019 energy function calculated rotation
angles within ± 12° of the native value for all of the surface-adsorbed peptides where
experimentally measured values are available.
3.3.3 Test #3: Orientation of multi-pass α-helical and β-barrel proteins
Accurately predicting peptide tilt angle is an important step toward predicting mem-
brane protein orientation; yet, most membrane proteins have multiple transmembrane
segments. Here, we examine how implicit membrane energy functions recapitulate
the orientations of α-helical and β-barrel protein domains with complex topologies.
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We sample protein orientations (Fig. 3.2a-c) using the protocol described in Test #1.
Then, because this data set is larger, we summarize the difference between the refer-
ence and calculated values across the set by computing the cumulative distribution
of residuals.
Dataset This test set was curated by Dutagaci & Feig [132] and includes 18 α-
helical and 17 β-barrel proteins (Table 3.7). In the dataset, 60% of proteins reside in
the E. coli outer membrane and 14% reside in the eukaryotic plasma membrane. The
remaining 26% reside in either the mitochondria inner membrane, archea, or the E.
coli inner membrane.
The most challenging step of this test is choosing reference data. There are various
methods for identifying protein tilt angles and penetration depths in lipid bilayers or
detergents including chemical modification, spin labeling, NMR, X-Ray scattering,
and electron cryo-microscopy [172]. The data vary in quality and have different
assumptions and error sources. For this reason, the current gold-standard data source
is the Orientations of Proteins in Membranes database of membrane protein structures
positioned in a 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) bilayer (OPM [117]).
OPM computes the spatial position of a membrane protein using PPM; a method
that combines an all-atom representation of the protein, an anisotropic model of the
lipid bilayer, and a universal solvation model. The final orientation is determined by
minimizing the water-to-bilayer transfer energy, which is computed as a sum of van
der Waals, electrostatics, and hydrogen bonding energies [164]. Using uncertainties
from multiple original experiments, the estimated accuracy of OPM reference data is
±10° for tilt angle and ±2.5 Å for depth [172].
Demonstration & Assessment. Membrane protein orientations predicted by
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franklin2019 in a DOPC bilayer are given in Fig. 3.2d-e and the cumulative distribu-
tion of residuals is shown in Fig. 3.2g-h. We rated performance by the number of
predictions that fall within the maximum uncertainty ranges of ± 10° for tilt angle
and ± 2.5 Å for depth. For α-helical proteins, protein depth was correctly predicted
for 62.5% of targets. In contrast, predictions were correct for 4% of β-barrel protein
targets. Tilt angle prediction was more consistent, with 60% and 70% of protein
tilt angles predicted within 10° of the OPM value for α and β proteins respectively.
Still, for β-barrel proteins, franklin2019 predicts several outliers. For example, the
predicted tilt angle for the alginate export protein (AlgE, 4afk) was 34°, whereas the
OPM predicted value is 3°. The franklin2019 prediction is likely unrealistic as it buries
the pore entry. Overall, the data reveal that franklin2019 predicts membrane depth
more accurately for α-helical proteins than β-barrel proteins.
3.3.4 Test #4: Membrane protein hydrophobic thickness
To overcome unfavorable exposure of non-polar side chains to water, membrane
proteins generally have a hydrophobic thickness compatible with the bilayer thickness.
Thus, hydrophobic thickness is an important parameter for predicting orientation
and stability. In this test, we predict hydrophobic thickness by placing the protein at
its OPM orientation and then iteratively rescoring the protein at membrane thickness
values ranging from 10-40 Å (Fig. 3.12). The protein hydrophobic thickness is then
defined as the bilayer thickness that minimizes the energy. This test uses parameters
for a phosphatidylcholine head group.
Dataset. This test uses the same proteins as Test #3. Experimentally, hydropho-
bic thickness is measured using various techniques that often introduce different
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Figure 3.2: Protein orientation predictions of α-helical and β-barrel proteins. Comparison
of membrane protein depth (a), tilt angle (b), and hydrophobic length (c) predicted by
franklin2019 relative to values predicted by the OPM anisotropic model [117]. A y = x
line is shown in each plot, with a light gray stripe for an error range of 2.5Å, 10° and 5
Å respectively. Targets that are α-helical (β-barrels) are represented as red (blue) points.
Cumulative distribution for residuals of (d) membrane protein depth, (e) tilt angle, and (f)
hydrophobic thickness. A distribution for all proteins is shown in black, and the distributions
for α-helical only and β-barrel only are shown in red and blue respectively. Points at 40 Å
indicate that full burial of the protein in the bilayer minimizes the energy.
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thickness of OmpX (1qj8) was determined assuming that the protein does not tilt
[173]. For this reason, we use predicted hydrophobic thickness values from the OPM
database [164] as our gold standard. OPM reports thickness as the bilayer thickness
that minimizes the water-to-bilayer transfer energy. The estimated uncertainty for
hydrophobic thickness values from OPM is ± 2.5 Å[172].
Demonstration & Assessment. A comparison of franklin2019 and OPM is shown
in Fig. 3.2f and Fig. 3.2i. The hydrophobic thickness was within 2.5 Å of OPM for only
30% of α-helical proteins and 10% of β-barrel proteins. At 5 Å, accuracy improves
for both categories to 75%; however, this threshold is large relative to the thickness
differences between varied lipid compositions. For 5 targets, we observed that the
energy continued to improve up to the limit of 40 Å. These points are plotted at
T=40 Å and indicate that franklin2019 prefers to completely bury these proteins in
the membrane. Overall, prediction of hydrophobic thickness was less reliable than
orientation.
To better understand areas for improvement, we examined the outliers in Fig. 3.2f.
The most outstanding incorrect prediction is for the bacterial semiSweet transporter
(4x5n, Fig. 3.2f). Here, franklin2019 predicted a hydrophobic thickness value of 21.5
Å whereas OPM predicted a value of 36.8 Å. This suggests error in pore estimation
because f ranklin2015 leaves the entry and exit of the pore more exposed than OPM
[117]. For five targets, franklin2019 was unable to find a minimum energy hydrophobic
thickness, meaning the minimum was T = 40 (the maximum thickness): photosyn-
thetic reaction center (1rzh), potassium channel KcsA (1r3j), opioid delta receptor
(4n6h), outer membrane protein A (1qjp), and the hemoglobin binding protease
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autotransporter (3aeh). It is less clear why these cases were outliers. Both the photo-
synthetic reaction center and opioid delta receptor have significant juxta-membrane
domains, suggesting franklin2019’s implicit membrane interfacial representation may
be insufficient to differentiate transmembrane from non-transmembrane segments.
Another possibility is that pore estimation further complicates predictions.
3.3.5 Test #5: Stability of transmembrane peptides at neutral pH
In cells, the translocon machinery is responsible for recognizing transmembrane
segments and integrating them into the bilayer. Once folded, membrane proteins
remain in the bilayer due to a favorable water-to-bilayer transfer free energy. To
keep the protein in the membrane, we therefore must accurately estimate the transfer
energy from solvent to the bilayer. In Test #5, we build on the calculations sapmling
all possible peptide orientations from Test # 1. Then, we compute the ∆G of insertion
as the energy difference between the lowest energy orientation of the peptide in
the lipid bilayer phase and in the aqueous phase (see SI Appendix) to compare to
experimental insertion energy measurements.
Dataset. The test set includes five poly-leucine peptides designed by Ulmschnei-
der et al. [165]. There are four peptides in the set that follow a GLXRLXG motif,
where X = 5, 6, 7, 8 (Table 3.8). The fifth peptide follows a different motif pattern by
adding a flanking tryptophan: GWL6RL7G. The reference transfer energies are taken
from molecular dynamics simulations in POPC bilayers that were validated against
intrinsic fluorescence measurements. The experimental uncertainty of the measured
∆Gins values is ±1.4 kcal mol−1.

























































Figure 3.3: Comparison of predicted and experimentally measured peptide insertion en-
ergies. (a) Prediction of the ∆∆G of insertion for five designed poly-leucine peptides of
varying length and flanking residues from Ulmschneider et al. (b) Prediction of the ∆∆G
of insertion upon pH shift from pH 8 to 4 for 16 variants of the pH-sensitive low insertion
peptide sequence from Weerakkody et al. Experimental measurements were taken by intrinsic
fluorescence in POPC liposomes and calculations were performed for DLPC.
water-to-bilayer insertion energy using a Gibbs insertion energy approximation. As in
many other Rosetta based calculations, we expect this energy function may reproduce
trends but not exact values. Thus, we evaluate the ability to reproduce trends using
the Pearson correlation coefficient (R2) between the experimentally measured and
predicted values (although as accuracy improves in the future, exact predictions can
also be evaluated). In calculating R2, we use a Grubbs test to eliminate outliers.
A comparison between the franklin2019 prediction in POPC bilayers and reference
∆G values from molecular dynamics is shown in Fig. 3.3a. Encouragingly, the Pearson
correlation coefficient is high (R2 = 0.996), and no points are outliers. The slope of the
best fit line is high (2.41 REU-mol/kcal), revealing that while the relative energies
are correct, franklin2019 overestimates the overall benefit of insertion. Further, the
comparison indicates a reference state calibration issue because the ∆G of inserting
the GL5 and GL6 peptides is favorable; whereas, the experiment indicates insertion is
unfavorable.
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3.3.6 Test #6: Stability of transmembrane peptides at acidic pH
The water-to-bilayer transfer energy is influenced by many factors including chang-
ing conditions in the intracellular and extracellular environment. Physiologically,
extracellular acidity is an important biomarker for tumor growth and development
[174]. To benchmark the ability of the energy function to capture pH, we evaluated
the prediction of peptide insertion energy when there is a change in pH. The test
performs two grid-style searches using the protocol described in Test #1 with Rosetta-
pH [175] to find the best peptide orientation at both pH 4 and 8 (see SI Appendix).
Then, the insertion energy difference is computed as the difference between the
peptide integrated into the bilayer at pH 4 and in the aqueous phase at pH 8 (i.e.,
∆∆GpH,ins = ∆Gins,pH4 − ∆Gins,pH8, see SI Appendix).
Dataset. The test set includes seventeen peptides designed by Weerakkody et
al. [166] that insert into membranes upon a shift from neutral to acidic pH, called
pHLIP peptides (Table 3.9). The reference value is the water-to-bilayer transfer
energy measured using titration and fluorescence experiments in the context of
POPC liposomes. The experimental uncertainty of the measured ∆∆GpH,ins values is
±1.0 kcal mol−1.
Demonstration & Assessment. A comparison of the franklin2019 and experimen-
tally measured values is given in Fig. 3.3b. Similar to Test #5, we aim to maximize
the Pearson correlation coefficient. In contrast to Test #5 at neutral pH, the correlation
between the experiment and calculation is poor, and the energy function prefers the
peptides in solution rather than in the bilayer. There are two areas that we suspect
cause gaps in performance. First, the underlying pKa values do not account for the
membrane. Second, the franklin2019 Coulomb term does not account for changes
90
in the dielectric constant in the membrane. This is a critical area of future energy
function optimization because the shifted pKa values in the bilayer affect the stability
of membrane proteins at all pH values.
3.3.7 Test #7: ∆∆G of mutation
Test #7 evaluates how changes to the sequence of a membrane protein affect its
overall thermostability. This quantity, called ∆∆Gmut, is a critical building block for
membrane protein design and evaluating the effects of genetic mutations on protein
function. To predict ∆∆Gmut, we used our previously described fixed-backbone and
fixed-orientation protocol [65] that evaluates the difference in total energy between
the mutant and wild-type (see Methods).
Dataset. We used three sets of ∆∆G measurements from the Fleming lab. All of
the measurements were taken at equilibrium in DLPC vesicles and in the context of a
β-barrel protein scaffold. The three datasets are: (1) mutations from alanine to all 19
remaining canonical amino acids at a lipid-exposed site on OmpLA [99] (2) mutations
from alanine to all remaining 19 canonical amino acids at a lipid-exposed site on
PagP [113] and (3) mutations from alanine to tryptophan, tyrosine, or phenaylanine
at different membrane depths on OmpLA [121]. The experimental uncertainty of the
measured ∆∆Gmut values is ±0.6 kcal mol−1.
Demonstration & Assessment. We previously reported the performance of
franklin2019 on the OmpLA and PagP datasets [161]. Here, we focus on the third
set which probes the contribution of aromatics to stability [120, 169]. To emulate the
experiment we modeled an implicit DLPC bilayer. A comparison of the franklin2019
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Figure 3.4: Comparison of predicted and experimentally measured depth-dependent
∆∆Gmut values. (a) Outer membrane protein phospholipase A (OmpLA, PDB 1qd6) with
each host site highlighted in blue. A comparison of predicted and experimentally measured
∆∆Gmut for mutations to tyrosine and tryptophan are shown in (b) and (c) respectively. Each
position is colored by depth relative to the membrane center plane in Å on a scale from blue
(closer to the center) to yellow (closer to the interface/water barrier). The y = x line is shown
as a bold black line. The experimentally measured values were taken from [121].
tyrosine because both demonstrate strong depth-dependence [121]. Unfortunately,
there was no correlation between the predicted and experimentally measured values.
The Pearson correlation coefficient was R2 = −0.135 for tyrosine and R2 = 0.023 for
tryptophan.
Interestingly, the Pearson correlation coefficient between the measured values and
the franklin2019 water-to-bilayer energy term was higher than that to the full energy
function, with R2 = 0.451 for tyrosine and R2 = 0.608 for tryptophan (Fig. 3.13). To
explore whether the ∆∆G was driven by factors other than membrane heterogene-
ity, we mapped the contribution of all component energy terms to the ∆∆G value
(Fig. 3.14 and Fig. 3.15 show all values over 0.01 REU). The largest contributions were
from rotamer energies, suggesting that steric clashes between guest side chains and
neighboring side chains inflated the cost of substitution.
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3.3.8 Test #8: Sequence Recovery
The next two tests concern the ability to identify residue types in design calculations.
Test #8 probes whether the energy function can recover native membrane protein
sequences. To run the test, we perform redesign using Rosetta’s Monte Carlo fixed-
backbone design protocol [116]. Each protein is initialized in the orientation from
the OPM database [117], and the orientation remains fixed. For simplicity, we use a
DLPC membrane in our calculations. We compute two metrics: (1) the fraction of
amino acids recovered (sequence recovery) and (2) the divergence of the designed
amino acid distribution from the native amino acid distribution (Kullback-Leibler
divergence). To tailor this test for the membrane, we also compute these metrics
for subsets of amino acids exposed to the aqueous phase (outside of membrane or
pore facing), lipid phase, and interfacial region. An optimal energy function would
maximize sequence recovery and minimize divergence.
Dataset. The test set includes 133 α-helical and β-barrel membrane proteins.
The starting dataset was curated by Koehler Leman et al. [105] and revised to only
include proteins with known sub-cellular localization [161]. In this set, all entries have
resolution of 3.0 Å or better, and no two sequences share more than 25% sequence
identity. The native and host lipid compositions for these proteins vary widely and
include compositions not yet covered by the franklin2019 lipid parameters. So here
for simplicity, we perform all design calculations in a DLPC bilayer.
Demonstration & Assessment. We previously reported the performance of
f ranklin2019 on the sequence recovery test (Fig. 4 in Alford et al.) [161]. Here,
the recovery rate was high (31.8%) and the divergence between designed and native
residue distributions was low (KL = −2.7). Both metrics improved relative to prior
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energy functions.
3.3.9 Test #9: Depth-dependent side chain distribution
Test #9 evaluates whether the energy function captures bilayer depth-dependent
features of membrane protein sequences. This test has been used previously for
calibrating statistical implicit membrane potentials [118, 119, 176]. To run the test,
we first generate redesigned proteins using the same protocol as in Test #8. We use a
kernel-density estimate to compute the depth-dependent (z-dependent) distribution
of amino acids in both the native and redesigned proteins. We then use numerical
integration to compute the difference in the area under the curve (AU∆C) between
the native and redesigned distributions. An effective implicit membrane energy
function qualitatively matches the shape of the distribution and minimizes the AU∆C
difference.
Dataset. This test uses the same set of 133 protein structures as in Test #8.
Demonstration & Assessment. The depth-dependent amino acid distributions
for proteins redesigned with franklin2019 are shown in Fig. 3.5, and the AU∆C values
are shown in Fig. 3.16. The profiles reveal both native-like and non-native-like
properties of franklin2019. The best predicted amino acid distributions were for polar,
non-polar, and some aromatic amino acids, namely T, A, P, F, Y, M, I, N, and G
(Fig. 3.16; AU∆C < 0.01). In contrast, leucine and valine were over enriched in the
membrane core, resulting in larger AU∆C values of 0.018 and 0.022, respectively.
The disparities were larger for charged amino acids. Specifically, the presence of D
and E is underestimated, whereas the presence of R and K is overestimated. Further,
lack of asymmetry in the distributions reveals that franklin2019 does not capture the
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Figure 3.5: Comparison of the depth-dependent side chain distribution in native and de-
signed protein sequences. The native amino acid distribution is shown with a solid line and
the designed amino acid distribution is shown with a dotted line. Each panel represents the
distribution for one of the twenty canonical amino acids with the membrane depth ranging
between -30 Å and 30 Å.
“positive-inside rule”, which dictates that cytosolic loops near the bilayer contain more
positively charged amino acids [119, 177]. Further, the distribution misses enrichment
of positively charged side chains in the inner leaflet. Both of these features have been
observed using the Elazar energy function [119].
3.3.10 Test #10: Native decoy discrimination
A key task for membrane protein energy functions is to distinguish near-native
from non-native backbone structures. So, the last three tests involve discriminating
between alternate structures. In previous work, there were two discrimination studies
with implicit membrane models for molecular dynamics [114, 138]. Recently, we
also reported structure discrimination results for franklin2019 [161] Here, we expand
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the test by increasing the number and structural diversity of decoy models. The
native discrimination test is performed by refining a set of decoy models with Rosetta
MPRelax [65] in the context of the candidate energy function. Then, we quantify
discrimination using the Boltzmann-weighted average root-mean-squared-deviation
(RMSD) over all models (D). We also qualitatively examine the ranking of decoys by
score and RMSD. An optimal energy function would exhibit a funnel-like arrangement
of decoys, with non-native decoys assigned high energies and near-native decoys
assigned low energies.
Dataset. The dataset includes five targets: bacteriorhodopsin (brd7), fumarate
reductase (fmr5), lactose permease (ltpa), rhodopsin (rhod), and V-ATPase (vatp).
Structural error is related to is the resolution of each crystal structure: 1.8 Å for brd7,
1.78 Å for fmr5, 3.5 Å for ltpa, 2.2 Å for rhod, and 2.1 Å for vatp. Each target is
represented by decoys from two datasets: (1) the Dutagaci et al. set [114] includes
decoys between 4–14Å RMSD from the native crystal structure, and (2) the Yarov-
Yarovoy et al. set [62] includes decoys between 5–40 Å RMSD.
To increase the number and diversity of decoys for each target, we used RosettaM-
PRelax to generate five models from each decoy structure to provide 0.5–1.5 Å RMSD
of additional variation. Since all of the X-Ray crystal structures were determined in
detergents, we performed the calculations in a default lipid composition of DLPC.
This bilayer is appropriate because all of the targets were expressed in E. coli.
Demonstration & Assessment. Fig. 3.6 summarizes the franklin2019 native struc-
ture discrimination results for all five targets, and Table 3.2 lists the discrimination
score for all decoys (Dall), Dutagaci decoys (DDut), and Yarov-Yarovoy decoys (DYY).
Consistent with previous results [161], discrimination of Dutagaci decoys for each
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Table 3.2: Native structure discrimination by franklin2019. D is the Boltzman-weighted
average RMSD over all models, with lower values indicating better identification of near-
native models.
Target Dall (Å) DDut (Å) DYY (Å)
brd7 7.8 4.6 7.8
fmr5 14.2 5.5 14.2
ltpa 4.8 4.8 13.7
rhod 4.3 4.3 12.7
vatp 4.0 4.3 4.0
brd7 fmr5 ltpa rhod vatp

































Figure 3.6: Decoy discrimination of five targets by the franklin2019 implicit membrane
potential. Each panel shows the decoys for each target ranked by energy (in REU) and RMSD
of the Cα atoms to the native (x-ray) structure. The high resolution (Dut) decoys (1–11 Å) are
shown in red, the low resolution (YY) decoys (5–40 Å) are shown in blue, and the refined
native structures are shown in green.
target is high and the models form a funnel. Interestingly, structure discrimination
worsens with the addition of low-resolution decoys for two targets: bacteriorhodopsin
and fumarate reductase. In both cases, there are models near 15 Å that score the same
or better than models near 4 Å, suggesting that the energy function requires improve-
ments to recognize native-like helix-helix contacts when there are large differences
between possible conformations.
3.3.11 Test #11: Helix kinks
A unique feature of membrane proteins is the distortion of α-helices into kinked and
curved conformations [178]. Upon first look, kinked transmembrane helices seem
counterintuitive because backbone hydrogen bonds are more stable in the membrane
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and kinks will break hydrogen bonds. In reality, there are multiple biochemical
possibilities to resolve the hydrogen bonds, including using a proline [179], a vestigial
proline [180], and non-canonical backbone hydrogen bonding patterns [181, 182].
To evaluate the energy function’s capacity to identify native non-canonical helical
conformations, we scored conformational ensembles of membrane proteins with at
least two conformational states with known structures where one structure exhibited
a kinked helix that straightens in the second structure. First, assuming the system
is stabilized by harmonic potentials [183], we generated conformational ensembles
using normal mode analysis to explore equilibrium modes. We used KinkFinder
[180] to compute the kink angle, and then, to test whether the energy function can
discriminate the native conformation, we calculated the energy of each model in the
conformational ensemble.
Dataset. The dataset includes three targets: (1) potassium channel KcsA, (2)
adiponectin receptor 1, and (3) platelet activating receptor (Table 3.10). The experi-
mental kink measurements are derived from the crystal structure. For these cases, the
native bilayer was ambiguous, thus for all calculations we chose a DLPC system.
Demonstration & Assessment. A comparison of energies and kink angles for
each state are shown in Fig. 3.7. As an example, we discuss the conformation of
transmembrane helix 2 (TM2) in the the potassium channel KcsA (Fig. 3.7a). In the
channel’s closed state, TM2 is kinked (red), whereas in the open state, TM3 is slightly
curved (blue). However, Figure 3.7a shows that the conformations cluster closer to
20° than 40° and assigns these decoys a significantly higher score, indicating that
Rosetta prefers to straighten TM2 in the open state, even though both states are














































Figure 3.7: Kinked and straight conformations of α helices are not distinguished correctly.
A structure discrimination experiment for kinked and straight helix conformations is shown
for three targets: the open (3f7v) and closed (1r3j) conformation of the potassium channel
KcsA (left), the active (3wxv) and inactive (5lxg) conformation of the adiponectin receptor,
and (c) the active (5zkp) and inactive (5zkq) conformation of the platelet activating receptor.
The top row shows the lowest energy conformation for both states and the bottom row ranks
the energy of each conformation by kink angle relative to the native (denoted by a dotted
line).
3.7b). This test demonstrates that improvements are needed to accurately capture
helix conformations.
3.3.12 Test #12: Membrane protein-protein interactions
A final challenging task for implicit membrane models is to distinguish near-native
from non-native membrane protein-protein interface structures. A range of studies
hint toward key features, including the GxxG motif [184], bifurcated Cα hydrogen
bonds [185], and apolar side chain packing [115]. However, there have only been a
few general efforts to dock membrane proteins [65, 158, 159, 186].
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Toward this goal, the final test is membrane protein-protein docking. Here, Roset-
taMPDock is used to search for the low-energy orientation of the protein partners by
performing rigid-body rotations and translations with cycles of side chain repack-
ing and torsion minimization (see Methods). For each target, we generated 5,000
candidate models and then used CAPRI metrics to evaluate the distance to crystal
structures [187]. We also computed two additional scoring metrics: (1) the number
of near-native decoys in the top 5 scoring decoys, ⟨N5⟩, and (2) the enrichment of
high quality models in the top 1% and 10% scoring models [52], ⟨E1%⟩ and ⟨E10%⟩
[66]. Angle brackets denote bootstrapped averages over resampled decoy sets.
Dataset. This test uses three existing benchmark sets. The first dataset comprises
18 homodimers formed by single transmembrane helices [158]. The second dataset
comprises 48 homo- and hetero-dimers formed by multi-pass α helical proteins [159].
The third dataset is a subset of the second consisting of nine targets with the starting
backbone generated by homology modeling [188] to simulate an "unbound" docking
scenario where the starting conformations of the partner are not pre-configured in
the bound state. For this test, all calculations were performed in a DLPC bilayer.
Demonstration & Assessment. Fig. 3.8 summarizes results for protein-protein
docking with franklin2019. First, we examined the efficacy of docking structures from
the crystalized bound state (Fig. 3.8a-b). We found that the membrane protein dock-
ing routine identifies high quality models for 90% of single-helix homodimer targets
and 45% of multi-pass heterodimer targets, as indicated by two-fold enrichment in the
top-scoring 1% of models. These data demonstrate that membrane protein docking
routines can identify some membrane protein interfaces, yet require improvement.
























































































Figure 3.8: Implicit potentials identified native-like membrane protein-protein interfaces
for nearly half of challenging targets. A summary of docking performance on bound (easy)
targets is shown on the left hand side. (a) Cumulative distribution for the enrichment of
high-quality models in the top 1% and 10% scoring models, given as ⟨E1%⟩ (solid line) ⟨E10%⟩
(dashed line) respectively. The distribution for single-transmembrane homodimers is shown
in gray (n = 18) and the distribution for multi-pass homo- and heterodimers is shown in black
(n = 48). (b) Cumulative distribution for the number of near-native decoys among the five top
scoring decoys, called ⟨N5⟩. Again, the distribution for single-transmembrane homodimers is
shown in gray and the distribution for multi-pass targets is shown in black. The success cutoff
of three models is shown in red. (c) Performance of docking nine challenging (unbound)
targets. Each panel ranks models with an interface RMSD in Å between 0 Å and 10 Å. Each
model is colored by CAPRI rank [187], with incorrect models in gray, acceptable models
in blue, medium quality models in orange, and high quality models in red. The bound
refined native models are shown in purple. The CXCR4 chemokine receptor which was
unsuccessfully docked is shown in (d) as a membrane view and (e) as a top view. The crystal
structure (3OE0) is shown in gray and the best scoring docked model is shown in blue.
right conformation for binding. To evaluate interface recognition in more detail, we
need to dock unbound targets.
Fig. 3.8c shows the performance of the nine homology-model docking targets.
Each panel plots all 5,000 models by interface RMSD and interface score, with each
model colored by CAPRI criteria. In four of the nine cases, the energy landscape
has a funnel pattern, with incorrect models scoring high and near-native models
receiving the lowest score, showing that the franklin2019 recognized near-native
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interfaces. Further, scores for the refined native structures (purple) are near the bottom
of the funnel of sampled docked structures. The four targets are halorhodopsin,
cytochrome C oxidase, mitochondrial respiratory complex II, and the NavAB voltage-
gated sodium channel. The five best-scoring models are shown in Fig. 3.18 and 3.19.
For the five remaining unbound targets, RosettaMPDock fails to recognize the
correct interface. For two cases (3CHX and 3OE0), the docking program did not
sample any high-quality models. Amongst the remaining cases (1M0L, 2QJY, and
3KLY), the energy function prefers acceptable or incorrect models over near-native
models. One example of a challenging case is the CXCR chemokine receptor (Fig. 3.8d-
e, 3OE0), where the low-scoring models have an incorrect bilayer orientation. These
targets may be rescued by improved representation of the lipid bilayer.
3.3.13 Summary of franklin2019 successes and challenges
Above, we described and demonstrated protocols for twelve scientific benchmark
tests. To integrate the test results, we established a threshold or optimization goal for
the summary metrics (Table 3.3).
Together, the benchmark results reveal strengths and pitfalls of a current en-
ergy function. For instance, test #1 demonstrates effective prediction of single-
transmembrane helix tilt angles. In addition, test #9 demonstrates the energy function
can predict many bilayer depth-dependent amino acid preferences. In contrast, test #5
illuminated the need to capture shifts in proton avidity for titratable sites in the low
dielectric bilayer. Test #4 suggests the need for better implicit membrane interfacial
representations to accurately predict hydrophobic thickness. Test #11 highlights possi-
ble pitfalls in the hydrogen bonding model. Further, tests #4 and #5 probe the balance
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Table 3.3: Summary of current benchmark test performance criteria
# Test Metrics Exp. Error Threshold/Goal
1 Tilt angle tilt 5° 10°
2 Rotation angle rotation 12° 12°
3 Protein orientation tilt/depth 10°/2.5Å 10°/2.5Å
4 Hydrophobic thickness thickness 2.5 Å 2.5 Å
5 ∆Gw,l at constant pH ∆Gins 1.4 kcal/mol max R2
6 ∆∆Gw,l with pH shift ∆∆GpH-ins 0.1 kcal/mol max R2
7 ∆∆Gmut ∆∆Gmut 0.6 kcal/mol max R2
8 Sequence recovery Rs/KL NA max Rs/min KL
9 Side chain distribution AUC diff NA min AUC diff
10 Decoy discrimination NA D 5Å
11 Helix kinks kink NA 10°
12 Docking ⟨N5⟩/⟨E1%⟩ NA 3/2
of forces in the overall energy function. Together, the pitfalls lay the groundwork for
the coming decade of membrane energy function optimization.
3.4 Discussion
We developed 12 scientific benchmarks to evaluate energy functions for membrane
protein modeling and design. Our approach overcomes the challenge of limited
experimental data by bundling many small sets to achieve a large feature-rich dataset.
The tests account for effects of the heterogeneous lipid bilayer on protein orientation,
stability, sequence, and structure. The tests encompass wide-ranging modeling tasks
from ∆∆G calculations to protein-protein docking and design. As a step forward
from single-test validation [114, 132, 139, 140] or four-test validation [161], we antic-
ipate that these benchmarks will accelerate development of the next generation of
membrane protein energy functions.
An interesting consequence of the membrane is the type of data that can be used
for benchmarking. For soluble proteins, energy functions for molecular modeling
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and force fields for molecular dynamics rely on a combination of small molecule
thermodynamic data and known macromolecular structures. For membrane proteins,
all-atom force fields also use physical chemistry data to derive parameters for different
lipid types. However, the analogous small molecule data are difficult to obtain for
implicit membrane simulations because organic solvents do not sufficiently mimic
the properties of heterogeneous biological membranes [95]. Further, it is challenging
to rigorously measure thermodynamic properties in lipid bilayers.
Hydrophobic length and membrane protein re-orientation can be observed on
short timescales, i.e. it is currently accessible via molecular dynamics [114]. However,
molecular dynamics is computationally expensive for modeling long-timescale biolog-
ical phenomena such as some conformational changes and protein binding. By using
a Monte Carlo approach with an implicit biologically-realistic implicit membrane, we
enabled fast calculation of both thermodynamic and structural properties. For a single
run, the tests require no more than 1,000 CPU hours. As a result, it is practical to
iteratively run the tests to maintain reproducibility and for continuous optimization.
For this purpose, we have implemented the tests on the Rosetta benchmark server
(https://benchmark.graylab.jhu.edu/). In addition, we have distributed the source
code through GitHub (https://github.com/rfalford12/Implicit-Membrane-Energy-
Function-Benchmark) to make the tests accessible to all membrane protein modeling
developers. We hope these resources will help the community share standardized
metrics for evaluating membrane protein energy functions.
This first multi-faceted benchmark is a base upon which the quantity and quality
of test data can be extended. For quantity, improvements in structure determination
will increase the number and diversity of known structures to benefit both sequence
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and structure tests. In contrast, the data are still sparse for stability and orientation
since these values are not revealed when structures are determined in detergents.
The paucity of data limits splitting the data into a training and a testing set, a key
practice for demonstrating generalizability of models. On the other hand, quality is
determined by various factors including the resolution of crystal and NMR structures,
the uncertainty of stability measurements, and the rigor of assumptions made to
obtain and analyze the data. The challenge of quality and quantity is well illustrated
by choosing a dataset of ∆∆G of mutation measurements. Kroncke et al. [139]
compiled a large dataset of ∆∆G of mutation measurements. However, the reference
state for each measurement varied (e.g., lipid composition, ion concentration in
aqueous phase), making it challenging to compare the datasets. As a result, we used
a smaller set of ∆∆G measurements to improve quality. Comparing measurements is
a consistent challenge of resolving the complexity of membrane proteins performed
in different lipid compositions and environments.
In this work, we evaluate energy functions with experimental reference data. By
transitivity, the energy function can only be as accurate as this reference data. For
soluble proteins, the wealth of biophysical and structural information compensates.
As of April 2020, there are more than 160,000 structures deposited in the Protein
Databank [141]. Consequently, soluble protein energy functions can be validated on
large and diverse datasets [60, 137]. In contrast, membrane protein structures can
require up to 160,000 crystallization trials to determine a single structure. A central
challenge is that many membrane proteins are not naturally abundant and cannot be
reconstituted into a membrane mimetic. For this reason, substantial improvements to
the energy function will require both reliable benchmarks and significant advances in
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experimental methods.
Important future work includes developing a framework to perform a global
optimization. A possible framework is to develop a series of objective functions that
define the relationship between the threshold and performance for all targets in the
dataset. For example, an objective function to define the performance of the tilt angle
test (Test #1) could be








0 f (xi) ≤ θ
( f (xi)− θ)2 f (xi) > θ
(3.2)
where xcalc is the predicted tilt angle, xexp is the experimentally measured tilt angle, i
is an iterator over all targets in the dataset, and θ = 10° is an allowable amount of
error. A quantitative system for rating test performance could fit these benchmarks in
a sophisticated optimization framework such as machine learning.
Looking ahead, our approach begs the question about the future role of optimiza-
tion tools to improve membrane protein energy function accuracy. Deep learning
has recently piqued the interest of the structural biology community [189]. Cur-
rently, deep learning approaches require large, high-quality datasets. Recently, Wang
et al. [190] used transfer learning to develop a transmembrane protein structure
prediction algorithm that relies on a soluble protein contact prediction algorithm
[191] and the Deep CNF transmembrane topology prediction algorithm [192]. Our
benchmark data can be used for direct learning, particularly toward incorporating
the all-important lipid composition and specificity features to move toward more
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Figure 3.9: Tilt angle prediction for biological peptides with a single transmembrane do-
main. A mapping between all sampled orientations and energies for (a) Acetylcholine receptor
segment M2, (b) Influenza A segment M2, and (c) VPU-forming domain of HIV-1 protein.
Here, tilt angle relative to the membrane normal (in degrees) is on the x-axis and depth
relative to the membrane center is on the y-axis. Each grid point is colored by franklin2019
energy, with low energies colored in dark blue and high energies colored in yellow. Further,
each grid point represents a 1Å and 1°increment. the lowest energy predicted orientation is
shown as a white circle, and where applicable the experimentally measured orientation is































Figure 3.10: Tilt angle prediction for designed peptides with a single transmembrane do-
main. A mapping between all sampled orientations and energies for (a) WALP23 and (b) a
poly-alanine helix with flanking tyrosine residues. Here, tilt angle relative to the membrane
normal (in degrees) is on the x-axis and depth relative to the membrane center is on the y-axis.
Each grid point is colored by franklin2019 energy, with low energies colored in dark blue and
high energies colored in yellow. Further, each grid point represents a 1Å and 1°increment.
the lowest energy predicted orientation is shown as a white circle, and where applicable the




























































































Figure 3.11: Rotation angle prediction for surface-adsorbed biological peptides. A map-
ping between all sampled orientations and energies for (a) Ovispirin 1 (b) Novispirin G10,
(c) Novispirin T2, (d) Magainin-cercopin hybrid, (e) Magainin-cercopin hyrbrid P2, and (f)
Magainin-cercopin hybrid P1. Here, rotation angle relative to the membrane surface plane
(in degrees) is on the x-axis and depth relative to the membrane center is on the y-axis. Each
grid point is colored by franklin2019 energy, with low energies colored in dark blue and high
energies colored in yellow. Further, each grid point represents a 1Å and 1°increment. the
lowest energy predicted orientation is shown as a white circle, and where applicable the





















































Figure 3.12: Change in energy with different bilayer thickness for hydrophobic length
estimate. The energy is normalized relative to the maximum score for the protein. Each
curve represents the change in energy with bilayer thickness for a different target. Each point













































































Figure 3.13: Comparison between experimentally measured ∆∆Gmut and franklin2019
water-to-bilayer score. Values for mutations to tyrosine and tryptophan are shown in (a) and
(b) respectively. Each position is colored by depth relative to the membrane center plane in
Å on a scale from blue (closer to the center) to yellow (closer to the interface/water barrier).
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Figure 3.14: Contributions of component energies to the ∆∆Gmut for mutations to tryp-
tophan. Energies are only listed for contributions > 0.1 REU to the ∆∆Gmut. These en-
ergy terms include the van der Waals attractive energy (fa_atr), repulsive energy (fa_rep),
Lazaridis-Karplus solvation energy (fa_sol), intra-residue repulsive energy (fa_intra_rep),
intra-residue Lazaridis-Karplus solvation energy (fa_intra_sol), orientation-dependent com-
ponent of Lazaridis-Karplus solvation energy (lk_ball_wtd), Coulomb electrostatics energy
(fa_elec), backbone-side chain hydrogen bonding energy (hbond_bb_sc), side chain to side
chain hydrogen bonding energy (hbond_sc), omega torsion energy (omega), Dunbrack ro-
tamer energy (fa_dun), knowledge-based backbone ϕ, ψ energy (rama_prepro, p_aa_pp),
amino acid reference energy (ref), and franklin2019 water-to-bilayer energy (dG_memb).
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Figure 3.15: Contributions of component energies to the ∆∆Gmut for mutations to ty-
rosine. Energies are only listed for contributions > 0.1 REU to the ∆∆Gmut. These en-
ergy terms include the van der Waals attractive energy (fa_atr), repulsive energy (fa_rep),
Lazaridis-Karplus solvation energy (fa_sol), intra-residue repulsive energy (fa_intra_rep),
intra-residue Lazaridis-Karplus solvation energy (fa_intra_sol), orientation-dependent com-
ponent of Lazaridis-Karplus solvation energy (lk_ball_wtd), Coulomb electrostatics energy
(fa_elec), backbone-side chain hydrogen bonding energy (hbond_bb_sc), side chain to side
chain hydrogen bonding energy (hbond_sc), omega torsion energy (omega), Dunbrack ro-
tamer energy (fa_dun), knowledge-based backbone ϕ, ψ energy (rama_prepro, p_aa_pp),












Figure 3.16: Difference in the depth-dependent side chain distribution between native
and designed sequences. The difference in distributions is calculated as the difference
between the area-under-the-curve for the native and designed amino acid distributions. The



































































Figure 3.17: Helix kink predictions for Adiponectin receptor 1 and Platelet activating re-
ceptor. A structure discrimination experiment for kinked and straight helix conformations
is shown for two of four targets: the open (5lxg) and closed (3wxv) conformation of the
adiponectin receptor 1 (left) and the active (5zkp) and inactive (5zkq) conformation of platelet
activating receptor 1. In (a) and (c), energies and kink angles for transmembrane helix 5
(red), 6 (blue) and 7 (purple). In (b) and (d), Conformation of the five lowest scoring models





Figure 3.18: Comparison between the native and five lowest scoring docked membrane
protein complexes from membrane view. The native membrane protein complex is colored
in gray and the docked models are colored by CAPRI criteria. Here, high-quality models are
in red, medium-quality models are in orange, acceptable models are in blue, and incorrect
models are in dark grey. Each panel shows docked models for one of the nine unbound
docking targets: (a) halorhodopsin, (b) bacteriorhodopsin, (c) cytochrome C oxidase, (d)
mitochondrial respiratory complex II, (e) cytochrome bc1, (f) methane monooxygenase, (g)






Figure 3.19: Comparison between the native and five lowest scoring docked membrane
protein complexes from top view. The native membrane protein complex is colored in gray
and the docked models are colored by CAPRI criteria. Here, high-quality models are in red,
medium-quality models are in orange, acceptable models are in blue, and incorrect models
are in dark grey. Each panel shows docked models for one of the nine unbound docking
targets: (a) halorhodopsin, (b) bacteriorhodopsin, (c) cytochrome C oxidase, (d) mitochondrial
respiratory complex II, (e) cytochrome bc1, (f) methane monooxygenase, (g) pentameric





















































































































































































































































































































































































































































































































































































































Table 3.6: Multi-pass α-helical and β-barrel proteins for orientation and hydrophobic thickness
test
PDB Protein Class
1fep Ferric enterobactin receptor β
1gzm Bovine rhodopsin α
1hxx OmpF porin channel β
1m0l Bacteriorhodopsin α
1nqe Cobalambin transporter β
1okc Mitochondrial ATP/ADP Carrier α
1p4t Neisserial surface protein A β
1qd6 OMP phospholipase A β
1qfg Ferric hydroxamate receptor (FhuA) β
1qj8 OmpX β
1qjp OmpA β
1r3j Potassium channek KcsA α
1rzh Photosynthetic reaction center α
1v55 Cytochrome C oxidase α
1yce Rotor ring of F-type Na+-ATP-ase α
2cfp Sugar-free lactose permease α
2qom EspP autotransporter beta-domain β
2x9k OmpG β
3aeh Autotransporter Hbp β
3dzm TtoA β
3syb OMP carboxylate channel β
3wbn MATE multidrug transporter α
3wfd Nitric oxide reductase α
3wxv Adopinectin receptor 1 α
4afk Alginate transporter AlgE β
4d5b OMP CymA β
4fqe Oligogalacturonate KdgM β
4hyj Proteorhodopsin α
4m48 Dopamine transporter α
4n6h Delta opioid receptor α
4rl8 COG4313 outer membrane channel β
4uc2 TSPO transporter protein α
4x5n SemiSWEET transporter α
4yl3 mPGES-1 inhibitor complex α
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Table 3.7: Reference OPM values for hydrophobic thickness, tilt angle, and depth
PDB Protein Length (Å) Angle (°) Depth (Å)
1fep Ferric enterobactin receptor 24.3 1 12.8
1gzm Bovine rhodopsin 32.2 11 -0.4
1hxx OmpF porin 24 0 -6.6
1m0l Bacteriorhodopsin 31.8 0 -1.7
1nqe Cobalambin transporter BtuB 23.4 5 9.8
1okc Mitochondrial ATP/ADP Carrier 29.5 14.1 -4.4
1p4t Neisserial surface protein A 24.9 22 6.5
1qd6 OmpLA 23.9 0 -5.2
1qfg Ferric hydroxamate receptor 24.7 5 -12.4
1qj8 OmpX 23.6 12 -7.3
1qjp OmpA 25.4 11 -3.8
1r3j Potassium channek KcsA 34.8 0 2.1
1rzh Photosynthetic reaction center 31.8 2 8.6
1v55 Cytochrome C oxidase 28 0 2.5
1yce Rotor ring of F-type Na+-ATP-ase 37 0 -4.2
2cfp Sugar-free lactose permease 31.1 2.2 -4.4
2qom EspP autotransporter beta-domain 25.1 6 7.7
2x9k OmpG 24.7 5 -7.6
3aeh Autotransporter Hbp 25.2 4 -7.6
3dzm TtoA 28.5 16 11.4
3syb Carboxylate channel (OpdP) 23.6 8 -6.8
3wbn MATE multidrug transporter 31.8 8 -0.7
3wfd Nitric oxide reductase 31.7 11.6 -0.4
3wxv Adopinectin receptor 1 32.8 15 -2
4afk Alginate transporter AlgE 24.8 3 7
4d5b CymA 23.5 8.3 10.6
4fqe Oligogalacturonate-specific KdgM 22.2 2 3.3
4hyj Proteorhodopsin 30 15 -1.5
4m48 Dopamine transporter 30.8 12 1.9
4n6h Delta opioid receptor 34 14 -9.1
4rl8 COG4313 23.4 6 -6.2
4uc2 TSPO transporter protein 30.4 1 4.6
4x5n SemiSWEET transporter 36.8 1 0.8
4yl3 mPGES-1 inhibitor complex 29.8 0 -3.9
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Table 3.8: Sequences and measured insertion energies for designed poly-leucine peptides
Name Sequence Membrane ∆Ginsert
GL5 GLLLLLRLLLLLG POPC 2.1
GL6 GLLLLLLRLLLLLLG POPC 0.5
GL7 GLLLLLLLRLLLLLLLG POPC -0.5
GL8 GLLLLLLLLRLLLLLLLLG POPC -1.5
GWL6 GWLLLLLLRLLLLLLLG POPC -0.5
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Table 3.10: Targets for helix kink prediction
Target State PDB
Potassium channel KcsA closed 1r3j
open-inactive 3f7v
B2-adrenergic GPCR inactive 2rh1
active 3p0g
Adiponectin receptor 1 closed 3wxv
open 5lxg




An heuristic implicit model for
electrostatic interactions in the
membrane environment
4.1 Overview
Electrostatics play an intimate role in membrane protein structure and function.
However, accurately capturing electrostatic energies in the low-dielectric membrane
often requires expensive Poisson-Boltzmann calculations that are not scalable for
membrane protein structure prediction and design. In this chapter, we develop a
fast-to-compute electrostatics model that considers the lipid bilayer. In proof-of-
concept benchmarks, we demonstrate that the updated energy function improves
partitioning energy estimates for pH-sensitive transmembrane peptides. These results
demonstrate promise for the electrostatic model to improve the accuracy of membrane
protein structure prediction and design.
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4.2 Introduction
Electrostatic interactions play an intimate role in membrane protein stability, struc-
ture, and function. In particular, the hydrophobic core of the bilayer de-screens
interactions between charged particles, giving rise to biophysical features that are less
frequently observed in the aqueous phase. For instance, hydrogen bonds between
Cα and OH groups are more common, have energies up to 3 kcal/mol [196, 197],
and facilitate dimerization [185]. To minimize the cost of inserting charged groups
into the membrane, arginine and lysine have been observed to snorkel toward the
interfacial region [198]. The protonation equilibria of titratable sites are shifted to
favor charge-neutral states [199, 200]. Additionally, the non-polar bilayer can increase
the strength of traditional hydrogen bonds [201].
Despite their importance, electrostatic forces are challenging to capture during
computational modeling. A primary difficulty is the computational cost of sampling
both solute and solvent degrees of freedom. To overcome this hurdle, electrostatic
calculations are typically based on macroscopic electrodynamics that treat the solvent
as a continuous medium and ignores solvent-solvent interactions [202, 203]. In this
approach, the dielectric is modeled as a parameter rather than a constant [204, 205].
A common approach to electrostatic calculations of biological systems is to numer-
ically solve the Poisson-Boltzmann (PB) equation [206]. In this formalism, electrostatic
forces are expressed as a system of second-order partial differential equations that can
be solved for the electric field caused by a collection of charges [88]. The PB equation
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is given in Eq. 4.1.
−∇ · [ϵ(r)∇ϕ(r)] + ϵ(r)κ2(r)sinh[ϕ(r)] = e
kBT
4πρ(r) (4.1)
Here, ϕ = eψ/kBT is the reduced electrostatic potential, ϵ is the dielectric value
in different phases (water, membrane, protein), κ is the Debye-Huckel screening
parameter, ρ is the charge distribution, and r is the position in three-dimensional
space. This model has been used extensively to compute electrostatic features of
membrane proteins including pKa values [207], insertion energies [208], and mem-
brane potentials [209]. While reliable, the PB equation is not scalable for structure
prediction and design calculations which often require 106 − 109 energy calculations
per trajectory.
A popular alternative to the Poisson-Boltzmann model is the analytical gener-
alized Born approximation. This method approximates atoms as charged spheres
whose internal dielectric is lower than the environment [210, 211]. The screening on
each atom is then determined by the local environment: more neighbors indicates an
atom will be less screened by water. De-screening (Dij) is computed as a function of
the dielectric constant in the solvent ϵs, dielectric constant in the protein ϵp, and the

















Then, the generalized Born energy for an atom pair is computed as a function of
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the de-screening, Born radius, partial atomic charges on atoms i and j, qi and qj, and





The generalized Born approximation is commonly used in molecular dynamics
simulations of membrane proteins [89, 143]. Yet, the radius calculation is still expen-
sive in the context of searching both conformational and sequence space. A third
possibility is the heuristic Coulomb equation. To account for a variable dielectric, we
can introduce a distance-dependent dielectric constant [212]. In Rosetta soluble pro-
tein calculations, this model has yielded a significant speedup relative to generalized
Born calculations [213] and has improved modeling of hydrogen bonds [137].
In previous work, Lazaridis [64] developed a formalism to account for the di-
electric variation with the bilayer. However, this method has not yet been tested
in the context of structure prediction and design. In this chapter, I develop a new
fast-to-compute Coulomb electrostatics model that considers the lipid bilayer. To
account for the low-dielectric membrane, the model extends the Coulomb energy and
considers shifted proton avidity for titratable sites. In proof-of-concept benchmarks,
the updated energy function improves partitioning energy estimates for pH-sensitive
transmembrane peptides. These results demonstrate promise for the electrostatic
model to improve the accuracy of membrane protein structure prediction and design.
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4.3 Methods
4.3.1 Bilayer-dependent electrostatics energy
I developed a bilayer-dependent electrostatics energy based on Coulomb’s inverse-
square law for the force between two stationary charged particles.The Coulomb
energy, the integral of the force expression, is computed as a function of the distance
between atoms i and j (dij), the partial atomic charges for atoms i and j (qi,qj), the
dielectric constant ϵ and the Coulomb constant C0 = 322 Å kcal mol−1e−2 (Eq. 4.5).








For soluble proteins, Rosetta uses a modified version of the Coulomb energy
with a distance-dependent dielectric [214]. Here, the constant ϵ is substituted by a
sigmoidal function ϵ(dij) that describes the transition between the dielectric constant
in the protein core (ϵcore = 6) and in the solvent (ϵsolvent = 80) [60]. Additionally, the
distance-dependent dielectric dampens long-range electrostatics; thus, the potential
is truncated at 5.5 Å and shifted by 1/dmax to equal zero at dmax [61]. The updated










To accommodate the lipid bilayer, we altered the function ϵ(dij) to additionally
depend on membrane depth. Here, membrane depth is captured by fractional hydra-
tion h (called fhyd in Chapter 3) [161]: a function that captures the three-dimensional
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shape of the implicit membrane as a dimensionless number that describes the solvent
environment given the position of an atomic group. When an atomic group is exposed
to lipids, h = 0; whereas when an atomic group is exposed to water, h = 1.0. The
hydration fraction for the atom pair hij is computed as the geometric average of the
hydration fraction for atoms i and j.
We empirically developed a linear mixture equation for ϵ(dij, hij) based on the
following requirements: (1) for a close atom pair in water, ϵ = 20, (2) for a distant
atom pair in water, ϵ = 80, (3) for a close atom pair in the bilayer ϵ = 2, and (4) for a
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Figure 4.1: Coulomb electrostatics model with a varying dielectric. (a) Requirements for
a membrane-dependent electrostatics potential: The energy increases when entering the
bilayer and at close atom pair distances. Green arrows indicate the direction of increasing
energy. (b) Dependence of the dielectric constant ϵ on fractional hydration h (dimensionless)
and atom-pair distance r in Å. Each grid point corresponds to a different dielectric constant,
colored from low (dark blue) to high (yellow). (c) Variation of the membrane-dependent
electrostatics energy as a function of fractional hydration h (dimensionless) and atom-pair
distance r in Å. Each grid point corresponds to a sample energy calculation for point charges
with opposing signs, and the energy varies from low (dark blue) to high (yellow). Note,
energy is represented on a logarithmic scale.
The resulting equation is given in Eq. 4.7, where D0 and D are constants. The
variation of ϵ(di j, hi j) with atom-pair distance and fractional hydration is illustrated
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as a heatmap in Fig. 4.1b.
ϵ(hi,j, di,j) = (1 − hi,j)D0r + hi,jDr (4.7)
Finally, we substituted ϵ(dij) in Eq. 4.6 for Eq. 4.7. The resulting form of the
bilayer-dependent electrostatics energy is given in Eq. 4.8. Further, the variation of










4.3.2 Shifting the pKa in the lipid bilayer
Most macromolecular modeling calculations assume the system is at neutral pH with
fixed protonation states for titratable side chains. While this assumption is valid
for some systems, it breaks down in a heterogeneous membrane environment. In
particular, proton avidity for titratable sites (the pKa) is influenced by electrostatic
interactions within the lipid bilayer [215, 216]. To accommodate, we introduced
protonation state sampling and a potential function that accounts for a shifted pKa in
the lipid bilayer.
We began with the Rosetta-pH framework developed by Kilambi & Gray [175].
This framework evaluates protonation probability using a simplified version of the
potential developed by Onufriev et al. [217]. Here, the probability of protonating an
isolated site is given by Eq. 4.9, an expression that is algebraically equivalent to the
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Henderson-Hasselbalch sigmoidal titration curve [218].
fprot =
1
10pH - pKa + 1
(4.9)
In this formalism, the protonation probability is 1/2 when the pKa of an isolated
site is equal to the pH. The pKa is equal to the unperturbed intrinsic pKa value of a
model compound in solution (pKa = 4.0 for Asp, 4.4 for Glu, 6.3 for His, 10.0 for Tyr,
and 10.4 for Lys). Then, the protonation potential is given by Eq. 4.10 where the factor
kBT is assigned a value of 0.59 kcal/mol which corresponds to 298K.
EpH = −kBT
{︄
ln( fprot) if protonated
ln(1 − fprot) if deprotonated
(4.10)
To accommodate the bilayer, we substituted the constant pKa value for a function
that depends on the fractional hydration hi of the titratable site i. We derived the
function using constant pH molecular dynamics data from Teixera et al. [125] that
quantifies the increase or decrease of pKa along the bilayer normal. The discrete data
points were converted to an analytic functional form through non-linear regression to
a generalized logistic equation (Eq. 4.11).
fpKa =
pKa,max
1 + exp(−a(hi − b))
+ pKa,min (4.11)
The fitted parameters for the five titratable residue types are given in Table 4.1
and a comparison of the raw data and resulting analytic forms is shown in Fig. 4.2.
To create the bilayer-dependent protonation potential, we simply substitute the
constant pKa value by the bilayer dependent pKa function (Eq. 4.11).
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Table 4.1: Logistic parameters for bilayer-dependent pKa model
AA a b pKa,min pKa,max
ASP -3.19 0.44 1.9 6.84
GLU -3.03 0.44 1.32 7.06
HIS 0.82 2.47 -1.49 5.25
LYS 1.13 0.7 1.27 8.99
CYS -3.59 0.8 3.34 11.87















Figure 4.2: Dependence of site pKa values on the membrane environment Shift in pKa with
bilayer depth for five protonatable side chains: aspartate (red), glutamate (blue), histidine
(green), lysine (purple), and tyrosine (orange). Data points from constant pH molecular
dynamics simulations are shown as dots with error bars and the analytic fit is shown as a
solid line.
4.3.3 Sampling alternate protonation states
To sample alternate protonation states, we designed a task operation that modifies
Rosetta’s rotamer packing process. Typically, a packing process samples rotamers for
the same chemical side chain type. This new task operation, called pHVariantTask-
Operation, samples both protonated and de-protonated rotamers for titratable side
chains. The sampling algorithm then relies on the energy term (above) to select the
appropriate protonation state. The task operation can be easily added to any existing
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Rosetta protocol.
4.3.4 Integrating new energy terms with franklin
We integrated the new energy terms into the existing franklin energy function in the
following manner. First, we substituted the standard fa_elec term with our bilayer-
dependent electrostatics energy, called fa_imm_elec. We kept the weight fixed at
1.0 to be consistent with the philosophy that molecular mechanics terms should not
require weighting. The weight of the membrane-dependent protonation potential
called menv_pH was set at 1.0 to ensure that the Henderson-Hasselbalch criteria
is satisfied. Finally, we chose to down-weight the water-to-bilayer energy from 0.5
to 0.25 to eliminate potential double counting. This new energy function is called
franklin2020.
4.4 Results & Discussion
4.4.1 pH-sensitive peptide insertion into lipid bilayers
I first evaluated the electrostatics model using a test that predicts the partitioning
energy of pH-sensitive peptides (Test #6 in Chapter 3). We chose to start with this
test because the calculation is sensitive to both dielectric and pKa shifts. The test is
modeled after work by Weerakkody et al. [166] who rationally designed 16 variants
of the wild-type pH low-insertion-peptide (pHLIP) [215]. The authors quantified par-
titioning energy by intrinsic tryptophan fluorescence in the presence of 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) liposomes at high pH (pH 8) and low pH
(pH 4-5; Fig. 4.3a). Then, the authors computed the water-to-bilayer transfer energy
as the difference in Gibbs free energy (∆G) of the interaction of variants with the
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Figure 4.3: Performance of the membrane-aware electrostatics model on predicting bilayer
insertion of pHLIP peptides. (a) Weerakkody et al. [166] measured the interaction of pHLIP
variants with lipid bilayers at high pH (pH = 8) and low pH (pH = 4-5). Intrinsic fluorescence
experiments approximate the value of ∆∆Gw,b: the water-to-bilayer transfer energy. Then,
the change in energy upon pH-shift in the bilayer is measured as the difference of ∆∆Gw,b
and pH 4 and pH 8 (blue). Panels (b) and (c) show a mapping of orientations to energies for
pHLIP variant # 4 at pH 4 (red) and pH 8. Light hues correspond to high energies and dark
hues correspond to low energies. The bottom right-hand panel shows the performance of (d)
franklin2019 and (e) the updated model on prediction of the ∆∆Gb,pH for pHLIP variants. The
dotted line is the line of best fit.
To attempt to recapitulate the experimentally measured ∆∆Gb, pH values, we
generated mappings of all peptide orientations to energies at both pH 4 and pH 8.
Orientation is given as a function of tilt angle (°) and bilayer depth (Å). Importantly,
the peptide side chains were re-packed at every grid point to allow sampling of
the alternative protonation states. This procedure was repeated for all 16 variants
and a sample mapping for variant #4 at pH 4 and pH 8 is shown in Fig. 4.3b and
Fig. 4.3c, respectively. At pH 8, we found that the peptide preferred the aqueous
phase; whereas, at pH 4 the peptide preferred a membrane embedded orientation.
This result is consistent with the experimentally observed behavior for pHLIP peptide
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insertion.
Next, we computed the partitioning energy as the energy difference between the
lowest-scoring embedded conformations at pH 4 and pH 8. The data for predictions
with franklin2019 and the results for the new model franklin2020 are reported in
Fig. 4.3d and Fig. 4.3e respectively. In the previous model, there was no correlation
between the experimentally measured and predicted values (R = 0.197). In contrast,
the new electrostatics model results in a correlation of R = 0.679. Thus, the new
electrostatics and pH-sensitive energy terms significantly improved predictions. Note,
both R values exclude variants #3 and #16 as these peptides meet the Grubb’s outlier
criteria.
4.4.2 Transmembrane peptide insertion and neutral pH
Next, we investigated the performance of the model on the insertion of transmem-
brane peptides at neutral pH. To evaluate, we ran benchmark test #1 from Chapter 3.
In summary, this test generates a mapping of orientations to energies for six transmem-
brane peptides and then compares the lowest energy tilt angle to the experimental
measurement. The results are summarized in Fig. 4.4.
The performance of the new electrostatics model on the test #1 dataset is mixed.
For four targets (1a11, 2nr1, poly-W and poly-Y), the peptide preferred a reasonable
membrane orientation with a tilt between 0-30°and a depth close to the bilayer center.
However, for 1mp6 and 1pje, the tilt angle minimum was closer to 90°. This result
suggests that the new energy terms make the model too hydrophobic, thus incorrectly




































































































Figure 4.4: Prediction of non-pH dependent transmembrane peptide insertion. Prediction
of orientation for six transmembrane peptides: (a) acetylcholine receptor, PDB 1a11, (b)
M2 proton channel segment, PDB 1mp6, (c) VPU-forming domain, PDB 1pje (d) NMDA-
receptor, PDB 2nr1, (e) designed poly-alanine peptide with flanking tryptophan residues and
(f) designed poly-alanine peptide with flanking tyrosine residues. Each grid point represents
the energy at a particular orientation, given as a function of tilt angle in degrees and depth
in Å. The grid points are colored according to energy, with dark green hues corresponding
to low energies and light green hues corresponding to high energies. White green triangles
indicate the experimental solid-state NMR measurement of peptide tilt angle when available.
4.5 Conclusion
We have developed a molecular mechanics electrostatics model that considers the
influence of the lipid bilayer. To account for the low-dielectric membrane, the model
extends the Coulomb energy and considers shifted proton avidity for titratable sites.
In proof-of-concept benchmarks, we demonstrated that the updated energy function
improves partitioning energy estimates for pH sensitive transmembrane peptides.
A next step is to run the remaining 10 benchmarks from Chapter 3 and iteratively
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optimize the model. The model provides a starting point for considering two-body




An in silico method to analyze
ZMPSTE24 stability
This chapter includes material from Spear ED, Alford RF, Babatz T, Wood
K, Mossberg O, Odinammadu K, Shilgardi K, Gray JJ, and Michaelis S
(2019) "A humanized yeast system to analyze cleavage of Prelamin A by
ZMPSTE24" Methods 157:47-55.
5.1 Overview
Over the past decade, the parity of α-helical bundle and β-barrel membrane proteins
has been challenged by an influx of new membrane protein structures from previously
unexplored families [219, 220]. A key takeaway is that membrane proteins are not
simple cylinders: they occupy wide-ranging folds to perform their functions. For
computational tools, capturing sophisticated protein folds further complicates the
already difficult task of modeling the protein and bilayer. To learn more about
these systems, we embarked on a collaborative study of the Integral Membrane Zinc
Metalloprotease (ZMPSTE24). In this chapter, I describe a computational tool that
compliments an experimental assay to probe the influence of mutations in ZMPSTE24
136
on protein stability and function.
5.2 Introduction
The ZMPSTE24 gene has been associated with several rare diseases characterized by
premature aging phenotypes. Mutations in the LMNA gene cause the premature aging
disorder Hutchinson-Gilford Progeria Syndrome (HGPS) [221–225]. By one year of
age, children with HGPS manifest accelerated aging symptoms, including failure to
thrive, lipodystrophy, hair loss, join ailments, and cardiovascular disease [221, 226].
Mutations in the ZMPSTE24 gene cause recessive diseases that share many features
with HGPS. Restrictive dermopathy (RD) is a neonatal lethal disease with earlier onset
and greater sensitivity than HGPS, whereas mandibuloacral dysplaysia-type B (MAD-
B) develops later in life with milder symptoms. RD mutations ablate ZMPSTE24
function while ZMPSTE24 proteins with MAD-B mutations exhibit some residual
function [227–229]. Understanding the molecular mechanisms of these premature
aging diseases may bring significant insight into human health and longevity.
Previous work has revealed that the ZMPSTE24 protein is responsible for mat-
uration of the nuclear scaffold protein lamin A from its precursor prelamin A. The
complete biogenesis pathway of mature lamin A from its precursor, prelamin A, in-
volves four enzymatic steps (Fig. 5.1). Prelamin A terminates with a C-terminal CAAX
motif (where “C” is cysteine, “A” is generally an aliphatic amino acid and “X” is any
amino acid other than proline). The CAAX motif directs the post-translational pro-
cessing steps collectively called “CAAX processing” in which the cysteine sulfhydryl
is farnesylated, followed by endoproteolytic cleavage of the -AAX tripeptide, and
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carboxyl methylation of the farnesylated cysteine residue [229–232]. What distin-
guishes prelamin A from other CAAX proteins is that following these processing
steps, prelamin A undergoes an additional cleavage mediated by ZMPSTE24 [233,
234]. Failure to perform this final cleavage results in accumulation of permanently
farnesylated and carboxyl methylated prelamin A. This molecule causes aberrant
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Figure 5.1: Maturation of the nuclear scaffold protein lamin A from the precursor
prelamin A. The biogenesis of mature lamin A involves four steps: (1) farnesylation of
the CAAX domain, (2) cleavage of -AAX by ZMPSTE24, (3) carboxyl methylation of the
cystiene residue, and (4) full cleavage of the farnesyl domain.
ZMPSTE24 is an integral membrane proteins with seven transmembrane spans
that is localized to both the inner nuclear membrane as well as the endoplasmic
reticulum membrane [236–238]. The recently solved X-ray crystal structures of human
ZMPSTE24, and that of the virtually superimposable yeast Ste24, reveal a completely
novel and fascinating class of protease [239–241] (Fig. 5.2). The seven transmembrane
spans comprise a helical barrel that surrounds a voluminous intra-membrane “hollow”
chamber, large enough to accommodate about 450 water molecules. Surprisingly,
the HEXXH active site conserved among all zinc metalloproteases does not face the
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cytosol or nucleoplasm, but rather resides inside of this barrel in ZMPSTE24/Ste24.
Side portals apparent in the structure are likely to provide access into the chamber






Figure 5.2: Structure of the human integral membrane zinc metalloprotease ZMPSTE24.
(a) Crystal structure of the seven transmembrane spanning zinc metalloprotease (PDB 2ypt).
(b) Clipped view of ZMPSTE24 revealing the hollow chamber of water.
Recently, Dr. Michaelis and Dr. Spear developed a high-throughput assay to probe
structure-function relationships between ZMPSTE24 and its prelamin A substrate
[229]. The assay is a fully humanized Saccharomyces cerevisiae system that can assess
the activity and in vivo stability of disease or synthetic alleles of ZMPSTE24 relative
to wild type. An example of this analysis for human disease alleles is shown in
Fig. 5.3.In this chapter, we describe a complimentary in silico protocol to investigate
the molecular mechanism underlying these mutations.
5.3 Methods
Our computational analysis was performed using a protocol adapted from the Rosetta
∆∆G protocol with flexible backbones described by Barlow and coworkers [242, 243]:
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Figure 5.3: Structure-function studies of ZMPSTE24. (A) X-Ray crystal structure of human
ZMPSTE24 (PDB entry 2ypt) embedded in the lipid bilayer with zinc indicated by the yellow
ball and disease residues indicated with red balls. Disease alleles are labeled in black, with
alanine changes in blue. (B) Average cleavage and standard deviation of the mean for
three independent experiments is shown, with wild-type ZMPSTE24 activity set to 100% for
comparison. (C) ZMPSTE24 protein levels were analyzed by western blotting using anti-HA
(normalized to the loading control Sec61). The average and standard deviation of the mean is
shown for the same three experiments as in (B). Wild-type ZMPSTE24 protein levels are set to
100% for comparison.
Starting with the crystal structure of ZMPSTE24 (PDB 2YPT) [241], we applied the
∆∆G protocol to generate refined model of both the native and mutated proteins.
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Each model is an ensemble of 50 structures representing the most likely conformations.
Then, we calculated the change in stability using the Rosetta all-atom energy function
[61]. Rosetta calculates macromolecular energies as a linear combination of terms that
evaluate van der Waals, electrostatics, solvation, backbone, and side chain energies.
Here, we computed the ∆∆Gmut(X → Y) as the difference between the average score
of the mutant conformation ensemble ∆G(X) and the native conformation ensemble
∆G(Y) (Eq. 5.1).
∆∆Gmut(X → Y) = ∆G(X)− ∆G(Y) (5.1)
Further, we evaluated the contribution of individual energies to the using Py-
Rosetta tools described in Chaudhury et al. [66].
5.4 Results
We used the Rosetta macromolecular modeling suite [51] to explore if we could
generate structure-based hypotheses of each ZMPSTE24 variant’s role in stability.
Our approach is adapted from the flexible-backbone ∆∆G protocol described in
Barlow and coworkers [242, 243]. The goal was to calculate the free-energy change
for each mutant as compared to WT ZMPSTE24, since the predicted thermodynamic
cost of a mutation might provide insight into the observed changes in in vivo stability.
The first step was to compare the calculations to the experimental in vivo stability
and cleavage measurements from [229] for each variant. The calculated and experi-
mental data are graphed in Fig. 5.4. In general, for this panel of mutants, we observed
that the calculated values (y axis), expressed as Rosetta Energy Units (REU), exhibit
a strong negative correlation with protein stability (Fig. 5.4A). As the magnitude
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of ∆∆Gmut decreases, protein expression, which reflects in vivo stability, increases.
For instance, the P248L is predicted by Rosetta to be much less thermodynamically
stable than WT and Y399A is predicted to be more stable than WT, which roughly
match the experimental data. The ∆∆Gmut of L94P is an outlier in our dataset. These
results indicate that the thermodynamic stability measurements calculated by Rosetta
correlate reasonably well with in vivo stability and suggest that what the cellular
machinery detects as mis-folding is reflected in the Rosetta energy calculations of
thermodynamic stability.
Figure 5.4: Comparison of experimentally measured ZMPSTE24 stability and cleavage
with computed ∆∆Gmut values for mutant ZMPSTE24. The ∆∆Gmut is the predicted differ-
ence in free energy of folding between a WT and mutant protein. A) The calculated values
in Rosetta Energy Units (REU) (y axis) for the indicated mutant alleles of ZMPSTE24 is com-
pared with the level of ZMPSTE24 stability (denoted as expression; x axis). When the proline
mutation L94P is excluded, the correlation coefficient is -0.843. (B) Comparison of calculations
(y axis) with percentage of prelamin A cleavage determined in Fig. 4A (x axis). When the
proline mutation L94P is excluded, the correlation coefficient is -0.207. Disease variants are in
red and additional variants are in blue. Horizontal error bars are the standard deviation of
the mean.
In contrast to the stability measurements, the prelamin A cleavage results do not
correlate well with the Rosetta predictions (Fig. 5.4B). For instance, the of Y399C
is 1.711 REU, while that of Y399A is strikingly low, yet both show strong cleavage
defects. This result is not unexpected, because the Rosetta energy function is designed
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to capture thermodynamic and not catalytic effects.
To further investigate how the calculated ∆∆Gmut values relate to predicted struc-
tural changes for these two mutations, we used energy decomposition and struc-
ture visualization. The comparison of the energy breakdown and structures for the
Y399A/Y399C variants is shown in Fig. 5.5.
Figure 5.5: Structural and energetic effects of Y399A vs. Y399C in ZMPSTE24. We com-
pared the Y399A and Y399C variants by analyzing the decomposed Rosetta energies and
structural ensembles. (A) Decomposed ∆∆Gmut of the Y399C ZMPSTE24 variant. (C) Low-
est scoring structure in the native ensemble (gray) superimposed onto the lowest scoring
structure in the Y399A ensemble (purple). The native tyrosine is highlighted in blue and the
mutant alanine is highlighted in red. Side chains within 3.0Å of the mutation are shown. (D)
Lowest scoring structure in the native ensemble (gray) superimposed onto the lowest scoring
structure in the Y399C ensemble (purple). The native tyrosine is highlighted in blue and the
mutant cysteine is highlighted in red. Side chains within 3.0Å of the mutation are shown.
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In the Y399A variant, the conformation loses favorable van der Waals attractive
and electrostatic interactions, likely due to the loss of a hydroxyl group capable
of hydrogen bonding to nearby side chains (Fig. 5.5A). However, this mutation is
rescued by favorable side-chain conformations and solvation energies-define these
terms briefly. The rotamer score improves because alanine is very small and is easy
to fit into a pocket. The solvation score improves because position 399 is buried,
thereby minimizing exposure of the hydrophobic alanine to solvent (Fig. 5.5C). In
contrast, Y399C also loses favorable van der Waals and electrostatic interactions
(Fig. 5.5B). This variant is not rescued by favorable solvation because cysteine is not as
hydrophobic as traditional nonpolar residues. For Y399C, the structure is particularly
revealing (Fig. 5.5D). There is a cysteine nearby capable of forming a disulfide bond
with position 399, further deforming the aqueous cavity and potentially impacting
catalytic activity. Overall, this structure-based analysis of Y399A and Y399C provides
insight into the mechanism of stability loss and may ultimately be useful to suggest
sites for potential therapeutics that rescue activity.
5.5 Discussion
In this work, we developed a computational method to compliment the humanized
ZMPSTE24 assay. Our approach yielded in mechanistic models of ZMPSTE24 disease
alleles. As a result, we generated model-based hypotheses on how the protein quality
control machinery selects and degrades some mis-folded variants, while ignoring
others. In addition to ZMPSTE24 insights, this collaborative study also revealed key
areas for computational method improvement detailed below.
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Proline residues. Proline residues occur frequently in membrane proteins, espe-
cially to facilitate kink and hinge formation. In this study, we found that the stability
effects of disease alleles involving proline substitutions were not correctly modeled.
We hypothesize this occurs because the backrub protocol does not capture the large
backbone conformational change involved in accommodating a proline ring. This
suggests that additional sampling may be required to accurately capture the change
in stability due to proline substitutions.
Implicit membrane model. In this study, we used ref2015 to capture the energetic
costs of single point mutations. This approximation was practical because most
mutation sites were exposed to the inside of the aqueous chamber of ZMPSTE24.
However, it is more realistic to incorporate the membrane. Rosetta currently uses
an implicit membrane model that can capture different pore shapes, however this
does not extend to enclosed chambers. This suggests that the pore model will need to
become even more flexible in the future.
Large protein size. A third challenge is that many membrane proteins including
ZMPSTE24 include more than 500 residues. The large size significantly increases
computational cost of the modeling protocol. This suggests a need for more efficient
sampling strategies that can accommodate larger proteins.
Overall, this chapter reveals important future challenges for computational meth-
ods that model the effects of mutations on membrane protein stability. We anticipate
these takeaways will be helpful in guiding future methods development efforts.
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Chapter 6
Protein docking and steered
molecular dynamics reveal
alternative regulatory sites on the
SERCA calcium transporter
With permission from the publisher, this chapter includes material from
Alford RF, Smolin N, Young HS, Gray JJ, and Robia SL (2020) "Protein
docking and steered molecular dynamics suggest alternative regulatory
sites on the SERCA calcium transporter" Journal of Biological Chemistry
6.1 Overview
The transport activity of the sarco(endo)plasmic reticulum calcium ATPase (SERCA)
in cardiac muscle cells is modulated by an inhibitory interaction with a 52-residue
transmembrane peptide, phospholamban (PLB). Biochemical studies have revealed
that PLB interacts with a specific inhibitory site on SERCA; yet, there is also low-
resolution structural evidence that PLB interacts with alternative sites that are distinct
from the inhibitory site. High-resolution structures would illuminate the structural
determinants of regulation; however, experiments are complicated by the dynamic
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nature of the regulatory complex. In this study, we use computational approaches to
develop a structural model of SERCA-PLB interactions, toward a mechanistic under-
standing of SERCA transport regulation by PLB. Steered molecular dynamics (SMD)
and membrane protein-protein docking experiments were performed to investigate
the apparent affinity of PLB interactions with candidate sites on SERCA. We modeled
the relative binding of PLB to several different conformations of SERCA, represent-
ing different enzymatic states sampled during the calcium transport catalytic cycle.
Overall, the SMD and docking experiments indicate that the canonical binding site
of the ideal conformation is preferred, but the binding preference becomes more
ambivalent for other conformers. These structural models of SERCA-PLB interactions
suggest PLB can interact with many loosely defined binding sites though rotation
and translocation, enabling dynamic regulation of Ca2+ transport.
6.2 Introduction
The family of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCA) is responsible
for sequestering calcium into the sarcoplasmic and endoplasmic reticulum, creating
a reservoir for intracellular Ca2+ signaling. These transporters are important in all
cell types and are tightly controlled such that Ca2+ handling can rapidly adjust to
changing physiological demands [244, 245]. A prime example is the regulation of the
SERCA2a transporter in cardiac muscle cells. Calcium transport is reduced under
resting conditions in the unstimulated heart through an inhibitory interaction with
a single-span transmembrane peptide, phospholamban (PLB), which decreases the
affinity of SERCA for its substrate, Ca2+. The mechanism for this may be slowing
the rate of the structural transition that occurs after binding of the first Ca ion [246],
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and decreasing the rate of the transition between enzymatic states E1P and E2P
[247]. Inhibition of SERCA by PLB is relieved at high Ca2+ concentrations or by
phosphorylation of PLB by protein kinase A (PKA) [248] or calcium-calmodulin
dependent kinase II (CaMKII) [249, 250] after stimulation of the heart by adrenaline
[251]. Thus, PLB regulation of SERCA provides an “adrenaline trigger” to increase
Ca2+ transport and increase cardiac output during exercise. The importance of this
regulatory mechanism is underscored by the association of disordered Ca handling
and heart disease [252]. This makes SERCA an attractive therapeutic target [253, 254]
and motivates investigation of the structural elements that govern SERCA function.
Efforts to elucidate the mechanism by which Ca2+ and PLB phosphorylation
relieve SERCA inhibition have focused on the relationship between SERCA-PLB
binding and Ca2+ transport activity. Some studies suggested that SERCA inhibition
is relieved by dissociation of the complex [255–257]. However, previous studies
by our lab [258–261] and others [262–268] indicate that PLB remains bound after
phosphorylation and in high Ca, and relief of inhibition is due to a structural change
of the intact regulatory complex. Specifically, we previously hypothesized that the
PLB transmembrane domain could become displaced from the canonical PLB-binding
cleft and translocate to a non-inhibitory site on SERCA [261].
Structural models have further illuminated the mechanisms of SERCA regulation
[269, 270]. Previous X-Ray crystallography studies have mapped out nearly every
step in the SERCA transport cycle, revealing the different conformations of the
intermediate enzymatic states [271, 272] (Fig. 6.1b) . Among the different states, the
cleft formed by transmembrane helices M2, M6, and M9 is relatively more open or
closed, structural transitions between SERCA conformers may alter contacts with
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PLB. However, high-resolution structures of the SERCA-PLB regulatory complex
have been elusive. One X-ray crystallographic structure that reveals aspects of the
SERCA-PLB complex (Fig. 6.1a, “4KYT”) [255] was obtained by exploiting a mutant
form of PLB that greatly increases affinity and inhibitory potency. The degree to which
this mutant recapitulates the regulatory complex structure of the wild-type protein
is unknown. Moreover, several alternative interactions between SERCA and PLB
are suggested by additional studies. X-ray crystallography [273, 274] and modeling
[275] studies of closely related P-type ATPase, the sodium/potassium ATPase (NKA)
indicated that NKA regulatory subunits, the FXYD family of proteins, bind to the
outside of helix M9 (Fig. 6.1a, green). Another accessory binding site was suggested
by electron crystallography of SERCA and PLB, which involves an interaction of PLB
with transmembrane segment M3 of SERCA (Fig. 6.1a, red) [276–278]. These studies
suggest novel regulatory complex configurations, but higher resolution models are
required to reveal the mechanistic significance of these alternative modes of PLB
binding.
Computational methods offer a promising route to elucidating protein-protein
interactions, especially when paired with experimental data. Methods for modeling
protein-protein interactions are well-established for soluble proteins [279]; however,
progress for membrane proteins has been delayed because of the paucity of known
structures [219] and difficulty accounting for the lipid bilayer. One approach is Molec-
ular Dynamics (MD) which simulates the time-evolved behavior of a macromolecular
system using Newton’s equation of motion. Molecular dynamics most accurately
represents the lipid bilayer; however, the large system size requires computationally



















Figure 6.1: Exploring possible binding sites for phospholamban on different enzymatic
states of SERCA. In this study, we examined the interaction of PLB with three different
enzymatic states of SERCA. The three states are shown in (a): the E1-like state of SERCA
bound to PLB (purple) (PDB 4KYT), the E2 calcium-free state (PDB 3AR4), and the E1 calcium
bound state (PDB 1SU4). The canonical inhibitory binding site is formed by helices M2, M6
(blue), and M9 (green). The two postulated alternative sites are binding to the outside of helix
M9 (green) and M3 (red). The role of each state in the catalytic cycle of ATP-mediated SERCA
transport is shown in (b). Panel (c) shows two methods for exploring PLB interactions with
SERCA. Steered molecular dynamics simulations pull PLB away from a postulated binding
site and quantitate the unbinding force. In contrast, membrane protein docking tests possible
interaction sites and quantitates the binding energy.
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docking aims to predict the best binding conformation between two macromolecular
partners [280]. Recently, a handful of protein-protein docking methods have been
adapted to account for the membrane [65, 159, 281]. These methods are faster to com-
pute and can examine both where and how macromolecular partners bind. However,
many of the membrane-adapted methods are validated on a small dataset [186] and
approximate features of the lipid bilayer.
When performed together, molecular dynamics and protein-protein docking can
provide complimentary information about ideal binding conformations. Molecular
dynamics approaches can account for explicit lipid-protein interactions; yet require
enhanced sampling techniques that bias interactions. On the other hand, protein-
protein docking tools can explore potential interactions in an unbiased manner yet
approximate the bilayer environment. To overcome these barriers, we used a compu-
tational approach that integrates both molecular dynamics and molecular docking to
develop a model for PLB interactions with the SERCA2a pump. For molecular dynam-
ics, we chose to employ steered molecular dynamics (SMD)[282]: a well-established
technique for examining protein-protein interactions by inducing receptor-ligand
unbinding on an accessible timescale (Fig. 6.1c, “pulling”). Importantly, SMD offers
the opportunity to quantify the unbinding force required to extract PLB docked to
a candidate site in the context of an all-atom lipid bilayer, with peak force taken as
an index of the affinity of PLB for that site. For molecular docking, we used Roset-
taMPDock: a tool that combines soluble Rosetta protein-protein docking [283] with
the membrane protein framework that accounts for the position, orientation, and
physical chemistry of the lipid bilayer (39) (Fig. 6.1c, “docking”). We applied these
techniques to modeling the relative binding of PLB to three conformations of SERCA
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(Fig. 6.1a) that represent major intermediates in the calcium transport cycle (Fig. 6.1b).
Together, these techniques revealed both where and how PLB binds to the SERCA
pump, providing insight into the structural determinants of the regulatory interaction
of PLB with different enzymatic states of SERCA.
6.3 Methods
6.3.1 Preparation of starting structures
The SERCA/PLB complex was modeled from crystal structures of SERCA1a, the
skeletal muscle isoform for which many conformations are available [272]. This iso-
form has high homology to the cardiac specific Ca pump, SERCA2a, and the recently
published first structure of SERCA2a showed that the known PLB-binding site is
highly conserved between these isoforms [284]. Here we generated models starting
from three different SERCA1a structures: 1SU4 [285], representing an E1 Ca-bound
state; 3AR4 [286], representing an E2 Ca-free state; and 4KYT [255], representing a
Ca-free state bound to PLB. The latter Ca-free X-ray crystal structure was designated
an E2 structure, but the conformation resembles an E1 structure, and is referred to as
“E1-like” in the present study. In that x-ray crystal structural solution, the cytoplasmic
domain of PLB was not observed. In addition, 4KYT contains structure of mutated
PLB; for experiments that simulate interaction of WT-PLB with SERCA we mutated
the residues back to the native sequence.
6.3.2 Steered molecular dynamics simulations
We examined transmembrane domain residues 22-52 of PLB docked in the canonical
binding cleft of 4KYT or the equivalent site on 1SU4 or 3AR4. To test the possibility of
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PLB binding to the putative alternative sites on SERCA, we created a model of the PLB
bound to M9 using as a guide the NKA co-crystal structure with a FXYD protein [274,
275]. PLB was also docked to M3 to test a possible interaction hypothesized from cryo-
EM studies of SERCA-PLB co-crystals [277, 278]. Additional models were generated
to represent different relative orientations of PLB with respect to the binding interface
on SERCA, rotating PLB around its long axis by 90°, 180°, and 270°.
All-atom MD simulations were carried out with the CHARMM 36 force field
[287–289] and TIP3P water model [290]. Energy minimization was performed on the
crystal structures using the steepest descent method for 1000 steps, then each model
was embedded into a POPC lipid bilayer and solvated in a rectangular water box
size with dimensions 130 Å by 130 Å by 160 Å . Na+ and Cl− ions were added to the
solution to neutralize the charge of the system and to produce an ion concentration
of 150 mM. The Particle Mesh Ewald method [291, 292] was used to calculate the
long-range electrostatic interactions and cut-off of 12 Å was used for the short-range.
Van der Waals interactions were reduced to zero by switch truncation applied from 8
to 12 Å. Simulations were carried out with an integration time step of 2 fs. To reach
the target temperature (300 K) and pressure (1 bar) the Berendsen method was used
with relaxation times of 0.1 ps [293]. After 1 ns equilibration, the production run was
performed in the NPT ensemble using the Nose-Hoover thermostat [294, 295] and
the Parrinello-Rahman barostat [296, 297] with relaxation times of 1.0 ps. The atomic
coordinates of the trajectories were saved every 1 ps. The steered molecular dynamics
(SMD) runs were carried out for 5 ns each.
To test the reproducibility of the experiments, three independent SMD runs were
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performed for each orientation of PLB. Pulling force was applied with a spring con-
stant of 1000 kJ/mol/nm with a constant pulling velocity of 0.001 nm/ps. Increasing
the pulling speed increases the rupture force [298], but does not change the relative
“stickiness” of candidate binding sites. Hence, this approach is useful for comparing
the relative affinities of different binding modes. For these computationally intensive
experiments we found that a pulling speed of 0.001nm/ps is an ideal compromise
that allows sufficient time for side chain and lipid motions. Force was applied to
backbone atoms of PLB transmembrane residues (ASN27 - ILE48), pulling PLB away
from the candidate SERCA binding site along line connecting the SERCA binding
site and TM region of PLB. During SMD run positions of SERCA Ca2+ atoms were
constrained and atoms of PLB were allowed to move only in XY direction (in the
membrane plane), and not along Z axis (normal to the membrane plane). During
SMD runs we recorded pulling force values as a function of time, recording the peak
force (rupture force) as an index of the affinity of PLB for the candidate binding site.
6.3.3 Protein-protein docking simulations
A search for SERCA-PLB interaction sites was performed using global and local
docking. Each crystal structure was first refined using RosettaMPRelax [65] to erase
artifacts from crystallization and prior binding ligands. To accomplish this, the
protocol performs cycles of small backbone torsion moves followed by side-chain
repacking and energy minimization of all torsion angles (ϕ, ψ, χ) [145]. For each
starting structure, 50 PLB orientations were generated, and the lowest energy confor-
mation was used as the next starting pose. Next, the ClusPro Fast-Fourier Transform
(FFT)-based rigid-body docking server [299, 300] was used to perform a global search
for SERCA-PLB binding sites. Then, the following criteria were used to filter solutions
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from the best-scoring clusters: (1) the conformers are in the correct direction (e.g.
V49G) and (2) the conformers span the membrane.
Following global docking, RosettaMPDock [65] was used to locally search for
PLB binding orientations. RosettaMPDock an adaptation of the RosettaDock [283]
minimization protocol that locally searches for docked PLB orientations through two
stages (a) a coarse-grained stage to quickly identify favorable orientations and (b)
an all-atom refinement stage that optimizes the rigid body position and side-chain
rotamers. To account for the membrane environment, RosettaMPDock samples the
protein-membrane orientation and represents the bilayer using an implicit membrane
model. An implicit approach represents the solvent as a continuous medium rather
than individual “explicit” solvent molecules. In this work, we used the Lazaridis
Implicit Membrane Model (IMM1/EEF1) [63, 64] which captures the membrane
environment as three phases: an isotropic water phase, an isotropic hydrophobic
phase, and an anisotropic phase corresponding to the interfacial region. The IMM1
model is 30Å thick which is similar to the thickness of the endoplasmic reticulum
membrane [6].
For each starting pose, 5,000 PLB orientations were generated. Then, the interface
analyzer protocol [301] was used to compute two properties: (a) Axial Angle – the
angle between the second principal axis of the 4KYT PLB conformation and the
candidate PLB conformation and (b) ∆∆Gbind - the change in Rosetta energy when
the chains are separated versus when they are in complex.
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6.3.4 Z-score analysis
To quantify the significance of each major mode of SERCA-PLB binding, we computed
two scores that measure the similarity of binding conformations, with values of zero
indicating the conformations are identical, and larger values corresponding to greater
differences. The first score called zall evaluates the relationship of a particular binding
conformation relative to the mean of all possible binding conformations. The second
score, called zsite , computes the same quantity but relative to the mean of all structures
interacting with a specific site (e.g. M3, M6/M9 or the outside of M9). For docking,
the mean was computed from the top 5% of structures ranked by ∆∆G of binding.
6.4 Results
To test whether PLB may bind to putative alternative sites, we performed steered
molecular dynamics and protein-protein docking of PLB to different conformations
of SERCA. These conformations are sampled as SERCA progresses through the
catalytic cycle (Fig. 6.1b), binding Ca ions from the cytoplasm and transporting them
into the lumen of the sarcoplasmic reticulum. In this study, we examined three
key SERCA conformations (Fig. 1A): (1) the calcium-free E1-like state bound by
PLB (represented by 4KYT) [255], the calcium-free E2 state (represented by 3AR4)
[286], which is characterized by a more open PLB-binding groove compared to
4KYT, and (3) the calcium-bound E1 state (represented by 1SU4) [285]. The starting
structure of the PLB TM domain was taken from the PLB-SERCA complex 4KYT. The
cytoplasmic domain of PLB was not detected in this X-ray structure and was omitted
from the SMD simulations. Previous biochemical studies have demonstrated that the
transmembrane domain is sufficient for binding and inhibition of SERCA [302].
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6.4.1 Steered Molecular Dynamics (SMD) Simulations
To perform SMD simulations, the SERCA residue Cα atoms positions were first re-
strained by applying a spring force to each Cα atom, preventing significant deviations
from the starting position. Pulling force was applied uniformly toCαresidues of PLB,
with force directed away from the center of mass of the SERCA TM domain. Fig. 6.2a
quantifies the force applied to PLB (vs. time) for three repeated simulations of PLB
interacting with the canonical cleft of 4KYT beginning with the original orientation of
PLB in the crystal structure. As the simulation progressed, the number of interacting
residues decreased until the interaction was broken. As pulling progressed, force
increased to a maximum, then rapidly declined to a non-zero plateau. The peak force
represents the point at which the PLB-SERCA complex ruptured and was quantified
as an index of binding affinity. The plateau force was due to viscous drag of the lipid
bilayer after the loss of the protein-protein contacts.
For the equilibrated PLB-SERCA crystal structure (4KYT), we determined a peak
force of 1292±69 kJ/mol/nm (error is standard deviation for n = 3). The simulation
was then repeated for four different PLB orientations, rotating the helix around its
long axis by 90°, 180°, and 270°. Simulations of alternative axial orientations showed
30% lower peak force (Table 6.1), Fig. 6.2b-c), which is consistent with the native
orientation of PLB in the X-ray crystal structure being the most stable configuration.
Z-score analysis is given in Supplementary Table 6.3.
6.4.1.1 SMD of PLB Docked to Alternative Sites
We performed SMD experiments comparing PLB bound to the canonical M6/M9 site

































Figure 6.2: Steered molecular dynamics simulations of PLB interactions with different
sites on three enzymatic states of SERCA. (a) Quantification of force that developed as PLB
was pulled away from the canonical cleft of the E1-like-PLB state of SERCA. Data are three
repeated measures of force for the original orientation of the X-Ray crystal structure (PDB
4KYT) and after axial rotation of PLB by 90°, 180°, and 270°. (b) Peak unbinding force from
SERCA in kJ/mol/nm upon dissociation with transmembrane (TM) helix 3 (M3; red), or the
canonical cleft formed by TM helices 6 and 9 (M6/M9; blue), or the outside of TM helix 9 (M9;
green). (c) Z-score analysis of peak unbinding forces relative to the mean pulling force at the
M3 (red), canonical (blue) and outside M9 (green) sites. Structural models of key interactions
with non-canonical sites are shown in the bottom row. (d) Interaction of PLB (purple) with the
canonical binding site formed by helices M6 (red) and M9 (green) in the E1-calcium bound
state of SERCA (PDB 1SU4). (e) Interaction of PLB (purple) with the M9 accessory site (green)
in the E2 calcium free state of SERCA (PDB 3AR4).
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Table 6.1: Summary of PLB interactions with different SERCA states quantified by steered
molecular dynamics
State Site
Mean Rupture Force (kJ/mol/nm)
0° 90° 180° 270°
4KYT
M3 546 ± 53 526 ± 41 485 ± 38 550 ± 27
M6/M9 1292 ± 69 982 ± 3 838 ± 31 914 ± 84
M9 686 ± 46 731 ± 45 688 ± 27 616 ± 44
3AR4
M3 544 ± 20 640 ± 52 698 ± 14 572 ± 9
M6/M9 848 ± 29 814 ± 22 729 ± 40 720 ± 94
M9 658 ± 40 580 ± 87 811 ±12 838 ±108
1SU4
M3 606 ± 49 655 ± 23 629 ± 25 601 ± 39
M6/M9 871 ± 25 775 ± 97 833 ± 81 766 ± 15
M9 682 ± 32 681 ± 55 736 ± 88 749 ± 60
trajectories simulated for each orientation (Supplementary Fig. 6.7). The average
peak force associated with the alternative sites was reduced by approximately 50%
compared to the canonical site. Binding to M3 or the outside of M9 was modestly
improved by axial rotation of the PLB transmembrane domain by 270° or 90°, respec-
tively (Table 6.1; Fig. 6.2b-c) but rupture forces were still lower than those observed
for various axial orientations of PLB at the canonical site. The data suggest that PLB
binds best to the M6/M9 site in the E1-like conformation captured in the SERCA-PLB
crystal structure. When bound to the canonical site, PLB interacts with side chains of
SERCA helices M4, M6, and M9. In contrast, when docked to the outside of M9 in the
manner of binding of FXYD proteins with M9 of the sodium/potassium ATPase [274,
275], PLB had interactions with M9 only which accounts for the lower rupture force
of this configuration.
6.4.1.2 SMD of Different SERCA Conformations
Next, we measured the relative binding of PLB to different conformations of SERCA
to test how PLB affinity might change as a result of SERCA structural transitions
159
during the catalytic cycle. Repeated SMD simulations revealed that peak rupture
force for PLB bound to the canonical binding site (Fig. 6.2b-c, Supplementary Fig. 6.8)
of the calcium-free E2 state (3AR4) structure was 34% lower than that observed for the
E1-like state (4KYT). Interestingly, the rupture force for PLB bound to the hypothetical
alternative site outside M9 in a 270° orientation (Fig. 6.2d) was slightly improved
for E2 compared to the binding of PLB to the outside of M9 of the E1-like structure.
Thus, due to improved binding to the outside of M9 and worsened binding to the
canonical M6/M9 site, the two alternative sites then showed similar maximal rupture
forces (838±108 and 848±29 kJ/mol/nm, respectively). The Ca-bound E1 structure
(1SU4) yielded a peak force that was 33% lower than that observed for E1-like state
(Fig. 6.2e, Supplementary Fig. 6.9). E1-Ca also showed a decrease in the rupture
force deficit between the M6/M9 site and the proposed site outside M9 compared
to the E1-like structure (4KYT). The magnitude of the difference in rupture forces
observed for 4KYT (Ca-free) vs. 1SU4 (Ca-bound) is in harmony with our previous
physical measurements that suggested a 41% difference in apparent binding for the
SERCA-PLB complex in low and high Ca conditions [261]. Overall, the data indicate
that there is a clear preference for the E1-like PLB-bound state captured by the crystal
structure. However, for other enzymatic states, PLB may bind with similar affinity to
the canonical site and the putative site on the outside of M9. This result is broadly
compatible with the hypothesis of diverse modes of interaction between PLB and
SERCA.
6.4.2 Membrane Protein-Protein Docking of the SERCA-PLB complex
Our molecular docking strategy involves two steps: (1) a global-docking step to
explore possible PLB binding sites in an unbiased manner and (2) a local docking
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step to optimize possible SERCA-PLB binding poses in the context of the lipid bilayer.
We required two steps because there are currently no global docking strategies that
account for the membrane. For step one, we used fast-Fourier transform (FFT)-based
global docking (48) to identify possible binding sites on different enzymatic states
of SERCA (represented by structures 4KYT, 3AR4, and 1SU4). For each structure,
the FFT method identified 30-50 overall docked SERCA-PLB complexes, ranked by
an energy function that uses desolvation and electrostatic energy terms, and filtered
based on the requirement for PLB to span the membrane in the correct orientation.
Using these criteria, we obtained eight SERCA-PLB complexes for the calcium-free
E1-like state of SERCA (4KYT) (Fig. 6.3a,d), five for the calcium-free E2 state (3AR4)
(Fig. 6.3b,e), and six for the calcium-bound E1 state (1SU4) (Fig. 6.3c,f).
Several docking solutions included PLB bound to the M6/M9 canonical site; while
the remaining solutions included PLB docked at the M3 accessory site. This result
contrasts with the SMD experiments, which showed no appreciable affinity of PLB
for this site. Moreover, while the SMD experiments suggested some affinity of PLB
for the putative binding site on the outside of helix M9, the unbiased protein-protein
docking experiments did not yield M9-docked structures among the most favorable
solutions. Additional comparison of the complementary methods is provided in the
Discussion section below.
6.4.2.1 Docking of Different Axial Orientations of PLB
After obtaining initial docked SERCA-PLB complexes, we used RosettaMPDock [65]
to optimize high-ranking PLB orientations within the membrane environment. Roset-
taMPDock is an adaptation of the RosettaDock [283] protocol that locally searches




Figure 6.3: Global protein-protein docking solutions for PLB interaction with different
enzymatic states of SERCA. For each enzymatic state of SERCA, we used a fast-Fourier trans-
form (FFT) based global docking program to find possible binding sites and conformations of
PLB at those sites. PLB binding solutions (purple) are shown bound to each enzymatic-state
of SERCA in a membrane-facing view (top row) and luminal view (bottom row): (a,d) 4KYT,
(b,e) 3AR4, and (c,f) 1SU4. The canonical cleft is highlighted with M6 in blue and M9 in green
and the alternative sites are highlighted with M3 in red and M9 in green.
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search with random rigid-body rotations and translations. Then, an all-atom stage
includes side-chain optimization and minimization along side chain torsion degrees
of freedom. RosettaMPDock uses an implicit model to represent the bilayer: meaning
the heterogeneous lipid bilayer is represented as a continuous medium rather than
individual “explicit” solvent molecules. In the context of this study, an important
consequence of an implicit model is that we cannot capture interactions between the
protein and specific lipids. Therefore, any displacement of PLB relative to SERCA is
due to changes in the protein conformation and any interchain interactions.
For each of the 19 SERCA-PLB docked complex starting structures we generated
5,000 high-resolution candidate structures. The resulting structures were ranked by
PLB angle of rotation around its long axis, tilt angle relative to the membrane normal,
and the ∆∆G of binding to SERCA. Importantly, RosettaMPDock follows the premise
that the observed complex is almost always in a low free-energy state [58]. Therefore,
the resulting complexes represent snapshots rather than dynamics of SERCA-PLB
interactions in energy minima. A summary of the strongest interactions of PLB with
each structural state of SERCA is provided in Table 6.2 and the full list of SERCA-PLB
interactions is provided in Supplementary Table 6.4.
Table 6.2: Summary of top ranking PLB interactions with different SERCA states identified
through protein docking




0 11 6 -53.1 -4.3 -6.1
1 46 25 -56.9 -5.8 -2.8




1 319 321 -49.3 -2.7 -2.8
17 89 87 -47.4 -2.0 -2.0




2 347 6 -53.8 -4.6 -4.8
5 277 267 -54.8 -5.0 -5.2
M3 6 278 298 -45.2 -3.0 -1.0
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For the E1-like state of SERCA (4KYT), we observed two SERCA-PLB complexes
at the M6/M9 site with strong binding affinity with rotational axial angles of 6° and
267°. Both structures exhibit a strong binding funnel (Fig. 6.4a), meaning that the
conformations with the lowest ∆∆G of binding are concentrated at a specific PLB
axial rotation angle. Further, both z-scores indicated strong and specific interactions,
with zall of -4.3 for the 6° PLB orientation and -5.2 for the 267° orientation. These
docked complexes are represented in Fig. 6.4b in red and blue, respectively. The first
orientation was closest to the SERCA-PLB crystal structure (4KYT) with an all-atom
root-mean-squared-deviation (RMSD) between PLB from the crystal structure and
PLB from the model of 0.89 Å (Fig. 6.4b). Fig. 6.4c shows a helical wheel representation
of PLB, highlighting key residues in the interface with SERCA for the 6° (red) and
267° (blue) orientations, and residues that are common to the interfaces of both
orientations (orange). The docking results implicating this face of the PLB helix
are in harmony with previous biochemical and cross-linking studies [303, 304] and
are consistent with the interpretation of the SERCA-PLB co-crystal X-ray structure
[255]. Global docking also identified a PLB rotational orientation that interacted
with the M3 accessory site, though the apparent binding affinity was weaker than
those observed for binding to the M6/M9 canonical site (Supplementary Fig. 6.11).
M3-binding yielded interface energy of -45.2 Rosetta energy units (REU) and both
z-scores indicated weaker binding (Table 6.2, Supplementary Table 6.4). Note, the
Rosetta Energy Unit is an arbitrary unit that approximates a kcal/mol. Overall, the
binding affinity for the M6/M9 is only modestly better (21% improvement in REU)
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Figure 6.4: High-resolution model of PLB interaction with the SERCA 4KYT canonical
cleft. Molecular docking identified two PLB orientations interacting with the 4KYT canonical
cleft, characterized by axial rotation angles of 6° and 267°. (a) Ranking of PLB orientations by
axial rotation angle and binding energy. The top 5% scoring points are colored in red for the
6° conformation and blue for the 267° conformation. (b) Conformation of the SERCA-PLB
regulatory complex, with a 2x zoomed view of the transmembrane domains. The 6° PLB
orientation is shown in red and then 267° orientation is shown in blue, with the M3, M6, and
M9 helices highlighted in dark gray. (c) Helical wheel diagram showing the PLB interface
residues. Positions unique to the 6° orientation are shown in red, positions unique to the 267°
conformation are shown in blue, and mutual positions are colored in orange.
6.4.2.2 Docking of PLB to different SERCA states
The global docking results were also consistent with a multiplicity of interactions
between PLB and other conformations of SERCA. Interestingly, there were two strong
binding interactions between PLB and the E2 conformation. The first was PLB binding
to M6/M9 at 321° with a binding affinity of -49.3 REU (Supplementary Fig. 6.12a-
c) and the second was PLB interacting with the alternative M3 site at 334° with a
binding affinity of -45.1 REU (Table 6.2, Fig. 6.5a and Fig. 6.5d). While the gap between
binding affinities to the canonical cleft and M3 site was 10 REU for the E1-like-PLB
state (4KYT), the gap narrowed in the E2 (3AR4) state to only 4 REU. Further, the
interaction z-scores were suggestive of a significant interaction with this site.
Finally, we also examined the affinity of PLB for different sites of the Ca-bound
structure of SERCA (1SU4). Overall, we found that PLB bound the most tightly
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to the M6/M9 canonical site for two rotation angles, 6° and 25° (Supplementary
Fig. 6.12d-f). Both sites exhibited strong binding funnels with zall scores of -6.1 and
-2.8 respectively. Interestingly, the first conformation was the same binding angle as
the low energy E1-like M6/M9 structure, suggesting that face of the helix encodes an
important sequence for SERCA interaction. PLB also bound to the M3 site at an angle
of 280° (Fig. 6.5b,e), a similar angle for which moderate binding was predicted for
docking to the E1-like structure. These data emphasize the role of M3 as an important
site for PLB binding. Binding to M3 of SERCA has been observed for both PLB [277]
and SLN [305] and is hypothesized to play a role in regulating the maximal activity
(Vmax) of SERCA [277, 306]. The docked complexes are most similar to our model
for PLB [277] where SERCA residues such as Val269 and Trp272 appear to stabilize the
interaction. In the recent model for the SERCA-SLN complex [305], SLN sits directly
along M3 though residues such as Val269 are predicted to interact in all cases.
6.4.2.3 Comparison of WT-PLB and PLB4 Binding to SERCA
To investigate the contribution of specific key side chains to the energetics of the PLB-
SERCA regulatory complex, we repeated the protein-protein docking experiments
with the quadruple mutant PLB4 (N27A, N30C, L37A, V49G) that was used to obtain
the 4KYT X-ray crystal structure (Supplementary Table 6.5). This super-inhibitory
mutant binds more avidly than the WT sequence [307]. Interestingly, PLB4 docking
solutions did not include significant binding to the alternative site on SERCA helix
M3. At the canonical M6/M9 site, we observed similar docking for WT-PLB and
PLB4, with a narrow binding funnel and interface energies ranging between -54 and
-57 REU (Table 6.5, Fig. 6.6a), but the interface energy was slightly more favorable
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Figure 6.5: High-resolution models of PLB interaction with the M3 accessory site in the
E1 and E2 enzymatic states of SERCA. . Molecular docking identified PLB interaction with
the M3 helix of the 3AR4 (E2) and 1SU4 (E1-2Ca) enzymatic states of SERCA. Panels (a) and
(b) show a ranking of PLB orientations by axial rotation and binding energy, with the top
5% scoring points shown in blue and red for 3AR4 and 1SU4 respectively. (c) Helical wheel
diagram showing PLB interface residues: side chains only interacting with 3AR4 are shown in
blue, positions only interacting with 1SU4 are shown in red, and mutual positions are shown
in orange. Panels (d) and (e) show structural models for PLB interactions with 3AR4 and
1SU4 respectively. PLB is highlighted in red or blue, and a 2x zoomed representation of the
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Figure 6.6: Interactions between SERCA and the PLB4 variant. Protein-protein docking
identified interactions between the PLB4 variant (N27A, N30C, L37A, V49G) and the canonical
cleft of the E1-Like state of SERCA. Panel (a) shows a ranking of PLB4 orientations by axial
rotation and binding energy with the top 5% scoring points shown in red. (b) Structural model
of PLB4 interaction with the canonical cleft of 4KYT. PLB4 is highlighted in red with mutation
positions colored in light blue. A 2x zoomed representation of the transmembrane domain
is shown to the right of the full SERCA model. (c) Helical wheel diagram showing PLB4
interfaces with different enzymatic states of SERCA. The PLB4 mutant sites are underlined.
Positions colored in red are part of the docking model interface, positions in blue are part of
the crystal structure interface, and positions in orange are common to both.
(Fig. 6.6a) than for WT (Fig. 6.4a). The data suggest that the mutations that enhance
PLB binding to SERCA increase the specificity of the interface with regard to the
range of favorable axial rotational angles of PLB and the preference for the M6/M9
cleft of SERCA. We noted that the SERCA-binding interface was different from WT,
and surprisingly, several of the mutated residues faced the bilayer, rather than the
SERCA-PLB interface. Only the N27A and V49G mutant residues participated in
direct interactions with SERCA (Fig. 6.6b-c).
6.5 Discussion
The goal of this study was to test the hypothesis that PLB may interact with alternative
binding sites on SERCA and determine how the population of the alternative sites
by PLB may shift with the transporter’s changing structural poise. The motivation
for the present computational study comes from consideration of previous physical
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measurements: a) SERCA-PLB binding affinity changes with SERCA conformational
changes [261], but PLB remains bound to SERCA throughout the enzymatic cycle [261,
263, 264] b) cryo-EM studies showed densities attributable to PLB near SERCA TM he-
lix M3 [277, 308]; c) X-ray crystallography of an analogous transporter, NKA, showed
its cognate regulatory peptide bound to the outside of TM helix M9. We investigated
modes of SERCA-PLB interaction through a combined strategy of hypothesis-driven
steered molecular dynamics and unbiased protein-protein docking. Overall, the data
support the hypothesis for multiple, loosely defined binding sites. The results pro-
vide new insight into the diverse modes of interaction for the PLB-SERCA regulatory
complex.
6.5.1 Structural Determinants of the SERCA-PLB Regulatory Complex
The most important point of comparison for the present results is with the high-
resolution structure of SERCA co-crystalized with PLB (4KYT) [255]. While that
structure did not resolve the PLB cytoplasmic domain, it did reveal details of an
interface between the PLB transmembrane domain and SERCA. PLB was found at the
expected location, in the canonical binding cleft comprising SERCA helices 2, 6, and
9. Residues that were identified as important for the PLB-SERCA interaction in that
structure and previous biochemical studies [303, 304] also emerged as key elements in
the SMD and unbiased protein-protein docking analysis performed here. Key binding
residues identified by biochemistry and crystallography include N27*, N30*, L31,
N34, L37*, I38, L42, I45, and V49* (residues marked with asterisks indicate residues
mutated to create the superinhibitory mutant PLB4) [253]. Those residues were the
majority of the interface observed by docking SERCA E1-like conformers with the
most favorable PLB rotational orientations (Fig. 6.4c). Those residues also partially
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overlapped with other PLB binding interfaces observed from protein-protein docking
(Fig. 6.5c) and SMD. The other major surface of PLB that repeatedly appeared in
docking experiments was the upper left quadrant of the helical wheel (Figs. 6.4c, 6.5c,
and 6.6c). Engagement of this surface was frequently associated with a significantly
different binding position for PLB, suggesting movement of the regulatory peptide
either through an upward shift in the membrane (Fig. 6.5d and 6.5e), or translocation
to a completely different alternative site (Fig. 6.2e). The involvement of residues near
the top of the helical wheel was also favored for the E1 Ca-bound conformation of
SERCA (1SU4, Fig. 6.5e), consistent with the concept that SERCA conformational
changes alter the nature of the binding of PLB, or, alternatively, that different modes of
PLB binding are important for different enzymatic states in the SERCA transport cycle.
The data may reconcile apparently contradictory studies of the calcium dependence
of chemical cross-linking and FRET experiments. PLB-SERCA FRET is maintained
in high Ca, suggesting the complex is intact [261, 263, 264], but cross-linking of PLB
is lost in high Ca [256, 257, 304, 309]. If the rotational angle and vertical register of
PLB changes with the E2-E1 transition it is not surprising that crosslinking of specific
residues is greatly diminished.
In this regard, it is instructive to compare the results of docking of wild-type
PLB to SERCA with docking of the high affinity, super-inhibitory quadruple mutant
PLB4. The latter interacts very avidly with SERCA [256] and provided a sufficiently
stable regulatory complex to achieve co-crystallization for X-ray studies [255]. Plots
of the interface energies of PLB rotational orientations show similar landscapes, with
PLB4 funnels (Fig. 6.6a) appearing at similar axial angles as those manifested by WT-
PLB (Fig. 6.4a). However, the WT sequence yields more deep funnels (Fig. 6.4a and
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Supplementary Fig. 6.10), suggesting the WT helix has more docking options that are
energetically acceptable. Therefore, we hypothesize that PLB mutations that caused
tighter binding to SERCA [303] and yielded well-ordered structures for crystallization
[255] tailored PLB to bind in a specific orientation to a specific (canonical) binding
site of a specific SERCA conformer.
6.5.2 Alternative Modes of Binding of PLB to SERCA
Protein docking studies identified transmembrane segment M3 in both the E1-2CA
and E2 states of SERCA as a potential interaction interface. Of the docked complexes
between SERCA and the wild-type PLB monomer, one of the solutions (model #6)
is similar to the previously described MD simulations of the SERCA-PLB pentamer
complex based on electron crystallography [277]. The docked complex is not identical
to the previous complex, though this is likely due to the PLB pentamer used in the
prior docking and MD simulations. In addition, that previous study used the human
PLB sequence (in which residue 27 is a lysine), while the present docking analysis
follows the X-ray crystallography study in using the canine PLB (with an asparagine
at position 27). Nonetheless, the PLB monomer in the docked complex (Fig. 6.5)
interacts with M3, but it is located more toward transmembrane segment M1 of
SERCA and it is shifted upward by one turn of the helix. The interaction interface
between SERCA and PLB is similar in the two models, with key residues such as F32
and I45 of PLB and K26 and Y272 of SERCA contributing. In the docked complex,
N34 interacts with E258. This fits with the previous conclusion that electrostatic
interactions, at least in part, draw PLB into this region of SERCA. The negatively
charged residues include D254 and E255 on M3 and additional residues on M1 (e.g.
D59 and E58). Finally, it is interesting to note that the protein docking of the PLB4
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variant used in the X-ray crystal structure of the SERCA-PLB complex did not yield a
docked complex at the M3 accessory site of SERCA. Only the wild-type PLB yielded
satisfactory docking to M3 of SERCA. As discussed above, the results suggest the
mutations increased the selectivity of PLB4 binding to the canonical binding site on
M6.
6.5.3 Complementary Approaches for Interrogating Membrane Protein
Complexes
Steered molecular dynamics and protein-protein docking provided complementary
perspectives in evaluating PLB-SERCA binding interactions. SMD offers an all-atom
view of SERCA’s behavior in a biologically realistic membrane, quantifying rupture
forces as an index of protein-protein binding affinity. On the other hand, protein-
protein docking provides an unbiased strategy. RosettaMPDock, in particular, is one
of a few specialized docking methods that can efficiently and inexpensively explore
new conformations while considering the physical properties of the surrounding
lipid bilayer. Overall, the results from the two types of experiments were in harmony.
Most notably, both suggested that the canonical binding cleft is the most favorable
site for PLB binding.
On the other hand, the methods provided different insights into the interactions
between PLB and alternative sites, and the binding of PLB to different SERCA con-
formers. Both SMD and protein-protein docking simulations suggest that M3 is a
plausible alternative site. Docking yielded a favorable PLB orientation at 298° binding
with weak-to-moderate affinity (Fig. 6.5). By SMD, the best M3 binding is seen for the
180° and 90° orientations, yielding a rupture force that was 1 or 2 standard devia-
tions from the mean rupture force, respectively. Interestingly, the 180° orientation
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that showed relatively weak affinity by SMD (1 standard deviation above the mean).
This configuration did not appear among high-scoring docking results, suggesting
it is not a preferred orientation. In contrast, there was an 80° PLB orientation with
weak binding affinity (-35 REU). We regard the 80° value (from docking) and 90°
value (from SMD) as representing a similar possible orientation of PLB bound to M3.
Another difference between the experiments is that the 298° orientation observed in
docking was not tested by SMD, because those experiments systematically evaluated
fixed PLB orientations at 90° intervals. The identification of a favorable “in-between”
orientation at 298° demonstrates the added value of an unbiased docking strategy
for identifying new quaternary arrangements that may be important for regulating
SERCA transport function.
Conversely, SMD provided insight into a possible interaction that was not detected
by docking. SMD experiments showed binding to hypothetical site on the outside
of M9 was relatively strongly site- and orientation-specific for PLB in for the E1-
like Ca-free (3AR4) conformation of SERCA. The 180° and 270° orientations of PLB
bound to M9 yielded rupture forces that appeared equally favorable to the canonical
cleft. However, despite this apparent site selectivity, it was a moderately weak
binder overall, as compared to all other interactions. Thus, the site was not ranked
highly enough to be discovered by protein-protein docking. On the basis of the SMD
experiments, we suspect that the outside of M9 may be populated by PLB for some
conformations of SERCA, such as the E2 Ca-free state represented by 3AR4 (Fig. 6.2).
An analogous interaction is that of the sodium/potassium ATPase, which binds FXYD
proteins on the outside of M9 of the NKA alpha (catalytic) subunit. This regulatory
complex also benefits from the contribution of additional contacts between the FXYD
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extracellular residues with the NKA beta subunit [274], accounting for the apparently
stable occupation of that position in the crystal structure. Overall, the disparity
between the SMD and docking results underscores the value of complementary
approaches for evaluating metastable interactions that may be biologically significant.
A possible future step is to use global docking poses as input to SMD to further
integrate information from these approaches
6.5.4 Challenges for modeling of protein-protein interactions in the mem-
brane
In this study, we applied two complementary strategies to investigate a physio-
logically important integral membrane interaction. This dual strategy enabled the
computational feasibility of exploring the wide protein-protein interaction space for a
large target (>1,000 residues) while also considering the context of a heterogeneous
membrane environment. This is an exciting study in membrane protein structural
biology because specialized methods for exploring membrane protein-protein interac-
tions are still in their infancy. In particular, there are many open questions about the
biophysical questions driving protein-protein interactions in the nonpolar membrane
environment. With this, these specialized methods require improvement in several
areas. For instance, the protein-protein docking program kept the backbone of both
SERCA and PLB fixed. However, it is likely that PLB bends or straightens to enhance
shape complementarity with its binding partner. This is especially notable because
transmembrane membrane helices are notorious for kinks and curvature [310]. Pro-
grams for incorporating backbone flexibility have emerged for soluble proteins [52,
311] and these developments will soon translate to membrane proteins. Another
challenge is incorporating the effect of bilayer deformations induced by the protein
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that influence the landscape of available protein-protein complex conformations. Fur-
ther, the all-atom membrane in SMD only included one lipid type, whereas biological
membranes include hundreds of different lipid types [6]. While building membrane
models with complex lipid compositions is computationally expensive due to a long
equilibration time, improved computing capabilities will make these models within
reach.
6.5.5 Implications for our understanding of SERCA-PLB interactions
This study represents a shift for our understanding of regulation of cardiac calcium
handling. The reasonable first assumption about the regulatory complex of SERCA
with PLB was that there was a simple, specific, lock-and-key mechanism where PLB
occupies a single stringent binding site with a fixed orientation and a well-defined
binding interface. Previous physical measurements have gradually undermined
this simplistic model. FRET measurements suggested additional binding interfaces,
characterized by different binding affinities [261]. Additional interfaces were also
demonstrated by cryo-Electron Microscopy [277, 308]. Moreover, a number of non-
specific hydrophobic peptide sequences were shown to functionally inhibit SERCA
[312], indicating a looser specificity than was previously appreciated. The present
results may reconcile these previous findings, as they suggest PLB can bind SERCA
at three alternative sites using several different favorable orientations. The preference
among these sites and orientations is determined by the enzymatic poise of the
structurally dynamic SERCA pump, which may explain ligand-dependent changes in
site-specific chemical cross-linking of PLB to SERCA [256, 313]. The structural details
revealed by the present study may suggest new binding interfaces that could be
explored with cross-linking, mutagenesis, or other physical experiments. Finally, the
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results reveal a possible mechanism for the gain-of-function of PLB4, a superinhibitory
mutant of PLB [307].
6.5.6 Summary
In conclusion, we find that PLB-SERCA binding interactions are more diverse than
can be appreciated from previous studies that suggested PLB binds with a fixed
orientation to a single site on a specific SERCA conformer. Instead, the present data
are consistent with spectroscopic results that suggest PLB interacts with all SERCA
enzymatic states and structural data that suggest additional alternative binding sites.
We propose PLB equilibrates between different modes of binding. Some of these mode
changes are minor shifts of PLB within a binding pocket (e.g. rotation about the PLB
long axis, or normal translations in the bilayer), while others involve translocation
to completely different sites (e.g. to the outside of M9 or to M3). Based on the
increased apparent specificity of the superinhibitory PLB4 mutant for the M6/M9
site, we conclude that the canonical binding mode mediates functional inhibition,
and we presume that the other sites are non-inhibitory, or possibly even stimulatory
[247, 277, 306]. Thus, PLB transitions between different structural poises may deliver






Table 6.3: Summary of z-scores for PLB conformations explored by steered molecular dynam-
ics
State Site Angle (°) Force (kJ/mol/nm) zsite zall
4kYT
M3
0 546 -1.13 -0.68
90 526 -1.26 -1.01
180 485 -1.52 -1.68
270 550 -1.1 -0.61
M6/M9
0 1292 3.73 2.77
90 982 1.71 0.76
180 838 0.77 -0.18
270 914 1.27 0.32
M9
0 686 -0.21 -0.25
90 731 0.08 0.36
180 688 -0.2 -0.22
270 616 -0.67 -1.2
3AR4
M3
0 544 -1.14 -0.71
90 640 -0.51 0.86
180 698 -0.14 1.8
270 572 -0.96 -0.25
M6/M9
0 848 0.84 -0.11
90 814 0.62 -0.33
180 729 0.07 -0.89
270 720 0.01 -0.95
M9
0 658 -0.4 -0.63
90 580 -0.9 -1.7
180 811 0.6 1.47
270 838 0.77 1.84
1SU4
M3
0 606 -0.74 0.3
90 655 -0.42 1.1
180 629 -0.59 0.68
270 601 -0.77 0.22
M6/M9
0 871 0.99 0.04
90 775 0.36 -0.59
180 833 0.74 -0.21
270 766 0.31 -0.65
M9
0 682 -0.24 -0.3
90 681 -0.25 -0.31
180 736 0.11 0.44
270 749 0.2 0.61
178
Table 6.4: Summary of PLB binding conformers in complex with different states of SERCA
State Site # Start (°) Axial (°) Energy (REU) zsite zall
1SU4
M6/M9
0 11.41 5.85 -53.091 -4.26 -6.13
1 45.57 25.15 -56.9 -5.82 -2.83
2 250.55 266.67 -49.41 -2.77 -2.19
3 35.53 55.75 -47.93 -2.15 0.58
5 298.32 303.334 -41.64 -0.42 -1.52
M3 9 279.61 272.93 -46.15 -3.49 -4.45
3AR4
M6/M9
1 319.01 321.477 -49.33 -2.72 -2.8
2 336.29 341.806 -44.7 -0.83 -0.77
17 88.58 86.711 -47.43 -1.95 -1.97
M3
6 335.41 333.569 -45.09 -2.99 -0.94
10 142.1 131.42 -41.31 -1.57 -0.72
1SU4
M6/M9
0 49.82 52.63 -46.23 -1.46 -1.44
1 29.93 36.52 -43.77 -0.45 -0.36
2 346.97 5.734 -53.8 -4.55 -4.76
3 57.03 287.873 -47.82 -2.11 -2.14
4 252.61 255.553 -44.2 -0.63 -0.54
5 276.54 266.95 -54.83 -4.97 -5.22
M3
6 277.7 298.45 -45.2 -3.03 -0.98
7 292.29 69.44 -41.45 -1.61 0.66
Table 6.5: Summary of PLB4 binding conformers in complex with different states of SERCA
State Site # Start (°) Axial (°) Energy (REU) zsite zall
1SU4
M6/M9 1 17.47 17.501 -53.77 -3.15 -2.97
M3 2 102.32 56.8 -42.49 -0.75 -0.04
3AR4
M6/M9
1 322.12 324.08 -49.53 -2.289 -1.87
2 337.69 338.96 -49.46 -2.28 -1.85
3 57.17 59.62 -52.76 -3.57 -2.71
M3 4 115.47 329.37 -38.75 0.283 0.92
4KYT
M6/M9
1 25.25 24.49 -56.62 -3.73 -3.71
2 28.71 43.8 -51.64 -2.718 -2.41
M3
3 60.93 65.29 -44.91 -1.41 -0.674











Figure 6.7: SMD simulations of the E1-Like-PLB state of SERCA with PLB. Quantification
of force that developed as PLB was pulled from the canonical cleft of the E1-like-PLB state
of SERCA (represented by 4KYT). Data are three repeated measures of force for the original
orientation of the X-Ray crystal structure (PDB 4KYT) and after axial rotation of PLB by 90°,

















Figure 6.8: SMD simulations of the E2 state of SERCA with PLB. Quantification of force that
developed as PLB was pulled from the canonical cleft of the E2 state of SERCA (represented
by 3AR4). Data are three repeated measures of force for the original orientation of the X-Ray
crystal structure (PDB 4KYT) and after axial rotation of PLB by 90°, 180°, and 270°. The data
















Figure 6.9: SMD simulations of the E1-2Ca state of SERCA with PLB. Quantification of
force that developed as PLB was pulled from the canonical cleft of the E1-2Ca state of SERCA.
Data are three repeated measures of force for the original orientation of the X-ray crystal
structure (PDB 4KYT) and after axial rotation of PLB by 90°, 180°, and 270°. The data are


































Figure 6.10: Ranking of all PLB conformers from all global docking solutions. Each
SERCA-PLB complex model is ranked by axial rotation and binding energy, with each sub-
panel corresponding to a particular enzymatic state (4KYT, 3AR4, or 1SU4) and binding site
(canonical cleft M6/M9 or M3). The top 5% scoring points are shown in red, blue, orange,
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Figure 6.11: Ranking of all PLB conformers from docking the E1-Like-PLB state of SERCA
with the M3 accessory site. Each SERCA-PLB complex model is ranked by axial rotation and
binding energy and the top 5% scoring points are shown in red or blue. A different color
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Figure 6.12: High resolution models of PLB interactions with the canonical cleft of the E2
and E1-2Ca states of SERCA. The model of the E2 state (represented by 3AR4) is shown in
the top row and the model of the E1-2Ca state (represented by 1SU4) is shown in the bottom
row. (a,d) Ranking of each SERCA-PLB complex model by axial rotation and binding energy.
The top 5% scoring points are shown in red or blue, with a different color indicating the model
was generated from a different global docking solution. (b,e) High resolution model of two
possible PLB conformers interacting with SERCA shown in red and blue, corresponding to the
colors in panels (a,d). A 2x zoomed view of the transmembrane domain is shown to the right
of the SERCA model. (c,f) Helical wheel demonstrating PLB conformer interface residues.
Positions colored in red correspond to the first conformer, positions in blue correspond to the
second conformer, and mutual positions are in orange.
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Chapter 7




Nanoscale channels are critical for directed transport within living systems. Within
synthetic biology, channels have potential applications in diagnostics, therapeutics,
and smart materials. Previous studies have engineered channels from DNA nanotubes
with various chemical modifications that enable membrane insertion. However, none
of these solutions guarantee both reliable assembly and insertion. In this chapter, I
explore an alternative route of designing channels from protein helical bundles. First,
I generate helical bundles with varying pore radii and point symmetries from 40-
residue poly-alanine α-helices. I apply a symmetric fixed-backbone design protocol
that searches for low energy sequences that also satisfy the design criteria. Then, I
evaluate monomer stability in the bilayer, a prerequisite state for insertion. Finally, I
identify a single viable sequence and outline next steps for experimental testing.
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7.2 Introduction
A major goal of synthetic biology is to develop a portfolio of engineered biological
circuits inspired by living systems [314]. These circuits can be integrated into nano-
devices for diagnostics, therapeutics, and smart materials. One circuit of interest
is membrane protein channels that facilitate directed transport of water, ions, or
other molecules through otherwise impermeable walls [315]. Such channels can
enable wide ranging processes driven by ion flux such as pumps, rotary motors, and
transport proteins.
DNA origami is an enticing material for synthetic biology design tasks because
carefully programmed DNA monomers have been shown to reliably fold into non-
arbitrary two- and three-dimensional shapes [316]. Synthesis of DNA nanotubes is
well established [317], and nanotubes provide an excellent scaffold for a channel. In
the past decade, several channel prototypes have been constructed from DNA origami
nanotubes. Thus far, the main challenge has been integrating the negatively charged
DNA nanopore into the non-polar membrane. Several chemical modifications have
been applied to improve compatibility including the addition of cholesterol [318],
ethyl protected phosphorothiolates [319], porphryn tags [320], tocepherol tags and
modification with streptavidin and biotin [321]. These approaches have achieved one
of two feats but not both: (1) fast assembly into the bilayer, and (2) stability in the
bilayer relative to the aqueous phase.
Proteins are a promising alternative because their sequences can be programmed
to insert and form stable folds in the bilayer. Further, there are examples of synthetic
pores, such as pPorA: a 40-amino-acid α-helical peptide that self-assembles into a
stable membrane channel called Porin Acj [322]. There has also been limited success
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engineering naturally ocuring membrane proteins to act as pores including the cWza
octomer [71] and redesigned OmpF [72].
To select for various materials, it would be ideal to design a pore with a customized
radius and height. This task requires de novo design: generating new proteins from
physical principles with novel sequences [54]. De novo design has already been used
to create a wide array of tools outside of what biology has already provided such as
for drug delivery [323] and process control [53, 324]. For membrane proteins, there
have been two significant de novo milestones. DeGrado and coworkers designed the
PRIME and ROCKR alternating access transporters formed by two tightly interacting
pairs of helices [70, 325]. And Lu et al. achieved de novo design of helical bundles that
insert into the membrane [75]. Yet, the field overall is still in its infancy relative to the
designs produced by DNA origami.
In this chapter, I aim to computationally design a protein pore that can be used
to transport material from a DNA nanotube into another membrane-enclosed com-
partment. I explore backbone geometries with varying pore radii and evaluate the
ability of the design to self-insert and self-assemble within the bilayer. Then, I aim
to propose sequences that can be synthesized and tested in the wet lab. While the
design goal is challenging, I believe this synthetic biology problem will provide many
insights into needed improvements for the design process.
7.3 Methods
7.3.1 Helical bundle generation
I used the BundleGridSampler application to generate starting backbones [326]. For
each backbone, the monomer unit was 40 alanine residues long. Helical bundles were
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generated for four cyclic point symmetries: C4, C6, C8, C10. For all bundles, I sampled
three values for the ω0 parameter (ω0 = −0.05, 0, 0.05) and three values for the δ0
parameter (δ0 = 0.33, 0.66, 1.00). The following ranges in Å Ire chosen for r0 given
the symmetry n: C4 = [4.5, 7.5], C6 = [6, 9] C8 = [10, 15], C10 = [12, 17]. For each
symmetry, I sampled 27 bundle geometries and chose the lowest scoring scaffolds
without clashes and unique Crick parameters to proceed in the next step.
7.3.2 Adapting franklin2019 for membrane proteins with cyclic point sym-
metry
The Rosetta program uses a general framework for modeling arbitrary symmetric
macromolecular systems [327]. Symmetric systems are abundant in nature; yet,
they are also large and computationally expensive to model. The Rosetta symmetry
framework improves efficiency by sampling only symmetric degrees of freedom
and explicitly simulating a subset of the interacting monomers. Unsurprisingly, the
symmetry framework requires that a macromolecular system is completely symmetric.
This constraint has important implications for modeling membrane proteins with
pores and cavities because the current method described in Chapter 2 is intrinsically
asymmetric. To adapt this method for symmetric proteins, I simplified the method to
assume the pore is a cylinder (Fig. 7.1).
The simplified pore representation follows a similar formalism to that described
by Lazaridis et al. [109]. Here, the geometry of a pore is represented by a circle with























Figure 7.1: Architecture of a symmetrical helical bundle pore. The architecture of a sym-
metric membrane protein pore is simplified relative to the pore estimation strategies for
non-symmetric proteins. (a) The pore is a cylinder with a center (x0, y0), a radius r, and
height t equal to the thickness of the transmembrane region. (b) Projection of the symmetric
architecture onto a generic helical bundle with C8 point symmetry in membrane view. Side
chains exposed to the aqueous phase are colored in blue, side chains exposed to the interface
are colored in teal, and side chains exposed to the lipid phase are colored in gray. Panels (c)
and (d) show a cytoplasm facing view of the pore with the same color scheme as in (b). Panel
(d) is a clipped view showing the pore at z = 0Å.
Then, the the hydration fraction fhyd is described as a function of gradius and the
transition steepness n as given in Eq. 7.2.





To explore the sequence space for helical bundles with different pore radii, I used a
fixed backbone design protocol that performs side chain repacking and minimization
with the franklin2019 energy function.
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7.3.4 Bilayer-dependent monomer energy landscape
I evaluated the bilayer stability of the monomer by searching for the low-free energy
orientation in the bilayer. The purpose of this step is to ensure the design scaffold can
exist in both the monomer and oligomer state. Here, orientation is defined by two
coordinates: (1) distance between the membrane center and peptide center of mass, d
and (2) angle between the membrane normal and helical axis, θ. To search for the low
energy orientation, I first apply side-chain packing and minimization to resolve steric
clashes. Then, I apply rigid-body moves to sample all combinations of θ and d values.
Membrane depths were sampled between −60 Å and 60 Å with a 1 Å step size and
tilt angles were sampled between 0° − 360° with a 1° step size.
7.4 Results
7.4.1 Design strategy
The overall goal is to design a protein channel fused to a DNA nanotube that will insert
into the membrane and self-assemble. DNA nanotube assembly is a well-established
process [317]; thus, this chapter will focus on design of the protein component. At
the outset, I proposed the following mechanism (Fig. 7.2). The initial state is an
unfolded polypeptide chemically fused to a DNA tile. The polypeptide is driven into
the membrane by a favorable water-to-bilayer transfer energy. Upon insertion, the
peptide folds into an α-helix to satisfy hydrogen bonds within the non-polar lipid
bilayer. Then, in excess of monomers, the subunits will assemble into an oligomeric
pore. Our design strategy was to engineer the final oligomer state and then work






Figure 7.2: Proposed mechanism for insertion and assembly of a DNA-protein channel. (a)
The starting conformation is an unfolded peptide (purple) linked to a DNA tile segment (grey)
in the aqueous phase. (b) Next, membrane insertion is driven by a favorable water-to-bilayer
transfer energy. Upon insertion, the polypeptide folds into an α-helix to resolve unsatisfied
hydrogen bonds. (c) Then, multiple monomer segments self-assemble into a protein pore
linked to the self-assembled DNA-nanotube.
7.4.2 Generating helical bundles with variable pore radii
The starting point for oligomer design is a helical bundle: a coiled coil of two or more
helices supercoiled around a central axis [328]. This geometry is described by the
parametric Crick equations which describe a bundle of n helices with supercoil twist
ω0, α-helical twist ω1, supercoil radius R0, helix phases ψ1, ψ2, ..., ψn, and helix offsets
z1, z2, ..., zn [329]. For this design problem, helical bundles are advantageous for two
main reasons. First, the parametric description enables generation of backbones with
multiple symmetries and pore radii. Second, helical bundles are very stable folds
[330] and have been previously shown to insert into lipid bilayers [75].
I used the BundleGridSampler [326] to generate helical bundle backbones. For
each backbone, the monomer was a 40 residue poly-alanine helix. I chose to use an
extra-long helix to ensure the monomer spans the membrane even if "coiling" shortens
the effective length. I generated 27 bundles for four symmetries: C4, C6, C8, C10 (total
192
Figure 7.3: Representation of Crick coil-coil parameters. Geometrical meanings of the
superhelical radius (R0), the helical radius (R1), the superhelical frequency (ω0), the helical
frequency (ω1), chain axial offset (∆Zoff), chain superhelical phase offset (∆ψ0), and starting
helical phase (∆ψ1). The interfacial axis is shown in green, local helical axes are shown in
orange, and the helical curve that passes through Cα atoms is shown in gray. The distance
along the interfacial axis between an inward-facing point (orange) and its closest counterpart
on the opposite helix is defined as ∆Zoff. This figure is reproduced with permission from "Grigoryan
G & DeGrado WF (2011) Probing designability via a generalized model of helical bundle geometry" J
Mol Biol. 405(4):1079-1100.
108 designs). Then, I chose the best backbones in each symmetry group as models
with unique parameters, no clashes (E < 0), and the lowest energy. The resulting
bundle geometries are summarized in Table 7.1 and shown in Fig. 7.4. Overall, the
pore radii r range between 5.75-17 Å.
Table 7.1: Crick parameters for low energy helical bundles
Cn r (Å) ω (rad) δ (rad)
4 5.75 0.05 0.66
4 7.5 -0.05 0.66
6 9 0.05 0.33
8 12.5 0.05 0.33
8 15 0.05 1
10 14.5 0.05 0.33
10 17 0.05 1
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C4
r = 5.75 Å
C4
r = 7.5 Å
C6
r = 9 Å
C8
r = 15 Å
C8
r = 12.5 Å
C10
r = 14.5 Å
C10
r = 17 Å
Figure 7.4: Low energy helical bundles with variable radi I used the BundleGridSampler
application to search for low energy helical bundle backbones with four point symmetries:
C4, C6, C8, and C10. Backbone conformations with unique parameters and no clashes (E < 0)
were selected for further design. The resulting seven scaffolds are shown here.
7.4.3 Symmetric bundle design
Next, I applied a symmetric design protocol to search for low energy sequences.
First, each protein was set up as a symmetric system and then initialized in the
franklin2019 implicit membrane. Then, I used a Monte Carlo fixed-backbone design
protocol to sample possible sequences. The protocol uses a full protein-and-rotamer
sequence optimization and multi-cool annealer simulated annealing protocol to
explore sequence space. The resulting monomer sequence for each backbone is listed
in Table 7.2.
Table 7.2: Designed sequences for each pore radius









I evaluated the designs by generating a sequence logo frequency plot (Fig. 7.7)
that represents the position-specific frequency of different amino acids. All of the
sequences have a hydrophobic stretch of amino acids between positions 8-31. Outside
this range, the amino acids are predominantly charged and polar. This pattern signals





































































































































































































Figure 7.5: Sequence logo of designed monomers. Sequence logo frequency plot demon-
strating the diversity of amino acids at each position within the 40 amino acid monomer.
Amino acids are colored according to the following scheme: positively charged (blue), nega-
tively charged (red), non-polar (black), polar (green), and special (pink).
I expected that many designs would include polar or charged residues in the
transmembrane region to accommodate an aqueous pore. Interestingly, this was not
the case for all designs except the C8 symmetric 12.5Å pore. The C8 design includes
four charged or polar residues per monomer: T7, E14, R18, and K27. To visualize
the relative placement of polar, charged, and non-polar side chains, I generated a
helical wheel diagram of the monomer in Fig. 7.6b. Helical wheels for the remaining
sequences are shown in Fig. 7.8.
The helical wheel shows that the helix is amphipathic, with hydrophobic side
chains on the left and polar/charged side chains on the bottom right. This is ideal
because the hydrophobic moment can orient the helix during oligomer assembly.
These properties suggest that C8 would be viable in both the oligomer and monomer
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A B
Figure 7.6: Analysis of 12.5ÅC8 design. (A) Lumen-side view of the C8 symmetric helical
bundle design with a 12.5Åpore radius. The backbone is shown in cartoon representation
and polar/charged side chains T7, E14, R18, and K27 are shown as sticks. (B) Helical wheel
representation of the monomer sequence from position 5-35. The charged termini are excluded
to represent side chains that contact the interfacial or lipid phase of the bilayer. Amino acids
are colored according to category, with non-polar amino acids in yellow, positively charged
amino acids in blue, negatively charged amino acids in red, polar amino acids in pink, and
special case amino acids in brown. The hydrophobic moment is indicated in the center of the
wheel.
states. I therefore test this hypothesis in the next section.
7.4.4 Membrane stability of the C8 monomer
Finally, I computationally evaluate the stability of the monomeric state in the mem-
brane. To explore this question, I use the MembraneEnergyLandscapeSampler [161]
to generate a mapping of energies to all possible orientations of the monomer in the
bilayer. The resulting map is shown in Fig. 7.7.
In the energy landscape, I observed two low-energy wells at (0 Å, 30°) and (0 Å,
330°). These orientations correspond to helices that span the membrane with realistic
tilt angles. The water-to-bilayer transfer free energy of the monomer is -9 REU,




















∆G = -9 REU A
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Figure 7.7: Stability the C8 monomers in the membrane. (Left) The mapping of protein
orientations to energies computed by franklin2019 is shown for the C8 12.5 Ådesign. Each
point represents a different orientation and the color corresponds to the energy, with low
energy points colored in blue and high energy points colored in green. (Right) Important
conformations in the energy landscape diagram: (A) the lowest energy orientation spans the
bilayer, whereas (B) the highest energy orientation is outside the membrane. The water to
bilayer transfer energy from state B to A is -9 REU.
would be stable and insert into the bilayer as well as in the oligomeric form.
7.5 Discussion
In this work, I computationally designed a membrane protein pore that self-inserts
and self-assembles from amphipathic monomers. The assembled pore is a C8 sym-
metric helical bundle with a pore radius of 12.5 Å. This design was the only monomer
that was sufficiently amphipathic for directional assembly. I believe that the design
process and the resulting sequence provides an excellent starting point for further in
silico and experimental testing.
This study was enabled by two recent milestones in membrane protein design.
First, Lu et al. [75] successfully demonstrated that helical bundle backbones could
be redesigned to embed in the membrane. This is the first example of fully de novo
designed membrane proteins. Second, I previously developed franklin2019 which is
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the first all-atom implicit membrane energy function that captures aqueous pores with
variable geometries [161]. As a result, I was able to easily construct backbones with
variable pore lengths. This design study demonstrates the importance of advancing
methods for membrane protein design. Before these advances, I could not have
tackled a problem of this complexity.
This study was proof-of-principle. To demonstrate the concepts at low computa-
tional cost, I under-sampled backbone space and sequence space. Therefore, future
work should expand the scope of the study. Further, the C8 sequence is encouraging;
yet, it remains a model. Thus, experimental testing is essential to ensure the designs









r = 7.5 Å
C6 
r = 9.0 Å
C8 
r = 15 Å
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r = 14.5 Å
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r = 17 Å
Figure 7.8: Helical wheel representations of monomer sequences. Helical wheel represen-
tations are shown for the remaining six designs: (a) C4, r = 5.75Å, (b) C4, r = 7.5Å, (c) C6,
r = 9.0Å, (d) C8, r = 15Å, (e) C10, r = 14.5Å, (f) C10, r = 17Å.The charged termini are ex-
cluded to represent side chains that contact the interfacial or lipid phase of the bilayer. Amino
acids are colored according to category, with non-polar amino acids in yellow, positively
charged amino acids in blue, negatively charged amino acids in red, polar amino acids in
pink, and special case amino acids in brown. The hydrophobic moment is indicated in the
center of the wheel.
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Chapter 8
Conclusions and Future Directions
8.1 My contributions
Structural studies of proteins provide a blueprint for cellular function, an understand-
ing of how misshapen molecules make us sick, and insights into drug development.
Over the past 50 years, structural biologists have developed a collection of tools to elu-
cidate biomolecular structures including X-Ray crystallography, NMR spectroscopy,
and cryo electron microscopy. While these tools have been fruitful for proteins in
solution, experimental difficulties have delayed progress for membrane proteins.
Further, many of these tools are protein-centric and cannot capture the heterogeneous
lipid bilayer. Computational approaches that provide atomistic models of proteins
coupled with the lipid bilayer can compliment experimental structures and provide
mechanistic insight into function. Yet, computational models of the membrane are
either too expensive to compute or not biologically realistic. In this dissertation, my
main contribution is a membrane model that is fast to compute and more biologically
realistic. My model can be effectively used for structure prediction and design. I also
investigated three challenging systems involving membrane proteins to explore the
next steps needed to advance computational tools.
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8.1.1 From non-polar slabs to phospholipid bilayers
The first membrane models were implemented into the Rosetta macromolecular mod-
eling suite in 2007. These models laid the foundation for a decade of computational
membrane protein structural studies; yet, they encountered critical challenges. The
membrane model resembled a hydrophobic slab of fixed thickness, which is inconsis-
tent with our current knowledge of biological membranes. In Chapter 2, I developed
a new implicit membrane model that captures the anisotropic structure and nanoscale
dimensions of phospholipid bilayers. This is an important step forward because
biological membranes are predominantly composed of phospholipids. The model is
called franklin2019, and it improved the accuracy of structure prediction and design
tasks relative to prior models. In this chapter, I also demonstrated protein design tied
to different lipid compositions. As a result, including details of the lipid composition
is now standard for Rosetta calculations. This advance enabled simulations to be
more aligned with experiments, and it is consistent with the membrane literature that
emphasizes the importance of lipid composition in protein structure and function.
8.1.2 From one test to many
A significant challenge in membrane protein structural biology is collecting sufficient
experimental data to accurately describe membranes and their resident proteins. This
challenge is important because computational models are only as accurate as the
experimental data available to validate them. When I began my dissertation research,
the most common validation approach was to check a single application against a
single dataset. This approach led to many specialized applications; however, accurate
membrane models are necessarily general models. In Chapter 3, I developed a set
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of 12 diverse scientific benchmarks for evaluating implicit membrane models. The
tests probe four key areas: stability, orientation, sequence, and structure. The tests
are available to the public for use with Rosetta and other macromolecular modeling
packages. The tests are an important contribution to the field because they will
facilitate the development of more accurate and general energy functions for diverse
applications.
8.1.3 From intra-residue to inter-residue
An important conclusion from Chapters 2 and 3 is that while franklin2019 has yielded
progress, there are also many areas for improvement. A particular area of interest is
capturing electrostatics in the bilayer, as electrostatic interactions play an intimate role
in membrane protein function and protein-protein interactions. In Chapter 4, I devel-
oped a Coulomb electrostatics model that accounts for the low-dielectric membrane
environment. In addition, the model accounts for a shift in proton avidity in the mem-
brane core and subsequently samples relevant protonation states of titratable amino
acids. In preliminary tests, the model demonstrates significant improvement for
predicting the partitioning energies of pH-sensitive peptides. This proof-of-concept
model lays an important foundation for capturing electrostatic interactions in the
membrane and serves as a starting point for continued energy function development.
8.1.4 From safety to the wild west
When asked to generate a structural model with a given tool, computational biol-
ogists think deeply about a tool’s limitations. A common experience is to realize
that biological systems are far more complex than what tools can handle. Through
developing methods, I realized these complex systems spotlighted opportunities to
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push the boundaries of current methods and outline future steps. In my disserta-
tion, I applied this principle to explore two biological systems involving membrane
proteins. In Chapter 5, I examined the stability effects of mutations in the integral
zinc metalloprotease with a voluminous aqueous chamber. In this study, I helped
develop a hybrid computational-experimental assay for investigating stability effects
in this unique protein. Here, I learned that the geometry is too complex for current
implicit models and requires more flexible cavity representations. Then, in Chapter 6,
I explored interactions between the SERCA integral membrane calcium pump and
the regulatory transmembrane segment phospholamban. This interaction is physio-
logically important in cardiac response to stress such as exercise. My docking studies
support experimental evidence for a transient interaction mechanism, while also
demonstrating needed work in modeling protein flexibility within the bilayer.
8.1.5 From prediction to design
The penultimate chapter of my thesis describes a first attempt to design a membrane
protein in the context of a real nanotechnology problem (Chapter 7): design of
nanoscale channels for transport. Design is the ultimate application for a membrane
model because it asks if we can reproduce the rules for membrane protein structure
and stability. In this chapter, I identified a viable sequence for experimental testing.
Further, I learned important lessons for design problems including considering the
starting scaffold and including customized pore definitions. This design chapter is a
starting point for future design problems with franklin2019.
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8.2 Future directions
In Chapter 2, I demonstrated that implicit membrane models that capture different
phospholipid compositions improve structure prediction and design. Thus far, I have
developed model parameters for single-component phospholipid bilayers. A next
step is to develop parameters for more complex lipid mixtures. This work is especially
important as biological plasma membranes contain hundreds of chemically distinct
lipid types [19, 331] that are heterogeneous on the length scale of proteins and small
protein clusters (1-10 nm) [127, 332]. One possibility is to generate parameters for
membranes with specific mean-field features, such as asymmetric lipid distributions
[333] and anionic head-groups [126]. A second area is to consider cholesterol, a sterol
that constitutes 20-40% of animal cell membranes [334]. Cholesterol tunes bilayer
rigidity and may induce lateral pressure on the protein [335].
Importantly, some lipids facilitate protein function through explicit interactions.
For instance, cholesterol and phosphatidylinositol (PIP) lipids are tied to specific
conformational states of G-protein coupled receptors [336], and PIP lipids facilitate
dimerization of Bruton’s tyrosine kinase [337]. These biological examples suggest that
an exclusively implicit representation may not always be appropriate. One solution
is a hybrid implicit-explicit model, such as the Highly Mobile Membrane Mimetic
(HMMM) [131] that represents head-groups explicitly and the hydrophobic core
implicitly. An alternate path is to leverage the framework developed by Labonte et al.
[338] to represent a few lipids explicitly. Most likely, both implementations may be
useful.
Biological membranes also exhibit changes in morphology: rather than a rigid slab,
the bilayer can curve, bend, stretch, and compress in response to the environment
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[339]. An important future direction is to consider these changes during structure
prediction and design. First, membrane proteins sculpt the lipid bilayer, such as the
sodium-aspartate symporter reshaping the bilayer during conformational change
[340] and rows of F-ATPase dimers forming christea in the inner mitochondrial
membrane [341]. In these cases, evaluating hydrophobic mismatch may help tune
the shape of the implicit membrane model. Second, mechanical properties of the
bilayer also affect the protein. For instance, gramicidin dimerizes upon changes
in hydrophobic thickness [342] and mechano-sensitive channels open and close in
response to osmotic stress [133]. To address this challenge, several elasticity models
have been proposed [24]. Yet, previous work has also demonstrated that implicit
elastic models are insufficient to reproduce experimental results [135]. This suggests
the possible importance of a hybrid implicit-explicit model.
A prevailing question in membrane protein structural biology is how mimetics
used for structure determination alter the native structure. Recent work has high-
lighted differences between structures of the same protein determined by X-Ray
crystallography and NMR spectroscopy [343]. Accordingly, structural integrity can
be preserved in membrane mimetics, yet function may be compromised [344]. Could
parameters be derived to differentiate features of mimetics such as micelles, bicelles,
and nano-discs? A possible application is to use refinement protocols to resolve
structural differences invoked by mimetic environments. These models may lead
us toward a better understanding of membrane protein structures in their natural
environments.
Another important area to examine is the generalizability of the biologically
realistic implicit membrane model. In Chapter 2, I compared the performance of
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franklin2019 with implicit membrane models already implemented in Rosetta. How-
ever, there are alternate implicit models in several molecular modeling packages.
One technical challenge is that modeling packages choose different atom and residue
parameters. For instance, a tyrosine and serine hydroxyl group may be equivalent to
one package but not the other [61]. Recently, the Open Force Field project has sug-
gested new tools for resolving such differences [163]. Adopting these techniques may
facilitate comparisons, enabling a critical evaluation of membrane models outside the
context of a particular program.
Finally, energy functions can only be as accurate as available experimental vali-
dation data. This principle poses a special challenge for membrane protein energy
functions due to sparse data. Recent advances in biophysical techniques and structure
prediction have increased the number of thermodynamic measurements [345] and
known structures. Nonetheless, critical future work involves considering how to
better leverage existing experimental data and obtain new data points. An important
direction is to collaborate with experimentalists to design experiments for direct en-
ergy function calibration. Another area is to apply meta-, active- or transfer learning
to appropriately leverage sparse data. These techniques have been successfully ap-
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